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Abstract
The reactions catalyzed by the de novo purine enzymes Formylglycinamide
Ribonucleotide Amidotransferase (FGAR-AT), Aminoimidazole Ribonucleotide
synthetase (AIR synthetase) and Aminoimidazole Ribonucleotide Carboxylase (AIR
carboxylase) have been examined, using a variety of techniques, in an attempt to provide
evidence for, trap and characterize intermediates on the reaction pathway.
Evidence for the proposed phosphorylated enzyme and/or substrate intermediates of both
E. coli and chicken liver FGAR-AT was sought using positional isotope exchange (PIX).
Exchange reactions run in the presence of substrate FGAR, or with enzyme inactivated by
either iodoacetate or azaserine, a glutamine analog affinity label, afforded no positional
exchange for either enzyme. A kinetically competent ATP/ADP exchange was observed
for the chicken liver enzyme, confirming that a possible protein phosphorylated
intermediate exists for this enzyme In addition, it was established that the enzyme-
FGAR-ATP complex formed by chicken liver FGAR-AT is chemically competent.
No conclusive evidence was found for the existence of a phosphorylated enzyme or
substrate intermediate in the reaction catalyzed by E. coli AIR synthetase. This enzyme
does not catalyze an ATP/ADP exchange, nor is PIX observed. Rapid quench
experiments, designed to trap and hydrolyze the proposed aminoimidazole ribonucleotide
(AIR) phosphorylated intermediate, show that both phosphate and AIR are initially
produced in an enzyme dependent burst. This finding is consistent with either the
buildup of a cyclic, phosphorylated intermediate on the enzyme, or a mechanism in which
product release is rate limiting. AIR synthetase was found to undergo time dependent
inactivation when incubated with fluorosulfonylbenzoyl adenosine (FSBA), an ATP
analog. ADP affords protection against inactivation. FSBA forms a covalent adduct with
AIR synthetase, and only one adduct per enzyme is necessary to completely inactivate the
enzyme. Enzyme inactivated with [14 C]FSBA was cleaved with trypsin and the
radioactive labeled peptide was isolated. The covalent FSBA adduct was found to occur
only at lysine-27. Subsequent site-directed mutations at this site yielded enzymes that
show increased V/K parameters compared the wild type enzyme.
Finally, the reaction catalyzed by AIR carboxylase has been found to proceed via the N-5
carbamate of AIR. The enzyme PurK has been shown by NMR to catalyze the formation
of this carbamate, N5-CAIR, in the presence of AIR, bicarbonate and ATP. PurE has
been shown, by NMR spectroscopy and kinetic analysis, to catalyze the reversible
conversion of N 5-CAIR and CAIR. N5-CAIR has a half-life of 0.7 min at pH 7.8 and 30
°C. Thus, two new enzymatic activities and a new intermediate have been discovered in
the de novo purine biosynthetic pathway of E. coli.
Thesis Supervisor: Prof. JoAnne Stubbe
Title John C. Sheehan Professor of Chemistry
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Chapter 1
Introduction to the de novo Purine Biosynthetic Pathway
21
The de novo synthesis of purine nucleotides is accomplished by a series of
fifteen enzymes which catalyze the production of adenosine monophosphate
(AMP) or guanosine monophosphate (GMP) from 5'-phosphoribosyl-l'-
pyrophosphate (PRPP, Scheme 1.1). In eucaryotes, many of these enzymes exist
as multifunctional proteins. Since the products of this pathway are important in
a wide range of cellular functions, it is not surprising that imbalances in purine
regulation are implicated in numerous disorders, including trisomy 21 or Down's
syndrome (Fuller et al., 1962), the neurological disorder Lesch-Nyhan syndrome
(Seegmiller et al., 1967), gout (Sorenson, 1962) and urinary and bladder stones
(de Vries & Sperling, 1977). Elevated levels of the de novo purine enzymes have
been found in several types of cancer cells (Daubner & Benkovic, 1985; Elliott &
Weber, 1984; Weber, 1983). Inhibitors of these enzymes, targeting mainly the
folate and glutamine requiring enzymes, have received a great deal of attention
as candidates for chemotherapeutics (Sant et al., 1992; Beardsley et al., 1989;
Bertrand & Jolivet, 1989; Jayaram et al., 1990; Lyons et al., 1990).
The mechanism for the regulation of expression of the pur genes, those genes
encoding for enzymes of the de novo purine biosynthetic pathway, has been
recently elucidated. The studies from the laboratories of Nygaard, Smith and
Zalkin, discussed below, suggest that this regulation is predominantly at the
transcriptional level. The activity levels of the various Pur enzymes decrease as
hypoxanthine and guanine levels increase, in a process that requires the
regulatory protein PurR (Meng & Nygaard, 1990). He et al. (1990), using lacZ
fusion proteins, determined that this PurR mediated process reduces the
transcription of all pur genes (except purB) by 5 to 17-fold. Additionally, the purR
gene product was found to bind to a specific 16-base pair region overlapping the
22
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promoter sequence of each gene, termed the pur box. The PurR protein has been
isolated and characterized (Rolfes & Zalkin, 1990; Koduri & Gots, 1980), and was
determined to have a Kd of 1.7 p.M and 7.1 gM for guanine and hypoxanthine,
respectively. PurR with co-repressor bound has an apparent Kd of 3.4 nM for the
pur box of the purF promoter.
The enzymatic reactions and intermediates along the pathway were largely
characterized in seminal experiments by Buchanan and co-workers in avian
systems in the 1950s and 1960s (Buchanan & Hartman, 1959). They have since
been found to be conserved in species ranging from bacteria to humans. The de
novo purine biosynthetic pathway proposed by Buchanan and co-workers has
remained essentially unchanged for thirty years. However, within the last year,
three new enzyme activities have been found to operate in this pathway. A new
GAR transformylase, denoted PurT, which uses formate and ATP instead of
N 10-formyl tetrahydrafolate was discovered and cloned by Nygaard & Smith
(1993), and isolated by Marlewski & Benkovic (1993). The mechanism of CAIR
formation, catalyzed by PurK and PurE, has also been found to deviate from
Buchanan's proposal, proceeding though a previously unidentified carbamate
intermediate in work described in this thesis. In addition, a great deal remains to
be discovered about the mechanisms and the structures of the individual
enzymes within the pathway. The next three chapters of this thesis describe
investigations of the mechanisms of FGAR-AT (purL) and AIR synthetase (purM).
The last chapter presents the evidence for a new intermediate and two new
enzyme activities within this pathway ("AIR carboxylase," purEK).
Formylglycinamide ribonucleotide Amidotransferase (FGAR-AT)
FGAR-AT, also known as FGAM synthetase (E. C. 6.3.5.3), catalyzes the
reaction shown in Scheme 1.2. The enzyme has been cloned from E. coli
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Scheme 1.2: Reaction Catalyzed by FGAR-AT
(Schendel et al., 1989; Sampei & Mizobuchi, 1989), B. subtilis (Ebbole & Zalkin,
1988), S. cerevisiae (Giani et al., 1991), M. thermoautotrophicum (Jenal et al., 1991), P.
chrysosporium (Alic et al., 1991) and L. casei (Gu et al., 1992). Cloning of the
human enzyme is in progress (Barnes et al., 1992). The enzymes from S.
typhimurium, chicken liver and E. coli are of similar size (Mr of 133, 135 and 135
kDa respectively). The gene sequence of E. coli FGAR-AT encodes for a protein
of Mr 141 kDa, and deletion analysis has localized the glutamine binding domain
to the C-terminus and the FGAR and binding domain to the N-terminus of the
enzyme (Sampei & Mizobuchi, 1989). All three of the above enzymes are
monomers in solution, determined either by gel filtration or ultra centrifugation
on sucrose gradients. In contrast, the enzyme from B. subtilis and L. casei are
proposed to be composed of two peptides, one containing the glutamine binding
domain (PurQ) and the other the FGAR and ATP binding sites (PurL; Ebbole &
Zalkin, 1988; Gu et al., 1992).
FGAR-AT has been purified from S. typhimurium (French et al., 1963), Ehrlich
ascites tumor cells (Chu & Henderson, 1972a), E. coli (Schendel et al., 1989) and
chicken liver (Schendel & Stubbe, 1986; Mizobuchi & Buchanan, 1968a). The
kinetic constants for enzymes from three different sources (Table 1.1), and the
kinetic mechanisms have all been determined. Chu and Henderson (1972b)
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Table 1.1: Kinetic Constants for FGAR-AT
Chicken Erlich ascites Chicken
livera E. colib tumor cellsc liverd
Km MgATP 1.2 mM 51 pM 1.5 mM 360 p.M
Km -FGAR 100 M 30 M 110 M 18 M
Km L-gln 40 M 64 giM 110 M
K + for optimal activity 60 mM 10mM
free Mg2+ for optimal
activity 20 mM 20mM
pH optimum 8.0 7.2
a Buchanan, 1973. Determined at pH 8.0
b Schendel et al., 1989
c Chu & Henderson, 1972b
d This work, chapter 2. Determined pH 7.25
concluded that FGAR-AT from Erlich ascites tumor cells proceeds through a
ping-pong mechanism which begins with glutamine binding to the enzyme,
hydrolysis of the amide and glutamate release. This is followed by ATP binding
and hydrolysis to release ADP, and then FGAR binds and chemistry occurs.
Phosphate was found to precede FGAM release. This model (Scheme 1.3)
contrasts with the kinetic mechanism proposed for chicken liver, which was
determined to be sequential, partially ordered, with glutamine binding first
followed by random binding of the remaining substrates (Li & Buchanan,
1971a,b). The E. coli enzyme kinetic mechanism was found to be sequential
ordered, with glutamine binding first, then rapid equilibrium addition of MgATP
followed by FGAR (Schendel et al., 1989).
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Scheme 1.3: Kinetic Mechanisms for A. Erlich Ascites and B. E. Coli FGAR-AT
FGAR-AT belongs to the general class of enzymes, glutamine amido-
transferases, which all share the ability to hydrolyze glutamine and to utilize
high concentrations of ammonia as a substitute for glutamine. Sequence analysis
and studies with glutamine affinity labels have suggested that in each enzyme in
this class, a cysteine is essential for covalent catalysis (Zalkin, 1985). The
glutamine binding domain from chicken liver FGAR-AT was the initial prototype
for this class of enzymes. Buchanan and co-workers used a number of
y-substituted glutamine analogs (Li & Buchanan, 1971a) including the first
mechanism based inhibitor, azaserine (Buchanan, 1973; Buchanan, 1982, Figure
1.1) to provide information abut the role of glutamine in the delivery of an
"NH3" equivalent.
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Figure 1.1: Glutamine Analog Inhibitors of FGAR-AT
Intriguingly, FGAR-AT forms a 1:1 complex with substrate glutamine, which
can be isolated by gel-filtration chromatography. The half-life of the chicken
liver complex is 125 min at 2 oC (Mizobuchi & Buchanan, 1968b). The E. coli
complex has a half-life of 22 min at 4 OC (Schendel et al., 1989). When the E. coli
FGAR-ATgln complex was formed with [14 C]-glutamate and isolated on
Sephadex G-50, the bound radioactivity was found to co-migrate with glutamate
on cellulose F thin-layer plates using an ethanol/2-methyl-2-propanol/formic
acid solvent system. On the other hand, rapid quenching of the isolated complex
with 1M hydroxylamine and 6M guanidine hydrochloride yielded y-glutamyl-
hydroxamic acid, suggesting that the complexed glutamine exists as a thioester
or perhaps a thiohemiacetal with the active cysteine. This isolated complex,
however, when incubated with ATP and FGAR does not catalyze formation of
FGAM, indicating that it is not chemically competent (Schendel et al., 1989). This
is an unexpected result based on the postulated kinetic mechanism.
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The enzyme also forms a stable complex with ATP and FGAR; both are
required for complex formation. The chicken liver enzyme-FGAR-ATP complex
forms in a 1:0.7:0.7 ratio, with a half-life of 62 min at 2 oC. When the enzyme is
pre-treated with iodoacetate before incubation with ATP and FGAR, the half-life
of the complex is increased to 340 min. A similar experiment using azaserine to
inactivate FGAR-AT reduces the complex half-life to an estimated 18-20 min
(Mizobuchi et al., 1968).
Mechanistic studies to ascertain the role of ATP in this reaction have been
accomplished by Schrimsher et al. (1989). Incubation of [18 0-C2]FGAR, ATP
and glutamine with FGAR-AT produced a stoichiometric amount of 18 OPO3-3.
One interpretation of these results is that the reaction proceeds through a FGAR-
phosphorylated species such as the one depicted in Figure 1.2.
2
- O 3 PO
H
-- .. ,N .H
O
HO OH
Figure 1.2: Postulated FGAR-Phosphorylated Species in FGAR-AT Reaction
Our interest with this enzyme is directed at determining the mechanistic
details of the catalytic mechanism. Specifically, we are interested in further
analyzing the chemical and kinetic competence of the enzyme-FGAR-ATP
complex and probing for the existence of enzyme as well as substrate
phosphorylated intermediates. The results of these experiments are presented in
Chapter 2.
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5-Aminoimidazole ribonucleotide Synthetase (AIR synthetase)
AIR synthetase, the fifth enzyme in the de novo purine biosynthetic pathway
(E. C. 6.3.3.1), catalyzes the cyclization of the amidine FGAM (Scheme 1.4) to
produce the aminoimidazole ribonucleotide AIR. This process, as in the case of
FGAR-AT, also requires ATP.
180
kk,
2- O3PO° AIRsynth 2-Po
;~~~ .""
ATP AD18P3 -HO H P 3 HO OH
FGAM AIR
Scheme 1.4: Reaction Catalyzed by AIR synthetase
The enzyme was partially purified from pigeon liver in 1963 by Flaks and
Lukens, and was later purified to homogeneity from chicken liver (Schrimsher et
al., 1986a) and E. coli (Schrimsher et al., 1986b). The kinetic parameters for the
two enzymes are amazingly similar. The kinetic mechanism for the E. coli
Table 1.2: Kinetic Constants for AIR synthetase
Chicken E. coli
Km ATP 65 WiM 78 iM
Km FGAM 27 4lM 9 BM
pH optimum 7.8 7.7
enzyme has been determined to be sequential ordered, however the mechanism
for the chicken liver enzyme remains ambiguous. Both enzymes form 180P03-3
when incubated with 180 labeled FGAM at the formyl oxygen (Scheme 1.4).
These experiments suggest that the reaction catalyzed by AIR synthetase
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proceeds through an AIR-phosphorylated intermediate in a mechanism similar
to FGAR-AT. (Fig 1.3).
2-
Figure 1.3: Postulated FGAM-Phosphorylated Species in the
AIR synthetase Reaction
Although the kinetic and mechanistic characteristics of chicken liver and E.
coli AIR synthetase are similar, the primary and quaternary structures of these
two proteins are very different. AIR synthetase from E. coli exists as a dimer of
identical subunits, each with an Mr of 38,500 Da (Schrimsher et al., 1986b). In
contrast, the enzyme from chicken liver was determined by SDS-PAGE to have
an Mr of 110,000 Da, a reflection of the fact that the chicken liver enzyme is
actually a tri-functional polypeptide containing in addition glycinamide
ribonucleotide (GAR) synthetase and GAR-transformylase (Daubner et al, 1985).
The quaternary structure of this protein is ambiguous, as sucrose gradient ultra
centrifugation experiments suggest that the protein exists as a monomer but gel
filtration chromatography indicates the native molecular weight of the protein is
330,000. It was subsequently discovered that both murine (Caperelli, 1989) and
human AIR synthetases (Chang et al., 1991) are also expressed as a GAR
synthetase-AIR synthetase-GAR-TF fusion. The drosophila enzyme is
constructed as a GAR synthetase-AIR synthetase-AIR synthetase-GAR-TF fusion,
due to an apparent gene duplication (Henikoff, 1986). In yeast AIR synthetase is
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part of a bifunctional enzyme, and is expressed in both S. pombe (McKenzie et al.,
1987) and S. cerevisiae (Henikoff, 1986) as a fusion protein with GAR synthetase.
Based on analysis of the gene sequence, the enzyme from S. typhimurium (Westby
& Gots, 1969), and B. subtilis (Smith & Daum, 1986) are proposed to be
monofunctional.
The proposed similarity for intermediates in the FGAR-AT and AIR
synthetase catalyzed reactions is intriguing. It is also noteworthy that none of
the well defined ATP binding motifs are shared by these two enzymes, based on
sequence searching (Saraste et al., 1990). Work described in chapter three of this
thesis describes our attempts to provide evidence for the existence of
phosphorylated intermediates (substrate and enzyme derived) along the reaction
pathway. Chapter four details the results of studies with fluorosulfonybenzoyl
adenosine, an ATP affinity label, to determine the ATP binding site of AIR
synthetase, in an attempt to define the domain responsible for catalyzing the
formation of the putative substrate phosphorylated intermediates.
5-Aminoimidazole carboxylase (AIR carboxylase)
AIR carboxylase has been investigated from a variety of procaryotic and
eucaryotic sources, and has been proposed to catalyze the conversion of AIR and
bicarbonate or CO2 to CAIR (Scheme 1.5). Early genetic studies by Gots and
co-workers revealed that two gene products, designated purE and purK, are
required for reactivity. Mutations in purE or purK result in purine auxotrophy.
However, in the case of the purK mutant, the requirements for purines could be
overcome by growth in an atmosphere enriched with CO2 (Gots et al., 1977).
This observation led to the postulate that PurE and PurK were subunits of AIR
carboxylase, and that the function of PurK was to deliver CO2 to PurE. The
enzyme from E. coli has been best characterized to date (Meyers et al., 1992). The
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in vitro reaction seems to require exceedingly high, non-physiological
concentrations of bicarbonate for activity to be observed.
03PO
ATP
NH2 H2
A5 0 3PO
ADP Pi
HO OH HO OH
AIR CAIR
Scheme 1.5: Reaction Catalyzed by "AIR carboxylase"
The purE and purK genes were recently cloned and sequenced from E. coli
(Tiedeman et al., 1989; Watanabe et al., 1989), where they exist as part of a single
operon. The operon is preceded by the purR regulatory binding site, and the
deduced Mr for PurE and PurK are 17,700 and 39,000 Da, respectively.
AIR carboxylase has also been characterized, to a lesser extent, in eucaryotes.
In yeast, loss of AIR carboxylase (ade2) activity results in the buildup of AIR and
a subsequent red coloring of mutant colonies (Strauss, 1979; Sasnauskas et al.,
1987). This simple screen has allowed the enzyme to be cloned and sequenced
from both S. pombe (Szankasi et al, 1988) and S. cerevisiae (Sasnauskas &
Janulaitis, 1992). Additionally, purE has been cloned and sequenced from HeLa
cells (Minet & Lacroute, 1990) by complementation to yeast ade2 mutants, while
chicken (Chen et al., 1990), B. subtilis and two methanobacteria purE homologs
were identified by complementation of the purK' E. coli auxotroph TX209
(Hamilton & Reeve, 1985a, b). In B. subtilis and E. coli, PurE and PurK are
expressed separately, while in yeast the enzymes are expressed as a PurEK
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fusion. Chicken and human PurE is found as part of a bifunctional protein which
contains SAICAR synthetase activity. Strikingly, no gene homologous with purK
has been found in these systems. Thus, while the chicken and methanobacterium
purE homologues can each overcome purine auxotrophy in E. coli purK mutants,
these organisms seemingly do not require a purK homologue.
Both PurE and PurK have been overexpressed and isolated from E. coli
(Meyer et al., 1992). As in the case of the chicken liver and sheep enzyme, PurE
alone was able to catalyze the carboxylation of AIR in the presence of very high
concentrations of HCO3-. The apparent Km for AIR was determined to be 430
gM, and the Km of bicarbonate was found to be an incredible 110 mM. The
function of PurK was determined only after the serendipitous finding that the
enzyme catalyzed an AIR dependent ATPase. It was subsequently discovered
that PurK facilitated the PurE dependent formation CAIR at low (10 mM)
bicarbonate. In this PurK dependent reaction ATP hydrolysis is coupled to
stoichiometric formation of CAIR (Meyer et al., 1992).
Our thinking about the AIR carboxylase reaction was radically changed after
reading that AIR, in a non-enzymatic reaction, can form a carbamate in the
presence of high bicarbonate concentrations (Alenin et al., 1987). Furthermore,
this carbamate produces CAIR after incubation at 70 oC (Scheme 1.6, R = CH3-,
1 M HCO 3' 70 °C
nonenzymatic f I
'02CHN
Scheme 1.6: Nonenzymatic Generation of CAIR from AIR
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ribose-5-phosphate). Work described in chapter 5 of this thesis addresses the
question of whether this carbamate, formed in the non-enzymatic reaction, has
relevance to the E. coli purine biosynthetic pathway.
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Chapter 2
A Search for Phosphorylated Intermediates in the Formylglycinamide
Ribonucleotide Amidotransferase Catalyzed Conversion of
Formylglycinamide Ribonucleotide to Formylglycinamidine
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INTRODUCTION
Formylglycinamide ribonucleotide amidotransferase (FGAR-AT) catalyzes
the fourth reaction in de novo purine biosynthesis. This enzyme catalyzes the
conversion of formylglycinamide ribonucleotide (FGAR) to formylglycinamidine
ribonucleotide (FGAM). The amide nitrogen of glutamine is used to form the
amidine of FGAM, forming glutamate, while ATP is hydrolyzed to ADP and Pi
(Scheme 2.1).
0
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'1
HO OH
FGAR FGAM
Scheme 2.1: Reaction Catalyzed by FGAR-AT
The enzyme has been purified to homogeneity from S. typhimurium (French et
al., 1963), and from chicken liver by Mizobuchi and Buchanan (1968a). The
chicken liver enzyme, which is historically the best studied source of enzyme, has
an apparent monomer molecular weight of 133,000 Da by SDS-PAGE and exists
as a monomer in solution. The E. coli enzyme, recently cloned, sequenced and
purified (Schendel et al., 1989), is also a monomer in solution, and has an Mr of
135,000 Da based on SDS-PAGE analysis, 141,418 Da inferred from the gene
sequence. Neither the chicken liver or E. coli enzyme is pure as isolated; the
contaminating bands have been found to cross react with antibodies prepared
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Figure 2.1: SDS-PAGE Gels of E. Coli (A) and Chicken Liver FGAR-AT (B)
Preparations. The gels depicted are 10% acrylamide with 2.7% cross linking.
A. E. coli FGAR-AT preparations show several minor bands in addition to the
desired (top) band at 135 KDa. All lanes contain 40 gg total protein. Lane (1)
FGAR-AT after standard purification. (2) FPLC purified (3) Phenyl Sepharose
purified (4) Molecular Weight Standards (in KDa): -galactosidase ,116;
phosphorylase B, 97.4; bovine serum albumin, 66; Hen Egg Albumin, 45 and
carbonic anhydrase, 29.
B. Typical FGAR-AT Isolation from Chicken Liver. Lane (1) and (7) Molecular
Weight Standards, as 2.1A, Remaining lanes all contain 40 4g total protein: (2)
crude enzyme (3) 0-45% (NH4 )2S0 4 precipitation (4) acid treatment (5) Sephadex
A-25 (6) Sephacryl S-200.
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against FGAR-AT, and are presumed to be fragments of the enzyme (Fig 2.1).
The gene encoding for FGAR-AT, purM, has been identified in B. subtilis (Ebbole
& Zalkin, 1987) by homology to the E. coli enzyme. Enzyme from this source
differs from those discussed above in that it appears to be composed of two
peptides: PurQ (Mr 24,755) has been proposed to be the glutamine binding
domain ,and PurL (Mr 80,300) proposed to carry out the amidation reaction. The
L. casei FGAR-AT has also been inferred, by gene sequence and homology to the
B. subtilis FGAR-AT gene, to be similarly constructed (Gu et al., 1992).
The glutamine binding sites of S. typhimurium (Dawid et al., 1963) and
chicken liver (Ohnoki et al., 1977) FGAR-AT were identified and characterized
through the studies of Buchanan and coworkers using azaserine. This glutamine
analog was the first example of a mechanism based inhibitor, and was followed
by the development of other similar compounds (Buchanan, 1973; Buchanan,
1982). The affinity labels, and the proposed mechanism for their action, is shown
in Fig 2.2.
FGAR-AT is unusual as it forms a stable complex with one equivalent of
glutamine, which has a half-life at 2 OC of 125 min (Mizobuchi & Buchanan,
1968b). Additionally, the enzyme also forms a ternary complex with FGAR and
ATP which has a half-live of 62 min at 2 oC (Mizobuchi et al., 1968). The E. coli
enzyme also forms a stable complex with glutamine (tl/2 22 min at 4 oC).
Hydroxylamine trapping experiments suggest that the glutamyl moiety in this
complex exists as a thioester which is not chemically competent to perform
further catalysis (Schendel et al., 1989).
Mechanistic studies on the E. coli enzyme have demonstrated that the role
of ATP in this reaction is to facilitate loss of the amide oxygen though
phosphorylation, and activate the carbonyl toward nucleophilic attack by an
"NH 3" equivalent (Schendel et al., 1989; Satterthwait & Westheimer, 1980).
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Figure 2.2: Glutamine Analogs as Mechanism-based Inhibitors.
Affinity Labels and their Proposed Mechanism of Action.
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These studies used FGAR labeled with 180 at the C2 carbonyl (Scheme 2.1).
Analysis of the products of the enzymatic reaction revealed that [HP 160 3180]2-
was formed stoichiometrically with FGAM. This result suggests several possible
mechanisms for the reaction of FGAR-AT, two of which are shown in Scheme 2.2.
In addition to the phosphorylated substrate intermediates depicted (1,3), there
may also exist one or more phosphorylated enzyme intermediates (E-P) to
facilitate phosphoryl transfer.
9O-· O
s-f ~ATP ADP N
CJ N-<H1
R O
"NH3'
0
2 NH3'
ATP ADP
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Scheme 2.2: Proposed Mechanism for FGAR-AT
FGAR-AT is proposed to share a common mechanistic motif with a variety of
enzymes including 5-oxo-L-prolinase (Li et al., 1987), CTP synthetase (von der
Saal & Villafranca, 1985; von der Saal et al., 1986), xanthine 5'-monophosphate
aminase (XMP aminase or GMP synthetase, Fukuyama, 1966) and the fifth
enzyme in the de novo purine pathway aminoimidazole ribonucleotide (AIR)
synthetase. The XMP adenylated intermediate has been isolated (Fukuyama,
1966) and the phosphorylated intermediate has been strongly inferred for CTP
synthetase (von der Saal & Villafranca, 1985; von der Saal et al., 1986).
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We were intrigued that two sequential enzymes within the purine pathway
might share a similar mechanism, but show no sequence homology for their
putative ATP binding domains. We therefore set forth to further elucidate the
mechanisms of these enzymes, probing for both enzyme and substrate
phosphorylated intermediates. Our studies with FGAR-AT are described below,
and our studies with AIR synthetase are described in the following chapter.
MATERIALS AND METHODS
Materials. AIR synthetase (3.3 U/mg) was isolated by the procedure of
Schrimsher et al., (1986b). When TX635/pJSll19 (Inglese et al., 1990) was used for
AIR synthetase isolation the size exclusion step was unnecessary. Glycinamide
ribonucleotide (GAR) synthetase (15 U/mg; Cheng et al., 1990) and
phosphoribosylpyrophosphate (PRPP) amidotransferase (PRPP-AT, ~38 U/mg;
Rudolph, 1993) were isolated as previously described. Glycinamide
ribonucleotide transformylase (GAR-TF; 12 U/mg) was a generous gift from the
Benkovic labs. 10N-formyl dideazafolate was synthesized using the method of
Acharya & Hynes (1975), modified by Wing Hang Tong. Sephadex G-25, A-25
and Phenyl Sepharose was obtained from Pharmacia. Lactate dehydrogenase
(LDH, 860 U/mg), pyruvate kinase (PK, 470 U/mg), phosphoenolpyruvate
(PEP), bovine serum albumin (fraction V, BSA), 5'-(p-fluorosulfonylbenzoyl)
adenosine (FSBA) adenosine-5'-diphosphate (ADP) and adenosine-5'-
triphosphate (ATP) were purchased from Sigma Chemical Co. ATPT32p (6000
Ci/mmol), [1- 14C]glycine (43 mCi/mmol) and [2, 8-3H]ATP (32 Ci/mmol) were
obtained from New England Nuclear. Filters of 0.45 glm and Centricon
ultrafiltration units were purchased from Millipore Corp. HPLC C-18 columns
were purchased from Altech. The Fast Protein Liquid Chromatography (FPLC)
apparatus used was from Pharmacia. The FPLC size exclusion column was a
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Spherogel (TM)-TSK, 7.5 mm ID x 60 mm, 10, from Altex. Radioactivity was
quantified using a Packard 1500 Tri-Carb Scintillation Counter. N, N-diisopropyl
dichlorophosphite and m-chloroperbenzoic acid were purchased from Aldrich.
ATPy1804 was synthesized from iH3 1804 (Risley & Van Etten, 1978) using the
method of Wehrli et al. (1965). The syntheses of N, N-diisopropyl dibenzoyl
phosphoramidite and l'-N-(Benzyloxycarbonylglycyl)-2', 3'-O-isopropylidene-D-
ribofuranosylamine were accomplished as previously described ([Uhlmann &
Engels, 1986] and [Chettur & Benkovic, 1977] respectively).
Methods. All standard molecular biological methods were taken from
Sambrook et al. (1989) Sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) samples were prepared and run as described by
Laemmli (1970) and developed using the alternate technique described by
Cooper (1977). Protein assays used the method of Lowry (1951) with BSA (279 =
0.667, Schachman & Edelstein, 1966) as a standard. Orcinol assays for the
quantitation of reducing pentoses were performed as described (Dische, 1962)
using ATP as a standard. Phosphate assays were accomplished using the
method of Ames and Dubin (1960). Flash chromatography was performed as
described (Still et al., 1978). Dry solvents were prepared using generally
accepted laboratory procedures (Perin & Armarego, 1988), and stored over
activated molecular sieves (Burfield et al., 1978). 1H NMR chemical shifts
reported are referenced to either tetramethylsilane or the methyl peak of 1,1,1
trimethylsilyl propane sulfonic acid.
The synthesis of p-nitrophenyl formate was as described (Martinez & Laur,
1982). After two recrystallizations from EtOH the compound was found to be
96% pure (determined by NMR) with the contaminant being identified as p-
nitrophenol. Contrary to the original claims, this compound was found to be
stable at room temperature for several weeks.
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Synthesis of I '-N-(Benzyloxycarbonylglycyl)-2', 3'-O-isopropylidene-D-
ribofuranosylamine 5' dibenzylphosphate (5). This synthetic strategy is based on the
work of Boschelli et al. (1989), and is outlined in Scheme 2.3. 1H NMR spectra for
the compounds reported in this chapter can be found in Appendix A. 1'-N-
(Benzyloxycarbonylglycyl)-2', 3'-O-isopropylidene-D-ribofuranosylamine (4, 100
mg, 263 mol) was added to a 50 mL two-neck flask containing tetrazole (74 mg,
1.05 mmol) and a magnetic stir bar. The flask and contents were dried in vacuo
over P 20 5 overnight, and the reaction was carried out the next morning under
dry argon. Dried methylene chloride was transferred to the flask by cannula (10
mL) and stirring was initiated. The solid contents did not completely dissolve.
The phosphorylating agent, N, N-diisopropyl dibenzoyl phosphoramidite in 2
mL CH2Cl2, was transferred dropwise to the stirring reaction mixture at room
temperature over five min. The mixture was stirred for two h, during which time
the insoluble matter partially dissolved. The reaction mixture was cooled to -40
oC in a dry ice/acetone bath. The oxidant m-chloroperbenzoic acid (50-60%
pure, 223 mg, 710 pLmol) was dissolved in 2.7 mL CH 2C12 and added dropwise to
the reaction mixture over three min. The reaction was warmed to 0 °C in an
ice/water bath and stirred an additional 45 min. Workup consisted of washing
the reaction mixture with the following: 2 x 10 mL 10%(w/v) Na2SO3, 2 x 8 mL
10% (w/v) NaHCO3, 8 mL H 20 and 8 mL saturated NaCl solution. The organic
layer was dried over Na2SO4 and concentrated to a sticky oil in vacuo.
Purification was effected using flash chromatography in 10:1 EtOAc/CH 2C12.
1H-NMR 250 MHz (CDC13): 6 7.45 (broad, 1H, amide Cl'), 7.3 (s, 15H, aromatic),
5.86 (broad, 1H, amide-CBz), 5.70 (d, J = 7.6, 1H, Cl'), 5.12, (s, 2H, CH2-CBz), 5.06
(m, 4H, PO-CH2-Ph), 4.48 (overlapping, 2H, C2', C3'), 4.26 (m, 1H, C4'), 4.02 (m,
2H, C5'), 3.83 (m, 2H, C3), 1.52 (s, 3H, CH3 acetal), 1.30 (s, 3H, CH3 acetal). Yield
89% by weight.
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Deblock to 2', 3'-O-isopropylidene-1 '-N-(glycyl) -D-ribofuranosyl-amine 5'
phosphate (6). The blocked GAR nucleotide 5 (27.5 gmol by phosphate assay) in
500 gL EtOAc was added to a flat bottomed, screw top tube with 2 mg 10%
Pd/C, and potassium phosphate buffer (1 M, pH 7.2, 500 iL) was added. The
mixture was placed in a Parr hydrogenator, flushed three times with H 2 gas,
shaken under 2 atm (30 psig) H2 for 60 min, and then the catalyst was removed
by filtration. The filter cake was washed with 3 x 0.5 mL water. Filtrate and
washings were combined and brought to dryness in vacuo. This material was
exchanged in 3 x 500 gL D 20 and a 1H NMR was taken (300 MHz, D 20): 6 5.70
(d, J= 2.1, 1H, C'), 5.05 (d, J = 6.3, 1H, C3'), 4.86 (dd, J = 6.3, 2.1, 1H, C2'), 4.49 (d, J
= 2.1, 1H, C4'), 3.8-4.0 (overlapping, 4H, C5', C3), 1.57 (s, 3H, CH3 acetal), 1.40 (s,
3H, CH3 acetal).
Deblock to Wc/3 GAR (Z). To compound 6 (1.4 mmol) was added 44 mL 1:1
(v/v) Dowex 50W-8X (H+) in water. The mixture was swirled in an oil bath (65-
70 OC) for one h. The resin was then filtered off and washed with 5 x 10 mL H20.
Combined filtrate and washings were dried in vacuo and exchanged as above.
1H-NMR 300 MHz (D 20): 6 5.80 (d, J = 4.7, 0.2 H aC1'), 5.52 (d, J = 5.4, 0.8 H,
[C1'), 4.29 (overlapping, 2 H, C2', C3'), 4.13 (m, 1 H, C4'), 3.8-3.9 (overlapping, 4
H, C5', C3). The yield of 5-GAR was determined using GAR synthetase, and alp
GAR was calculated using 1H NMR. Yield (for both steps) was 87% (a/fGAR).
Synthesis of a/3 FGAR. WAc/ GAR (7, triethylamine salt, 100 nol) was placed
in a 5 mL pear shaped flask, then dried in vacuo over P20 5 overnight. Dimethyl
formamide (DMF, 500 gtL), which had been dried over CaH2 and freshly distilled
in vacuo (bp = 34 O C), was added. Solid p-nitrophenylformate was also dried in
vacuo over P205 overnight, and used to make a 2 M solution (0.193 g in 579 pL) in
anhydrous DMF. From this stock, 1 mmol was added to the above GAR
containing solution as it stirred at 0 oC. The final addition was diisopropyl
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ethylamine (100 gL, 1 mmol) which had been freshly distilled from P 20 5 . The
now bright yellow mixture was stirred at 0 OC for one h. The mixture was
diluted to 100 mL in cold water and titrated from pH 5.7 to 7.3 with 1 M NaOH.
The solution was loaded onto a column of A-25 DEAE Sephadex (bicarbonate
form, 2.5 x 12 cm). After washing with 100 mL of water the product was eluted
with a 400 x 400 mL, linear gradient of 0 to 400 mM TEAB. Fractions were
assayed by the orcinol assay, and those containing a/-FGAR were pooled,
extracted with 4 x 100 mL Et2O (until the yellow color was removed) and the
aqueous solution concentrated in vacuo. P-FGAR concentration was determined
using the Bratton-Marshall assay (below). 1H NMR (300 MHz, D20): 6 8.19 (s, 1
H, formyl), 5.74 (d, J = 4.7, 0.4 H, aCl'), 5.48 (d, J = 5.4, 0.6 H, PC1'), 4.26 (dd, J =
4.5, 4.2, 1 H, C2'), 4.19 (dd, J = 5.4, 5.1, 1 H, C3'), 4.12 (m, 1 H, C4'), 4.03 (s, 2 H,
C3), 3.91 (m, 2 H, C5'). Yields were calculated as an ac/ mixture using NMR
data. An average yield for three syntheses was 42 + 4%. alW ratios ranged from
80:20 to 60:40.
Substrate Assays. The concentration of -FGAR was determined using the
Bratton-Marshall assay as modified by Schendel & Stubbe (1986). All FGAR
concentrations reported are for the 3 anomer only, even though FGAR is used as
an cal mixture (40:60). The concentration of D-GAR was determined with an
endpoint coupled enzyme assay which employs the reversibility of GAR
synthetase, described by Cheng et al. (1990)
Enzyme Assays. In all cases one unit of enzyme activity is defined as the
amount of enzyme necessary to produce one pmol of product in one min at
37 oC, unless indicated otherwise. FGAR-AT was assayed using a mixture
containing 50 mM Hepes (pH 7.25), 20 mM MgC12, 80 mM KC1, 2 mM ATP,
2 mM L-gln, 0.15 mM 3-FGAR, 0.01 U AIR synthetase and 0.5 - 2.5 x 10-3 U
FGAR-AT in 300 gL. After incubating the reaction at 37 oC for 5 min, AIR
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production was determined using the Bratton-Marshall assay (Schendel &
Stubbe, 1986; Schrimsher et al., 1986a). ADP production was determined
spectrophotometrically using the PK/LDH coupled assay or Pi extraction
techniques described by Schrimsher et al. (1986a)
Enzymatic Synthesis of [2-14C]f-FGAR. The reaction mixture contained, in a
final volume of 5 mL: 100 mM TrisCl (pH 7.5), 4.2 mM N 10-formyldideazafolate,
21 mM L-glutamine, 2.5 mM ca-PRPP, 3.4 mM [1- 14C]glycine (S.A. 1.0x10 6
cpm/pmol), 5.7 mM ATP, 20 mM MgC12, 8 mM PEP, 2 mg/mL BSA, 10 mM KCl,
10 units PK, 0.84 units GAR-TF, 0.95 units GAR synthetase and 0.95 units
PRPP-AT. The mixture, minus enzymes, was carefully titrated to pH 7.5 and pre-
incubated at 37 OC for five min. When the enzymes were added, PRPP-AT was
added last to initiate the reaction, which was typically incubated for 135 min at
37 OC, at which time it was diluted to 50 mL with cold water and loaded onto an
A-25 DEAE Sephadex column (2.5 x 10 cm, HCO3 - form) in water. After washing
the column with 50 mL water, the column was developed with a 500 x 500 mL
linear gradient of TEAB from 0 to 400 mM. Fractions were collected and 75 gL of
every other fraction was analyzed by scintillation counting. A single peak,
eluting at 200 mM TEAB was detected. Appropriate fractions were pooled and
the solvent removed. An endpoint Bratton-Marshall assay indicated an isolated
yield of 50% -FGAR from PRPP.
Purification of E. coli FGAR-AT. The enzyme was isolated as described
(Schendel et al., 1989). Enzyme could be further purified using either size
exclusion FPLC or hydrophobic chromatography. Although these techniques
removed contaminating ATPases, no noticeable increase in specific activity was
observed in either case.
(A) Purification of E. coli FGAR-AT Using Size Exclusion FPLC. FGAR-AT (100
pL, 6 mg, 13 units) was injected onto an FPLC size exclusion column equilibrated
54
in 50 mM potassium phosphate (pH 6.5), 1 mM EDTA, 5 mM DTT and 5 mM
-mercaptoethanol (ME). The single protein peak, as determined by A280, was
pooled and concentrated over a Centricon-30 membrane affording a 50-70%
recovery of units.
(B) Purification of E. coli FGAR-AT Using Hydrophobic Chromatography. A
column of degassed Phenyl Sepharose (0.7 x 4.5 cm) was equilibrated with 50
mM potassium phosphate (pH 6.8), 1 mM L-gln, 6 mM P-ME buffer brought to
20% saturation with (NH4 )2SO4 (114g/L). FGAR-AT (15 units, 6 mg, 100 pL) was
also brought to 20% saturation in (NH4)2S04 and loaded onto the column, which
was washed with 10 mL each 20% (NH4 )2SO4 and 10% (NH4)2S04 saturated
buffer. The protein eluted after washing in buffer free of ammonium sulfate.
Concentration over a Centricon-30 membrane afforded purified protein in >90%
yield.
Purification of Chicken Liver FGAR-AT. Enzyme was purified using the
procedure of Schrimsher et al. (1986a), incorporating both hydroxylapatite
(Biorad) and Sephacryl S-200 sizing columns. This procedure yielded protein
that was ~80% pure by SDS-PAGE with a specific activity of 0.8-1.0 U/mg. The
enzyme was further purified by injecting 1 mg (2 units, 500 AL) onto a Mono
QTM FPLC equilibrated in 10 mM potassium phosphate (pH 7.2), 1 mM L-
glutamine, 1 mM EDTA, 10% (v/v) glycerol and 5 mM 5-ME. The peak of
interest, which eluted in the void, was identified by activity assays, pooled and
concentrated in a Centricon-30. This procedure did not change the specific
activity, but did remove the ATPase present in the preparations. Recovery of
units for purification by FPLC ranged from 60-70%, giving protein with an
ATPase of 0.05% of the normal reaction.
Determination of KmATp and KmFGARfor Chicken Liver FGAR-AT. Reactions
were run in 50 mM HEPES (pH 7.25), 20 mM MgC12, 80 mM KC1 and 2 mM L-gln
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with 1 mM PEP, 0.2 mM NADH and 10 U each of PK and LDH. When
determining KmATP, 0.2 mM 3-FGAR and 1.4x10-2 units FGAR-AT were
included in a 500 gL reaction volume. KmPFGAR was determined using 10 mM
ATP and 8.4x10-3 units FGAR-AT in a 1 mL reaction volume. Reaction rates were
measured by monitoring the change in A340 using a Cary 210 spectrometer. Data
were analyzed using the programs of Cleland (1979).
ATP/ADP Exchangefor (Chicken Liver) FGAR-AT. Initial experiments were
identical to those of Mizobuchi et al. (1968). Reactions contained 20 mM
potassium phosphate (pH 7.4), 1.6 mM [8-14C]ADP (SA 2.4 x 106 cpm/upmol), 1.6
mM ATP, 3.3 mM MgC12, and 0.0035 units FGAR-AT in a final volume of 300 jiL.
A separate set of reactions were carried out, which were identical to those above
expect that 0.3 mM -FGAR (ca mix) was included. Aliquots (30 gL) were
removed at 0, 3, 6, 9, 12, 15, 30 and 45 min and quenched into 20 p.L of 25 mM
EDTA (pH 7.4), then frozen in liquid N 2. Samples were diluted to 210 4L with 50
mM sodium phosphate (pH 6.5), 12.5 mM Bu4NBr, and analyzed using ion
pairing HPLC on an Altex C18 column (see Materials) equilibrated in 50 mM
sodium phosphate (pH 6.5), 12.5 mM Bu4NBr and 12% (v/v) methanol. Using
this system ADP eluted at 7.5 min and ATP eluted at 11 min. Fractions
containing ATP were collected and analyzed by scintillation counting.
Further experiments were done to see if the ADP/ATP exchange was
dependent on nucleotide concentration and enzyme concentration. Reactions
were carried out in 300 L and contained 20 mM potassium phosphate (pH 7.2),
2 mM MgC12, 0.11 or 0.22 units FGAR-AT and ADP/ATP in a 1:1 ratio, each at
concentrations of 0.18 mM, 0.36 mM and 0.72 mM ([8-14C]ADP SA = 2.4x106
cpm/tmol). After initiating with enzyme, 30 gL aliquots were removed at 0, 10,
20, 30, 40, 60, 90, 120, and 180 min, quenched and worked up as above. HPLC
analysis was as above except 18% methanol was used. With this system ADP
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eluted at 7 min and ATP eluted at 10.5 min. FGAM production of the enzyme
under these exchange conditions was measured using the Bratton-Marshall
assay.
Formation of (Chicken Liver) Enzyme.FGAR ATP Complex: Determination of Half
Life and Maximal Binding Stoichiometry. Reaction mixtures contained 100 mM
potassium phosphate (pH 6.5), 0.14 mM [2-14C] O-FGAR (1.2x10 6 cpm/gtmol),
2 mM [2, 8-3H]ATP (1.2x10 7 cpm/kmol), 6 mM MgC12 and either 7.7 or 6.7 gM
FGAR-AT (0.84 U/mg) in a final volume of 300 gIL. After 5 min at 37 oC, the
mixtures were loaded onto separate G-50 Sephadex columns (0.7x23 cm) at 4 OC
equilibrated in 100 mM potassium phosphate (pH 6.5), 5 mM MgC12. The height
of the reservoir of each column was adjusted in order to have columns which
could be eluted with an array of flow rates varying from 0.07 - 1 mL/min.
Fractions were collected using time, such that fraction volumes varied from 420-
550 gL depending on the experiment, and column profiles were generated by
A280. The eight fractions centered around the protein peak were analyzed using
the dual isotope counting method described by Cooper (1977) to determine the
amount of 14C and 3H species bound with protein. Protein was determined by
the method of Lowry.
Determination of the Composition of (Chicken Liver) Enzyme.FGAR ATP Complex:
Is it chemically competent? FGAR-AT was exchanged into 100 mM potassium
phosphate (pH 6.5), 5 mM MgC12 using a G-50 column, to remove glutamine.
Incubation mixtures contained 100 mM potassium phosphate (pH 6.5), 0.4
mM [2-14C]j-FGAR (SA 1.6x106 cpm/lmol), 3.6 mM [2, 8-3H]ATP (SA 8.2x106
cpm/pmol), 6 mM MgC12 and FGAR-AT (4.6 nmol) in a final volume of 300 [IL.
After five min at 37 OC the entire mixture was loaded onto a column of G-50
Sephadex (0.75x20 cm) equilibrated in 100 mM potassium phosphate (pH 6.5),
5 mM MgC12 at 4 OC. Elution was effected at 0.2 mL/min collecting 0.5 mL
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fractions. Fractions were assayed for protein content by A2 80, and the two
fractions containing protein were used for further experiments.
From each protein containing fraction two 200 L aliquots were removed.
One of these aliquots was brought to 2 mM L-gln using a 200 mM L-gln stock,
then both aliquots were incubated at 37 oC for 5 min and frozen in liquid N2.
Frozen samples were thawed, and brought to 5 mM TBAB using a stock 500 mM
solution, then were injected (200 IL) onto an ion pairing HPLC system using a
C18 column equilibrated in 50 mM potassium phosphate (pH 6.5), 5 mM TBAB at
1 mL/min. The column was eluted isocratically for 10 min and then with a
gradient from 0 to 20% methanol from 10 to 20 min. The column was then eluted
isocratically at 20% CH3OH for 30 min. This procedure effected baseline
separation of FGAM (4 min), FGAR (9 min), ADP (35 min) and ATP (41 min).
The remainder of the original enzyme-ATP-FGAR sample was used to determine
protein concentration. Fractions were collected and quantitated by scintillation
counting.
Inactivation of Chicken Liver FGAR-AT. Inactivations were based on previous
work done by Mizobuchi et al. (1968).
(A) Iodoacetate Inactivation. Iodoacetate was recrystalized twice from
chloroform (mp 79-80 OC), carefully weighed out and dissolved in 50 mM
potassium phosphate. These solutions were titrated before use to pH 6.5 using
1 M KOH. Inactivation mixtures of 45 L contained either 50 mM potassium
phosphate (pH 6.5), 2.1x10-2 units FGAR-AT and ICH 2CQ2H or 50 mM
potassium phosphate (pH 6.5), 0.26 mM 0-FGAM, 4 mM ATP, 12 mM MgC12,
2.1x10-2 units of FGAR-AT and ICH2CO2H from 0.4 to 20 mM. Aliquots of 5 pLL
were withdrawn at various times (1 - 20 min) and placed into 300 1L FGAR-AT
assay solutions in which inhibitor was diluted 60-fold in the presence of 2 mM
glutamine. FGAM production was determined using the Bratton-Marshall assay.
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(B) Azaserine Inactivation. Azaserine was dissolved in 50 mM potassium
phosphate, titrated to pH 6.5, and it's concentration was determined using
£250=19,500M-lcm- 1. Reactions investigating the rate of azaserine inactivation of
FGAR-AT were carried out at 37 °C in a final volume of 45 gL, and contained
50 mM potassium phosphate (pH 6.5), 0.06 - 1.0 mM azaserine and were initiated
with 2.3x10-2 units of FGAR-AT. Aliquots of 5 gL were removed at various times
and placed into 300 gL FGAR-AT assay mixtures, in which inhibitor was diluted
1/60 in the presence of 2 mM L-glutamine. FGAM production was determined
as above.
Iodoacetate Inactivation of E. coli FGAR-AT. A stock solution was made as
above to give 20 mM iodoacetate. Inactivations were run at 37 OC in 50 mM
potassium phosphate pH 6.5 in a final volume of 30 IL. Some inactivations were
run only with phosphate buffer, iodoacetate and enzyme. The majority were run
in buffer also containing 20 mM MgC12, 1 mM ATP and 0.19 mM -FGAR.
Aliquots of 3kL were removed at 0, 3, 5 and 10 min and placed into standard
FGAR-AT assay mixtures. After 5.25 min these assays were quenched and
FGAM production determined.
Azaserine Inactivations of E. coli FGAR-AT A stock solution of 9.3 mM
azaserine was made and assayed as above. Inactivations were accomplished at
37 oC and contained, in 30gL, 50 mM potassium phosphate (pH 6.5), 0.1 - 8.3 mM
azaserine and were initiated with 3 x 10-2 units FGAR-AT. At 0, 3, 5, and 10 min
aliquots of 3 IgL were removed and placed into 300 gL FGAR-AT assay mixtures,
diluting the inhibitor 1/100 into 2 mM L-glutamine. FGAM production was
quantified as above.
Analysis of Inactivation Experiments. Inactivation of FGAR-AT was assumed to
proceed via the model depicted in Scheme 2.4, in which inhibitor binds in a
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E+I Kin E-I k2 E-I*
Scheme 2.4: Model for Irreversable Enzyme Inactivation
reversible process followed by an irreversible inactivation (Foster et al., 1981) to
fit Equation 2.1. The equilibrium and rate constants reported below are defined
log (E/Eo) = -(kobs/2.303) x t Equation 2.1
in Scheme 2.4. A double reciprocal plot of the apparent rate constant (kobs) for
inactivation versus inactivator concentration (I) gives a straight line defined by
the equation:
1/kobs = (Ki/k 2) (1/I) + 1/k 2 Equation 2.2
Positional Isotope Exchange (PIX) Experiments. These experiments were based
on von der Saal et al. (1985).
(A) PIXfor (E. coli) FGAR-AT with ATP and FGAR. PIX reactions contained 50
mM HEPES (pH 7.25), 20 mM MgC12, 80 mM KC1, 6.6 mM ATPy180 4 (20%J803)
and 0.82 mM -FGAR in a final volume of 1.42 mL. After a five min pre-
incubation at 37 OC, a zero time sample of 250 gL was withdrawn and quenched
into an Eppendorf tube containing 50 gL 50 mM HEPES (pH 7.25), 100 gL CC14
and 500 gL of a 600 mM CHES, 500 mM EDTA (pH 9.0) solution. The quenched
sample was then subjected to centrifugation at 11,000 x g for 30 s, resulting in a
biphasic mixture with precipitated protein at the interface. A 750 pL sample was
taken from the top (aqueous) layer, frozen in liquid nitrogen and was stored at
-20 0C. The remaining PIX reaction mixture was then initiated with addition of
10.2 units (SA=2.0 U/mg) FGAR-AT. Aliquots of 300 pL were removed at 5, 10,
15, and 20 min and quenched into CHES/EDTA/CC14 as above. Samples were
stored frozen at -20 o C until NMR analysis was possible.
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(B) PIXfor (E. coli) FGAR-AT and ATP. PIX reactions contained all the
components above, except for FGAR, in a final volume of in 1080 pgL. The
reaction was run as described above, and samples were removed at 0, 5, 10, 15,
and 20 min. Samples were stored at -20 oC until workup for NMR.
(C) PIX of (Chicken Liver) FGAR-AT with ATP and FGAR. These reactions
contained 50 mM HEPES (pH 7.25), 20 mM MgC12, 80 mM KC1, 6.6 mM
ATPy1804 (35% y1803) and 0.51 mM ,-FGAR in a final volume of 1465 gL. After
a 5 min pre-incubation at 37 oC, a zero time sample (250 gL) was withdrawn,
quenched, frozen and stored as above. The PIX reaction was then initiated with
2.1 units of FGAR-AT (SA 1.4 U/mg), and aliquots of 300 gL were removed at 5,
10, 15, and 20 min and quenched as above. Samples were stored frozen until
workup for NMR spectroscopic analysis. This experiment was repeated using a
reaction mixture of 1150 gIL containing the components above, but with 1.14 units
of FGAR-AT (SA 1.0 U/mg). Samples were removed at 0, 20, 40 and 60 min,
quenched and stored at -20 oC until NMR analysis.
(D) PIXfor (Chicken Liver) FGAR-AT with ATP. The reaction mixtures were
identical to those above, except FGAR was omitted. The reaction contained 1.9
units of FGAR-AT. Samples were collected at 0, 5, 10, 15, and 20 min, quenched,
and stored at -20 C until analyzed.
(E) PIX with (Chicken Liver) FGAR-AT Previously Inactivated with Iodoacetate and
Azaserine. FGAR-AT (S. A. 0.34 U/mg) was used in these experiments without
FPLC purification. The enzyme was exchanged into 20mM potassium phosphate
pH 6.5 using a column of Sephadex G-25 (lx10 cm), then concentrated over a
Centricon-30. This stock was assayed for activity (Bratton-Marshal)l and protein
(Lowry), then split into two equal portions. One half (0.76 units) was inactivated
with 1.8 mM azaserine in 213 [tL 20 mM potassium phosphate (pH 6.5) for 20 min
at 37 OC. The other portion was inactivated with 0.94 mM ICH 2CO 2H, 0.27 mM
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j-FGAR, 3.7 mM ATP and 11.3 mM MgC12 in 213 pgL 20 mM potassium
phosphate (pH 6.5) for 20 min at 37 oC. Each sample was exchanged into 20 mM
potassium phosphate (pH 6.5) using a Sephadex G-25 (1x7 cm) column. Protein
containing fractions were identified (A 280) and concentrated over a Centricon-30
membrane. Each sample was assayed for activity (32Pi extractions), ATPase
using ATP 2P and the Pi extraction assays (Methods), and protein content
(Lowry). Under these conditions, both samples retained only -1% of their
original activity.
PIX reactions contained 50 mM HEPES (pH 7.25), 20 mM MgC12, 80 mM KC1,
6.6 mM ATPy180 4 (13.6%y1803) and 0.25 mM P-FGAR in a final volume of 900
gL. Azaserine inactivated FGAR-AT (1.2 mg, 0.42 units before inactivation) was
added to one reaction mixture. The other reaction contained iodoacetate
inactivated protein (1.0 mg, 0.34 units before inactivation) in a final volume of
600 gL. One zero point was taken for the two reactions before enzyme was
added. Each reaction was initiated by addition of the inactivated protein
samples described above, and 300 gL aliquots were removed at 10 and 20 min,
quenched and stored at -20 o C until NMR spectroscopic analysis occurred.
(F) NMR Analysis of PIX Experiments. Samples were thawed during
centrifugation at 11,000 x g for 10 min at 4 OC a few hours before analysis. NMR
grade d6-acetone was added to each sample to 20% v/v as a lock solvent and
samples were passed through a 0.45 gm filter to remove particulate matter. Two
types of spectrometer were used: Varian XL-300 and Varian VXR-500 which
record 31p spectra at 121 and 202 MHz, respectively. For the XL-300, a pulse
width of 10 ms was used with a sweep width of 5 KHz and an acquisition time of
2 s. With the VXR-500, a sweep width of 15 ms was used with a sweep width of
8080 Hz and an acquisition time of 2 s. Spectra were not proton decoupled. For
each sample the probe was tuned and the shims optimized, then an external
62
standard consisting of a sealed capillary containing 85% H 3P0 4 in a 20%
d6-acetone/H20 was used to set the window (sweep width). Spectra of 2000
scans were accumulated, and integrations were used to determine
ATPyl803/ATPy80 4 ratios.
Vpix was determined using the equations set forth by Rose (1979), which fit
the first order PIX reaction:
-In I 1-F I = V* t Equation 2.2
[ATP]
where V is the rate of exchange (Vpix), t is time, [ATP] stands for the
concentration of ATP used in the reaction and F is the fraction that the reaction
has progressed toward completion. Mathematically, F is defined as:
F = (pmol ATPyl 803)t - (gmol ATPyf803)t0 Equation 2.3
(pmol ATPy1803)to - (mol ATPy1803)to
where (mol ATPY180 3)t refers to the amount of ATPy160 180 3 determined at
time t.
RESULTS
Determination of KmATP and KmFGARfor Chicken Liver FGAR-AT. In order to
define the experimental conditions most likely to give maximal ATP/ADP
exchange rates, the Km for each substrate needed to be determined. The assay
system for (chicken liver) FGAR-AT was altered to replace Tris-HC1 (pH 7.8) and
substitute HEPES (pH 7.25). This change also increased the stability of the
enzyme; Tris-HC1 has previously been shown to cause inactivation of the
enzyme (Mizobuchi & Buchanan, 1968a).
Buchanan (1973) reported the following apparent Km values in Tris-HCl
(pH 8.0): 300-100 !pM [3-FGAR, 1.2 mM ATP, and 200 mM for L-gln in Tris-HCl
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(pH 8.0). A redetermination of apparent Km values in HEPES (pH 7.25), gave
values of 18 iM + 3 M for FGAR and 360 + 20 gM for ATP. The pH optimum of
the chicken liver enzyme is broad (85% activity pH 7.2-8.5), and thus it is unusual
that the Kms have been so markedly perturbed by this buffer change.
ATP/ADP Exchangefor (chicken liver) FGAR-AT. Exchange experiments are a
classic technique used to search for the existence of a phosphorylated
intermediate. However, ATP/ADP exchange cannot be observed unless ADP
can dissociate from the intermediate state, and [14C]ADP can rebind and be
reversibly converted to ATP. Experiments repeating the work of Mizobuchi et al.
(1968) (Fig 2.3) showed an ATP/ADP exchange rate of 1% the rate of FGAM
production under normal assay conditions. The rate of [14C]ATP production
from [14C]ADP is independent of FGAR. This reaction rate contrasts
dramatically with that previously reported by Mizobuchi et al. (1968), and may
be due to impurities in their enzyme preparation; the specific activity of their
enzyme preparation was 0.57 U/mg, compared to our 1.3 U/mg. In addition, as
described in Methods, extra effort was taken to remove contaminating ATPases.
It is interesting to note, however, that when FGAR-AT is assayed (Bratton-
Marshall) under the conditions of the ADP/ATP exchange reaction, FGAM
production is only 0.22% the rate observed in the normal assay mixture, in the
absence of product ADP. This is two orders of magnitude less than the
calculated rate if one assumes a purely competitive inhibition of ADP with ATP
and a Ki of 700 p.M (Li & Buchanan, 1971a). It is obvious that either the reported
Ki is not applicable for these conditions, or more than simple competitive
inhibition is at work in these reactions. Repeating this experiment using 0.5, 1.0
and 2.0 Km ATP (as determined above), and also varying the amount of enzyme
used gave the results shown in Table 2.1. FGAM production by FGAR-AT was
measured under each of these new exchange conditions by Bratton-Marshall
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Figure 2.3: ADP/ATP Exchange for Chicken Liver FGAR-AT. The reaction
shown contained 20 mM potassium phosphate (pH 7.4), 180 tM [8-14C]ADP (SA
2.4 x 106 cpm/pmol), 180 gM ATP, 3.3 mM MgC12, and 0.0035 units FGAR-AT.
One of the reactions also contained 300 !iM P3-FGAR (o) and the other contained
no FGAR ().
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(also Table 2.1). ADP/ATP exchange rates varied from 31 to 480% of the rate of
FGAM production under these new conditions.
Table 2.1: Comparing ATP/ATP Exchange Rates Under Varyin I Conditions
rate of FGAM rate of [14C]- rate of [14C]-
production ATP produced ATP produced
Concns of under conditions rate of [14C]- as % FGAM as % FGAM
ATP & ADP of the exchange ATP produced produced
(gM) reaction production under normal under these
(gmol/min) (gmol/min) assay conditions
180 4.2x10-3 1.3x10-3 1.2% 31%
360 5.9x10-3 3.5x10- 3 3.5% 59%
720 8.3x10-3 3.3x10-3 3.3% 40%
1650 1.2x10-4 5.8x10 4 1.1% 480%
These results suggest that an FGAR-AT enzyme phosphorylated intermediate
does exist, as first suggested by Mizobuchi et al. (1968). The facts that ATP/ADP
exchange occurs in an enzyme dependent fashion, and the exchange can be made
kinetically competent when compared to the reaction catalyzed under exchange
conditions, support this conclusion. This data is in conflict with the kinetic
mechanism determined by Li and Buchanan (1971a, b), who concluded that the
ternary complex forms with the initial binding of glutamine, followed by ATP
and FGAR. One must conclude that either the enzyme phosphorylated
intermediate suggested by these experiments is not along the reaction pathway,
or the kinetic mechanism is not the same in HEPES (pH 7.25) and Tris-HCl (pH
8.0).
Formation of (chicken liver) Enzyme FGAR ATP Complex and Determination of the
Half-Life and Maximal Binding. Mizobuchi et al. (1968) made the unusual
observation that FGAR-AT forms a ternary enzyme.ATPFGAR complex which
has a half life of 62 min at 2 °C. No stable FGAM or ATP enzyme binary
complexes were detected. Schendel & Stubbe (1986) found that FGAR analogs
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turned over by FGAR-AT also formed enzyme-substrate-ATP complexes.
Mizobuchi et al. (1968) performed experiments where ternary complex was
formed with ATPy32P and isolated. After chromatography on Dowex-1 and
elution with 0.25 N HC1, it was discovered that 25-50% of the ATP32P had been
hydrolyzed to ADP and 32pi. Similar experiments performed with [14C]FGAR
showed that this nucleotide was unchanged. The chemical and kinetic
competence of the complex was not investigated.
Initial experiments were performed to repeat those of Mizobuchi et al. (1968)
and Schendel & Stubbe (1986) to determine the stability and makeup of the
complex. A series of reactions were completed in which FGAR-AT was
incubated with [14C]FGAR and [3H]ATP, and the complex was isolated from
unbound substrates using a G-50 Sephadex column. The flow rate of the column
was changed in order to determine the effect on complex composition as the
isolation time was varied. Two different determinations were done, one of which
is depicted in Fig 2.4. The tl/2 of the E-FGAR ATP complex, averaged from these
two experiments, was found to be 44 + 2.2 minutes at 4 oC. The initial complex,
calculated from data extrapolated to zero time, was found to contain a ratio of
FGAR-AT-FGAR-ATP of 1:0.38(+ 0.06):0.48(+ 0.08). This compares favorably with
the results of previous investigators (Mizobuchi et al., 1968) who reported a ratio
of 1:0.68:0.68 and a half life of 62 minutes at 2 OC.
Composition of (chicken liver) Enzyme FGARATP Complex: Is this complex
chemically competent? To determine the chemical composition of this complex,
FGAR-AT was incubated with [14C]FGAR and [3H]ATP and separated from free
substrates on a G-50 Sephadex column. The complex was rapidly denatured
using TBAB, and the small molecules examined by ion-pairing HPLC
chromatography. Radioactivity was found to co-migrate with FGAR and ATP,
although only 75% of the radioactivity injected on the column was recovered.
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Figure 2.4: Stability of Chicken Liver Enzyme-FGAR-ATP Complex. Reaction
mixtures contained 100 mM potassium phosphate (pH 6.5), 0.4 mM [2-14C][3-
FGAR (SA 1.6x106 cpm/pimol), 3.6 mM [2,8-3H]ATP (SA 8.2x106 cpm/mnol), 6
mM MgC12 and FGAR-AT (4.6 nmol) in a final volume of 300 gL. After five min
at 37 OC, samples were loaded onto G-50 Sephadex columns. The plot shows
[3H]ATP (o) or [14C]FGAR ( ) protein stoichiometry for samples eluted from the
column at varying times. The half-life of the complex and the ATP/enzyme and
FGAR/enzyme ratios extrapolated to zero time were determined from these
plots
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Alternatively, the complex was mixed with 2 mM glutamine and after a 5 min
incubation at 37 OC, the mixture was analyzed for product formation using the
ion pairing HPLC system as above. Both [14C]FGAM and [3H]ADP were
detected, however only 40% of the substrates were converted to products. The
results are summarized in Table 2.2. The reason for this incomplete turnover is
not known, but could be explained if one or both of the substrates bound
unproductively to the enzyme (Rose, 1979), or dissociated before turnover could
take place.
Table 2.2: Conversion of E-FGAR-ATP Complex. (All species expressed as nmol)
sample enzyme 3H species 14C species FGAM FGAR ADP ATP
- gin A 0.82 0.29 0.17 -* - 0.026 0.17
+gln A 0.74 0.22 0.13 -* - 0.096 0.10
-gln B 1.3 0.29 0.19 0.000 0.180 0.018 0.27
+gln B 0.88 0.18 0.15 0.070 0.082 0.084 0.10
* FGAM and FGAR were not quantified in these experiments
One may question whether, under the conditions of this experiment, the
substrates dissociate from the enzyme and then re-bind and thus undergo
normal turnover. A crude calculation of maximal velocity for such a situation is
shown in Scheme 2.5. This calculation demonstrates that it is unlikely that
complex components are able to dissociate and rebind the protein under these
experimental conditions, as the substrates would be diluted far below the Km
values of the enzyme. Again, this finding is inconsistent with a kinetic
mechanism that requires glutamine binding before FGAR and ATP.
Inactivation of Chicken Liver FGAR-AT. Previous studies of Mizobuchi et al.
(1968) demonstrate that FGAR-AT inactivated with azaserine or iodoacetate
forms ternary complexes with altered half-lives. Iodoacetate inactivated enzyme
forms a complex with a half-life at 2 OC of 340 min while azaserine shortens the
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A
E*AT P*FGAR E*ATP*FGAR*Gln----E + ADP + glu + Pi +FGAM
B gin ATP 1
gin F AR
E + ATP + FGAR E*gln ' E*ATPoFGAR*Gln
Is product formation from the ternary complex due to pathway A or B (above)?
The expected amount of FGAM produced by pathway B can be calculated.
Using the data from Table 2.2 (sample +gln B)...
The amount of enzyme in the complex, and the maximal velocity, is:
Vmax = 0.88x10- 9 mol enzyme x 140,000g x 1000 x 0.32units = 3.9x10- 2 units
nmol
The substrates concentrations are:
ATP in complex = 0.18 x 10-9 mol
in 200 L yields a concentration of 0.9 jM ATP
FGAM in complex = 0.15 x 10-9 mol
in 200 4L yields a concentration of 0.75 jiM f-FGAM
The substrate Kms, determined under these conditions, are:
Km ATP = 360 gM, Km DFGAR(ca4mix) = 20 apM
Glutamine is saturating, so the equations reduce to a two substrate system.
For convenience, I have stated all concentrations in BM.
v = Vmax x [FGAR1] x [ATP]
Km + [FGAR] Km + [ATP]
3.9x10-2 0.75 x 0.9
20 +0.75 360 + 0.9
= 3.5 xlO mmole/min
This calculation overestimates the amount of product formed, as it assumes that
the inital rate is sustained over the entire course of the reaction. However,
assuming this rate, in 5 min 0.018 nmol of FGAM will be produced,
compared to the 0.07 nmol of FGAM found.
Scheme 2.5: Calculation for FGAM Generated if ATP and FGAM Diffuse
from the Ternary Complex and Rebind to React
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half-life to an estimated 19 min. It was therefore anticipated that PIX rates of
FGAR-AT might be altered by inactivating the enzyme with either azaserine or
iodoacetate. Experiments were carried out to establish the conditions necessary
to completely inactivate the chicken liver enzyme with each of these inhibitors.
Incubation of FGAR-AT with a variety of inhibitor concentrations and assay
for FGAR-AT activity gives the results shown in Fig 2.5. The data (Fig 2.5A) can
be used to determine the rate constants for inactivation (Scheme 2.4). The
dissociation constant for the E I complex, Ki, was calculated to be 56 +17gM,
identical within experimental error to that previously reported by Mizobuchi et
al. (1968). The results of inactivation of FGAR-AT with iodoacetate are shown in
Fig 2.5B. Significant inactivation was found only when MgATP and -FGAR
were both included in the inactivation mixture (Fig 2.5B).
Inactivation of E. coli FGAR-AT by Iodoacetate and Azaserine. The effect of
inactivation of E. coli FGAR-AT on formation of the FGAR-AT-ATP-FGAR
complex is unknown. However, azaserine is a glutamine analog, and is a good
choice for a stable, competitive glutamine inhibitor for PIX studies. Iodoacetate
inactivation of E. coli FGAR-AT has not been studied, but may also alter the
stability of the tertiary complex as previously determined for the chicken liver
enzyme.
Inactivation of the E. coli enzyme with azaserine (Fig 2.6A) is complex.
The data are clearly multiphasic and do not fit the simple first order process in
which inactivation occurs through an E * I complex (Scheme 2.4). The observed
curvature has several possible explanations (Main, 1973). One is that during the
assay the enzyme has time to reactivate, presumably via hydrolysis of the
covalent linkage. This seems unlikely as S. typhimurium FGAR-AT 14C-azaserine
adducts are stable under denaturing conditions from pH 2.4-9.5 (Dawid et al.,
1963) The proposed covalent linkage (Buchanan, 1982) of azaserine to S.
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Figure 2.5: Inactivation of Chicken Liver FGAR-AT with Azaserine (A) and
Iodoacetate (B). A. Reactions were run in 50 mM potassium phosphate (pH 6.5)
containing 0.06 mM (+), 0.20 mM (A) 1.0 mM (x) and no (o) azaserine.
B. Iodoacetate inactivations contained 50 mM potassium phosphate (pH 6.5) and
2.1x10-2 units FGAR-AT along with 20 mM iodoacetate (x), or 0.4 mM
iodoacetate, 0.26 mM -FGAR, 4 mM ATP and 12 mM MgC12 (A). A control
reaction without iodoacetate was also run (o).
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Figure 2.6: Inactivation of E. coli FGAR-AT with Azaserine (A) and
Iodoacetate (B). A. Azaserine concentration of zero (o), 0.1 mM (+), 0.9 mM (A),
2.8 mM (x) and 8.3 mM (e) were incubated with 3x10-2 U FGAR-AT using
conditions identical to those in Fig 2.5.
B. Iodoacetate reactions contained: no iodoacetate (o), 18 mM iodoacetate (+),
1.9 mM iodoacetate, 20 mM MgC12, 1 mM ATP and 0.19 mM -FGAR (A) or 18
mM iodoacetate with 20 mM MgC12, 1 mM ATP and 0.19 mM -FGAR (x) in 50
mM potassium phosphate (pH 6.5).
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typhimurium FGAR-AT is very stable, and it is highly probable that E. coli FGAR-
AT will be very similar (Fig 2.2). A second possibility is that a least two
interconvertable forms of FGAR-AT exist. Inactivation curves like those shown
in Fig 2.6A have been seen for cholinesterases, and have been explained by
invoking multiple forms of the enzyme (Main, 1973). It may be that the
multiphasic behavior reflects a multiplicity of domains present in the enzyme
preparation, caused by multiple proteolysis products. In any case, E. coli
FGAR-AT is resistant to inactivation by azaserine in comparison to the chicken
liver enzyme.
The iodoacetate experiments (Fig 2.6B) once again gave significant
inactivation rates only in the presence of MgATP and j3-FGAR. The Ki for this
inactivator, although it cannot be determined from this data, is in the low mM
range, which compares well with the reported value of 1 mM for chicken liver
FGAR-AT (Mizobuchi et al., 1968).
Positional Isotope Exchange (PIX). This method was first used by Midelfort
and Rose (1976) to probe for a phosphorylated intermediate in the reaction
catalyzed by glutamine synthetase. The advantage of this method is that the
intermediate need not diffuse from the active site, but free rotation about the PJ-
O-Pp phosphodiester bond is necessary to detect an intermediate. The PIX
reactions outlined subsequently use ATP labeled with 180 in the Pp-O-Py bridge,
and Vpix is defined as the rate of scrambling of 180 out of this position. The
sequence of events that must occur to allow this to happen are shown in Scheme
2.6. An 180 bound to phosphate causes a 0.2 ppm shift as measured by 31p
NMR, which is used to detect isotope scrambling. An example of PIX data is
shown in Fig 2.7, and this data is graphed in Fig 2.8.
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Figure 2.7: 31p NMR Spectra of E. Coli FGAR-AT PIX Reactions. Exchange
reactions contained 50 mM HEPES (pH 7.25), 20 mM MgC12, 80 mM KC1, 6.6
mM ATPy1804 (21%y1803), 0.82 mM 1-FGAR and 0.28 units FGAR-AT. Samples
were removed and quenched as described in Methods. One half of the y-
phosphorous doublet of the ATP spectrum is displayed to show the variation in
peak heights through the course of the experiment. In the 31 p NMR, loss of an
180 from the y to the phosphorous results in a 0.02 ppm shift (2.4 Hz) down
field. As the reaction progresses, one can see the increase in the ATPP'18 0 3160.
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Figure 2.8: Determination of Vpix for E. Coli FGAR-AT. Analysis of PIX
reactions was accomplished as described by Rose (1979). Shown are the results
of two separate, identical experiments. The ATPyP180 3160/ATPyP1 804 ratio for
each sample is measured using peak height and integrations for each doublet
half of the Py resonance. F is defined in Equation 2.3, and is the fraction of the
reaction that has been completed. The error bars at each point represents the
standard deviation from four different determinations.
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Scheme 2.6: Positional Isotope Exchange (PIX)
PIX can conceivably be catalyzed by any ATP utilizing enzyme, and it is
therefore important to demonstrate that if positional exchange is observed it is
due to the enzyme of interest. This is usually accomplished by varying the PIX
rate in a way that demonstrates that PIX is due to the enzyme under study, such
as adding substrates or specifically inactivating the enzyme. In addition, a
comparison of the PIX rate with the normal rate is required to define kinetic
competence. In the case of CTP synthetase (von der Saal et al., 1985), these
requirements were met by adding one of the substrates to the exchange reaction,
which increased Vpix. FGAR-AT is amenable to investigation using PIX
experiments as previous studies show this enzyme forms an enzyme
phosphorylated intermediate, and it is probable that the stability of this
intermediate can be altered by adding substrates or glutamine inactivators
(Mizobuchi et al., 1968).
We have used PIX to probe for the existence of both an enzyme
phosphorylated (E-P) and substrate phosphorylated intermediates (e.g. species 1
and 3 in Scheme 2.2). The data for all PIX experiments with chicken liver
FGAR-AT are summarized in Table 2.3, while those for the E. coli enzyme are
summarized in Table 2.4.
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Table 2.3: PIX for Chicken Liver FGAR-AT
Treatment of Enzyme prepn ATPase Vcat Vpix
(date) !mol/min mg [tmol/min mg Vcat
none 9/10/90 1.0x10-3 1.4 0.097
none 2/ 4/91 3.6x10-3 1.3 0.03
+ FGAR 6/4/90 8.6x10-4 1.0 0.097
+ FGAR 6/ 4/90 3.0x10 4 0.38 0.055
+ FGAR 2/ 4/91 0.8 0.037
+ FGAR 5/14/91 1.4x10- 3 1.3 0.004
Iodoacetat inactn + PFGAR 9/10/90 5.0x10 4 0.34 0.16
Azaserine inactn + PFGAR 9/10/90 6.7x10 4 0.34 0.22
Azaserine inactn + PFGAR 2/ 4/91 0.8 0.031
Azaserine inactn + PFGAR 5/14/91 1.4x10-3 1.3 0.005
PIX was carried out using the chicken liver FGAR-AT under a variety of
conditions. Initial experiments were run with ATP1 8 0 4 and enzyme alone,
probing for an enzyme phosphorylated intermediate. Later exchange reactions
were carried out in the presence of P-FGAR and on inactivated enzyme, to
determine if these changes affected Vpix/Vcat.
As can be seen from the data, no exchange was ever found to be kinetically
competent when compared to the catalytic reaction (i.e. no Vpix/Vcat >1).
However, Vpix/Vcat rates as low as 0.03 have been used to prove existence of
phosphorylated intermediate for CTP synthetase (von der Saal et al., 1985). The
key to these experiments, as explained above, is that PIX was observed only after
UTP was added. In the case of FGAR-AT, exchange is not reproducibly affected
by the addition of FGAR, or after inactivation with azaserine. One must
conclude that although PIX can be measured for chicken liver FGAR-AT samples,
the exchange can not be attributed to the amidotransferase. It is important to
note the variability in the determined PIX rates between different enzyme
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preparations; this observation stresses the importance using one enzyme
preparation to compare the effects of different reaction conditions. It also
stresses the importance of using homogeneous proteins containing no ATPases.
Table 2.4: PIX for E. Coli FGAR-AT
Treatment of prepn ATPase Vcat Vix
Enzyme (date) gmole/min mg gmole/min mg Vcat
none 2/5/90 0.00018 1.95 0.032
none 2/5/90 0.00075 2.5 0.009
none 9/4/90 0.0028 1.4 4.1
+PFGAR 2/5/90 0.0004 2.1 0.09
+PFGAR 2/5/90 0.00003 2.0 0.047
PIX reactions with E. coli FGAR-AT show an even greater variability than the
chicken liver enzyme experiments (Table 2.4). One preparation, shown above,
exhibited a reproducibly high Vpix/Vcat. No differences between the enzyme
used for these experiments and the enzyme from the 2/5/90 preparations was
evident from SDS-PAGE. The ATPase in this preparation was 3-fold higher than
the other enzyme samples, and it is possible that the PIX observed is due to an
ATPase contaminant. Vpix/Vcat in other preparations varied from 1-10%, and
like the experiments with the chicken liver enzyme were not altered reproducibly
by addition of substrate FGAR. Thus, although a PIX rate can be measured for E.
coli FGAR-AT, it cannot unambiguously be attributed to the amidotransferase as
opposed to a contaminating ATPase enzyme.
DISCUSSION
The experiments of Stubbe and coworkers (Schendel et al., 1989) show that E.
coli FGAR-AT catalyzes the transfer of [180] from FGAR to Pi, and strongly
suggests that the role of ATP is to act as a dehydrating agent in the conversion of
FGAR to FGAM. The studies reported in this chapter are a continuation of this
work, using both PIX and ATP/ADP exchange studies to look for the postulated
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phosphorylated substrate intermediate(s) (Scheme 2.2) and/or a phosphorylated
enzyme intermediate (not shown) along the reaction pathway. The fact that both
the chicken liver and E. coli enzymes form stable binary and ternary complexes
with glutamine and ATP and FGAR respectively (Mizobuchi & Buchanan, 1968b,
Mizobuchi et al., 1968, Schendel & Stubbe, 1986; Schendel et al., 1989), suggested
to us that the intermediates of the reaction catalyzed by FGAR-AT may be
detectable using exchange studies.
The kinetic mechanism of the chicken liver FGAR-AT (Li & Buchanan,
1971a,b) and the E. coli enzyme (Schendel et al., 1989) implies that the formation
of any chemically relevant intermediate can only occur in the presence of
glutamine. Both enzymes follow a sequential ordered mechanism with
glutamine binding first, followed by binding of the remaining substrates to form
a quaternary complex. Work described in this chapter, however, causes us to
question this kinetic mechanism. Inactivation by iodoacetate occurs only in the
presence of ATP and FGAR. Furthermore, chicken liver FGAR-AT forms a
ternary enzyme ATP-FGAR complex that was shown in this chapter to be
chemically competent. In addition, ATP/ADP exchange studies, all
accomplished without glutamine, have demonstrated that an enzyme
phosphorylated intermediate occurs in a kinetically competent fashion. All these
data taken together suggest that FGAR-AT can bind ATP and FGAR to form a
chemically and kinetically competent intermediate state. Future studies should
be directed at re-analyzing the order of substrate binding for this enzyme.
Perhaps, a is now apparent with PRPP-AT, there are two totally separate
domains that interact only after a large conformational change.
Once evidence for the formation of an enzyme phosphorylated intermediate
with chicken liver FGAR-AT was found, positional isotope exchange
experiments were designed to probe for both E~P and phosphorylated FGAR
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intermediates along the reaction pathway (Scheme 2.2). These experiments hinge
on finding a PIX rate that can be demonstrated to be due to the enzyme of
interest. While a low (<10%) Vpix/Vcat ratio was found for both chicken liver
and E. coli enzymes, these rates were not reproducibly affected by addition of
FGAR or, in the case of the chicken liver enzyme, substitution of FGAR-AT by
inactivated enzyme. As a result, the PIX experiments are inconclusive, and the
observed PIX might be due only to impurities present in the enzyme
preparations. The fact that Vpix/Vcat varies when different enzyme
preparations are used supports this conclusion. Isolation of the chicken liver
FGAR-AT provides enzyme that is only 70-80% pure, as judged by SDS-PAGE
with Comassie blue staining (Fig 2.1). E. coli FGAR-AT is likewise contaminated
by several protein species comprising an estimated 5% impurity (Fig 2.1). These
other proteins are thought to be proteolyzed fragments of FGAR-AT, as they
react to antibodies made against SDS-PAGE purified FGAR-AT (Schendel,
unpublished results). It is possible that one of these clips, which varies in
abundance from preparation to preparation, is wholly responsible for the almost
500-fold variation in PIX rates seen in the E. coli experiments.
Thus, while this and previous work on FGAR-AT suggest that
phosphorylated species exist along the reaction pathway, we have been unable to
provide conclusive evidence for the existence of such intermediates. A more
highly purified source of FGAR-AT will be required if PIX experiments are to be
re-run in the future.
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Chapter 3
Mechanistic Studies on Escherichia coli Aminoimidazole
Ribonucleotide Synthetase
92
INTRODUCTION
Aminoimidazole ribonucleotide (AIR) synthetase, the fifth enzyme in the de
novo purine pathway, catalyzes the ATP dependent cyclization of the amidine
formylglycinamidine ribonucleotide (FGAM), to produce AIR (Scheme 3.1). The
180
-H ; '4
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0
AIR synthetase '3P N  ONH2
ADP + P1[ O0] Hu H-13'ATP ADP+ P 1['80] HO OH
FGAM AIR
Scheme 3.1: Reaction Catalyzed by AIR synthetase
enzyme has been at least partially purified from a number of prokaryotic and
eucaryotic sources including E. coli (Schrimsher et al., 1986b); rat (Hards et al.,
1986), chicken (Daubner et al., 1985) and pigeon liver (Flaks & Lukens, 1963); S.
pombe (Fluri et al., 1976); murine derived L5178Y cells (Caperelli, 1989) and HeLa
cells (Daubner et al., 1986). Intriguingly, in many higher organisms AIR
synthetase is expressed as a fusion with other purine biosynthetic enzymes to
form either bifunctional or trifunctional polypeptides. In chicken (Daubner et al.,
1985), murine (Caperelli, 1989) and human systems (Schild et al., 1990; Daubner
et al., 1986) the protein is a trifunctional 110 kDa polypeptide containing GAR
synthetase and GAR transformylase in addition to AIR synthetase. The yeast
strains S. cerevisiae (Henikoff, 1986) and S. pombe (Fluri et al., 1976; McKenzie et
al., 1987) express AIR synthetase at the C-terminus of a bifunctional fusion with
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GAR synthetase. Drosophila AIR synthetase exists in a GAR synthetase-AIR
synthetase-AIR synthetase-GAR-transformylase fusion protein, the AIR
synthetase component apparently arising from a gene duplication (Henikoff,
1986). AIR synthetase has recently has been identified and cloned in the fungi P.
chrysosporium and S. commune (Alic et al., 1991), where it is also thought to be part
of a multifunctional enzyme. The enzyme is monofunctional in S. typhimurium
(Westby & Gots, 1969), as well as in E. coli and B. subtilis (Smith & Daum, 1986).
Despite these differences between organisms, the primary structure of AIR
synthetases are highly conserved (Aimi, 1990). The observation of multiple
activities on a single polypeptide in eukaryotes, in contrast to monofunctional
activities observed in prokaryotes, has been observed in enzymes involved in
both purine (Daubner et al., 1985) and pyrimidine biosynthesis (Coleman et al.,
1977). While the basis for the evolution of this variation in structural
organization is unknown, it has been speculated that a single promoter of
multiple activities facilitates regulation within that pathway (Hardie & Coggins,
1986).
AIR synthetase from E. coli is the best characterized of these proteins. The
enzyme has been cloned and purified to homogeneity from this source (Smith &
Daum, 1986; Schrimsher et al, 1986b), and is found as a homodimer composed of
38.5 kDa subunits. The kinetic mechanism of E. coli AIR synthetase was
determined to be sequential ordered, with binding of ATP preceding the binding
of AIR. Initial experiments designed to test the mechanism of the cyclization
reaction made use of 180 (formyl) FGAM (Scheme 3.1). Incubation of this
substrate with ATP and enzyme resulted in stoichiometric transfer of 180 to
phosphate. These results support the hypothesis that the role of ATP is to
convert the oxygen
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Scheme 3.2: Proposed Mechanisms for AIR synthetase
of the proposed tetrahedral intermediate (3 or 4, Scheme 3.2) into a better leaving
group by phosphorylation. Two possible mechanisms for the enzyme reaction
are depicted in Scheme 3.2 (Schrimsher et al, 1986b). There is chemical evidence
for such intermediates in model systems Satterthwait & Westheimer (1980). In
addition to the intermediates shown above, it is also possible that one or more
enzyme phosphorylated intermediates (E-P) exist.
Similar mechanisms have been proposed for a number of additional ATP
utilizing enzymes, including 5-oxo-prolinase (Li et al., 1987) and CTP synthetase
(von der Saal & Villafranca, 1985). This mechanistic class of enzymes also
includes several purine enzymes in addition to AIR synthetase:
formylglycinamide ribonucleotide amidotransferase (FGAR-AT; Li & Buchanan,
1971; Schendel et al., 1989) and xanthine 5'-monophosphate aminase (XMP
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aminase or GMP synthetase, Fukuyama, 1966). It intrigued us that two
sequential enzyme activities in the purine pathway catalyze reactions are
proposed to have similar mechanisms, yet have no apparent sequence homology
in ATP binding domains and do not contain any of the common P-loop ATP
binding motifs (Saraste et al., 1990). As such, our lab initiated an effort to further
elucidate the detailed mechanisms of these enzymes involved in de novo purine
biosynthesis using a variety of kinetic techniques. The previous chapter details
our attempts to provide further evidence for a phosphorylated intermediate in
the reaction of the fourth purine enzyme, FGAR-AT. This chapter describes our
efforts to characterize a phosphorylated intermediate in the reaction catalyzed
by AIR synthetase.
MATERIALS AND METHODS
Materials. E. coli formylglycinamide ribonucleotide amidotransferase
(FGAR-AT, 2.3 U/mg) was purified as previously described (Schendel et. al.,
1989). Glycinamide ribonucleotide (GAR) synthetase (15 U/mg, Cheng et. al,
1990) and phosphoribosylpyrophosphate amidotransferase (PRPP-AT, -38
U/mg, Rudolph, 1993) were isolated as previously described. GAR trans-
formylase (12 U/mg) was a generous gift from the Benkovic labs. 10N-formyl
dideazafolate was synthesized using the method of Acharya & Hynes (1975),
modified by Wing Hang Tong. The scintillation fluid used in all experiments
was S¢intA-XF, purchased from Packard. Sephadex G-25 and A-25 were
obtained from Pharmacia. Lactate dehydrogenase (LDH, 860 U/mg), pyruvate
kinase (PK, 470 U/mg), phosphoenolpyruvate (PEP), bovine serum albumin
(fraction V, BSA), adenosine-5'-diphosphate (ADP) and adenosine-5'-
triphosphate (ATP) were purchased from Sigma Chemical Co. H 332P0 4 (8810
Ci/mmol) and ATPy32P (6000 Ci/mmol) were obtained from New England
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Nuclear. [14C]-fFGAR was synthesized enzymatically from PRPP as described
in chapter 2. Centricon ultrafiltration units and 0.45 gm filters were purchased
from Millipore Corp. HPLC EconosilTM C-18, 10 p, 4.6 x 250 mm columns were
purchased from Alltech. The Fast Protein Liquid Chromatography (FPLC)
apparatus and MonoQTM anion exchange column used were from Pharmacia.
H2180 (98-99%) was obtained from MSD Isotopes. ATPy180 4 was synthesized
from H 3P 180 4 (Risley & Van Etten, 1978) using the method of Wehrli et al. (1965).
General Methods. Standard molecular biology techniques were accomplished
as described by Sambrook et al. (1989). Sodium dodecylsulfate polyacrylamide
gel electrophoresis (SDS-PAGE) samples were prepared and run as described by
Laemmli (1970) and fixed, stained and destained using the alternate technique
described by Cooper (1977). Protein assays were done according to the method
of Lowry et al. (1951) using BSA (280 = 0.667 mL mg-1 cm-1; Schachman &
Edelstein, 1966) as a standard. Orcinol assays were performed as described
(Dische, 1962) using ATP as a standard. Phosphate assays were accomplished
using the method of Ames and Dubin (1960). Radioactivity was quantified using
a Packard 1500 Tri-Carb Scintillation Counter. The isotopic purity of ATPy 180 4
and H 3P 180 4 were determined using 31p NMR, described below. Dry solvents
were prepared using generally accepted laboratory procedures (Perin &
Armarego, 1988), and stored over activated molecular sieves (Burfield et. al,
1978).
Enzymatic Synthesis of fP-FGAM and [14C]P-FGAM. This amidine was
prepared using a modification of the procedure of Schrimsher et al. (1986b). A
typical reaction contained 40 mM Tris-HCl (pH 7.5), 10 mM ATP, 10 mM L-gln,
80 mM KC1, 20 mM MgC12, 10 mM PEP, 2.5 mM 3-FGAR (40/60 ac mix), 20 U
PK and 6 U FGAR-AT in a final volume of 4 mL. The reaction mixture without
enzymes was pre-incubated at 37 oC for 5 min, and was initiated by addition of
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FGAR-AT. After allowing the reaction to proceed for 30 - 45 min, the mixture
was diluted to 100 mL with ice cold water and loaded onto a DEAE A-25 column
(2.5 x 10 cm, HC03- form) at 4 OC. After washing the column with 100 mL H 20,
a 500 x 500 mL linear gradient from 0 to 300 mM TEAB was applied. Fractions
(10 mL) were collected and a column profile generated using the orcinol assay.
FGAM containing fractions, which eluted at 75-100 mM TEAB, were pooled and
brought to dryness in vacuo. The TEAB salts were removed by repeated
redissolution of the residue in MeOH and removal of the solvent in vacuo. The
product was dissolved in a small volume of cold water and immediately titrated
to pH 6.5-7.0. The pH of the compound is important, as it was discovered that
storing the amidine under mildly basic conditions (pH 8) resulted in complete
decomposition to FGAR within several days. Solutions were stored at -20 oC.
This procedure was used to prepare FGAR on a 1 - 20 gmol scale. Isolated yields
for eight reactions ranged from 60-80%.
Isolation of AIR synthetase. This enzyme was isolated as described by
Schrimsher et al. (1986b), with the exception that the final size exclusion column
was omitted. The enzyme was stored concentrated (> 25 mg/mL) in small
aliquots in buffer containing 10 mM HEPES (pH 7.7), 50 mM KC, 1 mM EDTA,
5 mM 3-mercaptoethanol (-ME) and 20% v/v glycerol, and had a specific
activity of 3.3 U/mg. The protein was quite stable under these conditions,
retaining 80% activity after 3 years.
When used in positional isotope exchange (PIX) experiments, AIR synthetase
was further purified using anion exchange (Mono QTM 5/5) column and FPLC.
The enzyme (5 mg, 200 gL) was injected onto a column equilibrated with 10 mM
HEPES (pH 7.7), 50 mM KC1. A 50 to 500 mM KC1 linear gradient was applied
over 1 h. Fractions (0.5 mL) were collected and analyzed for protein content by
A280. AIR synthetase, which eluted at 475 mM KC1, was pooled and
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concentrated using a Centricon-30. Recovery was 40% (2 mg). The specific
activity of the enzyme was 0.9 U/mg, and the ATPase was decreased seven-fold
to 1% of the normal enzyme activity.
Enzyme Assays. In all cases one unit of enzyme activity is defined as the
amount of enzyme necessary to produce 1 mol of product in 1 min at 37 °C.
AIR synthetase was assayed using the adapted Bratton-Marshall assay described
by Schrimsher et al. (1986a). ADP production was determined using the coupled
assay described by Schrimsher et al. (1986a)
ATP/ADP Exchange Catalyzed by AIR synthetase. Reaction mixtures contained
50 mM HEPES (pH 7.7), 3 mM MgC12, 480 mM KC1, 1 mM ATP, varied [14C]ADP
(specific activity 1.1x106 cpm/gmol), 1 mg/mL BSA, and 2.8x10-3 - 2.8x10 -2 units
AIR synthetase (0.61 U/mg, 0.41% ATPase) in a final volume of 200 gL. All
components except enzyme were pre-incubated for three min at 37 OC. After
initiating the reaction by addition of enzyme, 20 gL aliquots were removed at 0,
1, 2, 3, 5 and 10 min, placed in a boiling water bath for 1 min and then stored on
dry ice. Samples were analyzed after dilution to 220 gL in 50 mM HEPES (pH
7.7), 5 mM Bu4NBr; 100 gL aliquots were injected onto a C18 column equilibrated
in ion pairing buffer containing 200 mM potassium phosphate (pH 6.0) and 25
mM Bu4NBr. With this system ATP eluted at 15-16 min, and ADP eluted at 11-13
min. One min fractions were collected and quantitated by scintillation counting.
Positional Isotope Exchange (PIX) Experiments.
(A) EDTA Quenching of the AIR synthetase Catalyzed PIX Reaction. The success
of PIX analysis depends on finding a means to stop the enzyme reaction without
degrading ATP. A quenching strategy that has been used by previous
investigators (von der Saal et al., 1986) employs EDTA and carbon tetrachloride.
The appeal of this technique is two-fold: 1. EDTA addition aids the NMR
analysis of PDIX by chelating metals that may cause line broadening, and 2.
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extraction of enzyme with an organic solvent removes any enzyme that may bind
to ATP and change its relaxation properties in the NMR. To insure that addition
of EDTA would indeed stop the AIR synthetase catalyzed reaction, a comparison
of the effectiveness of quenching techniques was performed using EDTA/CC14
and potassium phosphate/TCA.
Two identical assays were run at 37 °C which contained 50 mM HEPES (pH
7.7), 3 mM MgC12, 400 mM KC1, 0.25 mM -FGAM, 2.5 mM ATP and 2 x 10-3 U
AIR synthetase in a final volume of 300 gL. After 5 min the reactions were
quenched in one of two ways. To one reaction was added 100 !iL of 1.3 M
potassium phosphate (pH 1.4), 20% TCA. To the other reaction was added 500
gL of 600 mM CHES/500 mM EDTA (pH 9.0), followed by 100OgL CC14. This
second sample was vortexed for 30 sec, then subjected to centrifugation at 11,000
x g for 30 sec. Two layers formed with precipitated protein visible at the
interface. From the top layer, 300gL was removed and incubated for an
additional 5 min at 37 oC. FGAM production in each sample was then quantified
using the Bratton-Marshall assay.
(B) PIX Catalyzed by AIR synthetase. PIX reaction mixtures were identical to
those described in the above control, but contained no 1-FGAM and 2.4 mM
ATPy1804 (30%y 1803) in a final volume of 1485 gL. After a 5 min pre-incubation
at 37 oC, the reaction was initiated by the addition of 1.38 units of AIR synthetase
(0.9 U/mg). Aliquots of 285 gL were withdrawn at 0, 20, 40, and 60 min. Each
aliquot was quenched using EDTA/CC14. Seven hundred-fifty 1L was
withdrawn from the top layer of each sample, rapidly frozen in liquid nitrogen
and stored at -20 oC for 5 days until analysis by NMR spectroscopy.
Before NMR analysis, each sample was thawed and d6-acetone was added
(20% v/v). The samples were filtered through a 0.45 gm filter using a clinical
centrifuge (20 min at -2200 x g).
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(C) NMR Analysis of PIX Experiments. Two types of spectrometer were used:
Varian XL-300 and Varian VXR-500 which record 31p spectra at 121 and 202 MHz
respectively. Parameters for the XL-300 included a pulse width of 10 ms, a sweep
width of 5000 Hz and an acquisition time of 2 s. With the VXR-500 a sweep
width of 15 ms was used with a sweep width of 8080 Hz and an acquisition time
of 2 s. For each sample the probe was tuned and the shims optimized, and then
an external standard consisting of a sealed capillary containing 85% H 3 PO4 in a
20% (v/v) d6-acetone/H20 was used to set the sweep width. A total of 2000
scans were accumulated for each sample, and both integration and peak height
were measured to determine ATPy18 03/ATPy 1804 ratio.
Rapid-Chemical Quench Methods to Probefor Intermediates in the AIR synthetase
Catalyzed Reaction. Rapid quench experiments were performed on a Model RQF-
3 Rapid Quench Apparatus made by KinTec, University Park, PA. Calibration of
the instrument and determination of the rate constant for base hydrolysis of 2,4-
dinitrophenylacetate were carried out as recommended in the manual (revised 8
Dec. 1988). Determined loop sizes are presented in a tabular form in Appendix
B. Also included in this appendix is a comparison of the measured and literature
values for the rate constant of 2, 4-dinitrophenylacetate hydrolysis.
ATPy32P used in these experiments was diluted to the desired specific
activity, which ranged from 0.77 - 2.8 x 106 cpm/gmol, and purified the day
before use. Typically 3 jtmol ATP was loaded onto a A-25 Sephadex column (2.5
x 12 cm, HC03- form). Ten mL fractions were collected as the column was
developed with a 500 x 500 mL linear gradient from 0 to 800 mM TEAB. ATP
eluted at 650 mM TEAB. Fractions containing the triphosphate were pooled and
concentrated in vacuo. Recoveries were ~85%.
(A) Rapid Quench Reactions. All experiments were performed at 37 OC.
Reaction times were selected so that the same loop (8) could be used for all time
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points, increasing the delay to vary reaction times. This technique has the
advantage of generating the same reaction volume (~400 L) for each sample, as
the same number of push steps (210) were used in every time point.
Syringe A contained 50 mM HEPES (pH 7.7), 3 mM MgCl2, 400 mM KCl, 526
gM -FGAM and 1.5 mM ATP. Syringe B contained 50 mM HEPES (pH 7.7), 3
mM MgC12, 400 mM KC1 and 30-100 .M AIR synthetase (3 U/mg). Separate
reactions were carried out using ATPy32P (2.18x106 cpm/pumol) or [14C]-fFGAM
(1.7 x 106 cpm/gmol). The contents of syringes A and B were mixed producing a
final reaction mixture containing 50 mM HEPES (pH 7.7), 3 mM MgC12, 400 mM
KCl, 268 gM [-FGAM, 764 jgM ATP and 15-50 pM AIR synthetase. The reaction
was allowed to react from 100 - 500 ms, quenched with 1% (w/v) HC10 4 and
ejected into a screw top Eppendorf tube containing 100 L CHC13. Reactions
were immediately reneutralized with a 1:1 solution of 1M KOH and 500 mM
Tris-HC1 (pH 7.5), subjected to centrifugation (11,000 x g) for 30 s, and then
frozen in liquid nitrogen. Control reactions were run to show that this
quenching method was effective. Samples were stored at -20 oC until they were
thawed at 4 oC by spinning at 11,000 x g for 6 min just before analysis.
(B) Analysis of Rapid Quench Reactions. Quantitation of products in the above
reactions was accomplished using two different methods. When [14C]FGAM
was used as a reporter, anion exchange FPLC analysis was performed using a
Mono Q 5/5 column (1 mL, 5 x 50 mm) at 4 oC. The entire aqueous portion of
each sample (-400 gL) was removed by syringe, then added to a solution
containing 2 jnol of AIR and diluted to 1 mL with water at 4 °C. This entire
sample was injected onto the anion exchange column. Buffer A contained 10 mM
Tris-HCl (pH 7.5 at 4 C), and buffer B was identical to A with the addition of 750
mM NaCl. The products were eluted using the following protocol: 0% B for five
min, a linear gradient to 40% B over the next 20 min, and a step to 100% B over
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the next min, followed by elution at 100% B for an additional ten min. The flow
rate was 1 mL/min, and fractions of 0.5 min (500gL) were collected directly into
scintillation vials. To each vial was added 4 mL Stint A fluid and the sample
quantitated by scintillation counting. The elution profile for each species was
determined with authentic radio labeled material. Using this gradient FGAM
eluted in a broad peak over 1.5-8 min, AIR at 13 min, phosphate at 13.5 min and
ATP at 22 min. A typical profile is shown in Fig 3.1.
In the set of experiments using ATPy32p, the inorganic phosphate (Pi) was
quantified using a phosphate extraction method, a modification of the technique
described by Schrimsher et al. (1986a). The entire aqueous portion of the reaction
(-400 gL) was added to 2 mL of ice cold 1% w/v (NH4)6Mo7024 4H20 in 0.8 M
HC10 4 containing 0.5 gmol sodium phosphate. Two mL of a 1:1
isobutanol/benzene mixture was immediately added, and the biphasic mixture
was vortexed for 20 sec. The mixture was subjected to a brief centrifugation (30 s
at ~2200 x g ) to facilitate separation of the layers. One mL of the aqueous (top)
layer, was removed for scintillation counting.
Initial analysis of these reactions was accomplished using the model in
Scheme 3.3. In this model, AIR formation ([P]obs) can be mathematically
fast
E + ATP + FGAM .---  E-ATP-FGAM
k-111k
E-ADP-FGAM-P k2 E + ADP + Pi + AIR
k-2
Scheme 3.3: Model for Rapid Quench Experiments
103
Figure 3.1. Elution Profile of the Mono Q FPLC for the Rapid Quench
Experiments. The profile shown depicts the gradient and retention times for
14C-FGAM (2.5 min), 14C-AIR (13 min), 32pi (13.5 min) and ATPy32P (22 min)
using the conditions described in Materials and Methods. Fractions were
collected every 0.5 min. Elution profiles: o - 14C, - 32p
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described by the following equation (Johnson, 1992).
[P]obs = A(l - e-Xt) + kcat * t
Rapid quench reactions were run with substrates at saturating concentrations,
thus one can assume that substrate binding is fast and effectively irreversible.
The second assumption implicit in the analysis is that k-2 is negligible, as AIR
synthetase is essentially an irreversible reaction (Schrimsher et al., 1986b).
However, the validity of this assumption is unknown and can not be easily
tested. In addition, to simplify the analysis, the contribution of k-1 is assumed to
be small, since a burst of product was observed in these experiments. This
assumption can be tested using the isotope trapping experiments of Rose (1980).
Using these assumptions, kcat, Ao (amplitude of burst) and X (rate of burst) all
depend on two rate constants:
kcat = klk 2/(kl + k2), A = [kl/(kl + k2)] 2 , and X = kl + k2
RESULTS
Does AIR synthetase Catalyze ATP/ADP Exchange? ATP/ADP exchange is a
classic technique used to probe for the existence of enzyme phosphorylated (E-P)
intermediates. However, this method absolutely requires that ADP be able to
diffuse from the enzyme~-PADP ternary complex if any exchange is to be
observed. As ATP binds first in the AIR synthetase reaction (Schrimsher et al.,
1986b), exchange experiments can be set up in the absence of the second
substrate, AIR. It is important to realize when designing these experiments that
exchange may not be observed at all ATP/ADP ratios, and that the maximum
rate of exchange will theoretically occur using saturating ATP with ADP added
to give 50% inhibition (Kosow & Rose, 1970). For this reason a range of
ATP/ADP ratios were used where ATP was saturating (KmATp 65 gM, KiADP
106
11 IgM), while ADP concentrations were varied to give from 50 to >90%
inhibition. Ideally, the rate of maximal exchange will be greater than or equal to
the rate of the overall reaction. This requirement, however, is seldom fulfilled as
the second substrate is often required for maximal exchange. It is also important
to demonstrate that the exchange is enzyme dependent.
The kinetic data for these experiments are summarized in Table 3.1. Enzyme
used in these experiments had a low specific activity (0.6 U/mg), and a low
FGAM independent ATPase (0.41%). A control reaction, run without enzyme,
showed an unusually high amount of [14C]-ATP background. A reasonable
explanation for this background is that [14C]-ADP contained small amounts of a
radio labeled impurity that co-migrated with ATP. HPLC separation, shown in
Fig 3.2, gives baseline resolution of ATP and ADP, indicating that the
radioactivity observed in the ATP peak is not a consequence of trailing from the
earlier eluting ADP peak. Although backgrounds are high, the time courses of
exchange show no reproducible production of [14C]-ATP over ten min. The most
telling aspect of this data is that no [14C-]ATP is produced even when enzyme
concentration is increased ten-fold. The rate of ATP/ADP exchange for AIR
synthetase was less than 0.3% of the normal reaction rate, which is the limit of
detection for these experiments. These results are in accord with earlier work by
Schrimsher (unpublished results). While these results do not provide evidence
for the presence of a phosphorylated intermediate for the AIR synthetase
reaction, the absence of exchange does not preclude such an intermediate. As
with all exchange experiments, if ADP cannot dissociate from the putative E-P
species, then [14C]-ADP cannot bind and no radiolabel can be incorporated into
ATP.
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Figure 3.2. Separation of ATP from ADP in ATP/ADP Exchange Experiments.
Shown is the separation of [14C]-ATP from [14C]-ADP present after incubating
0.028 U AIR synthetase with 0.3 mM 14C-ADP (1.1x106 cpm/pmol) and
unlabeled ATP for 3 min. The radioactivity in fractions 10-18 is presented in the
table above.
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fracion
10 76
11 1332
12 1684
13 114
14 66
15 180
I6 155'
17 57
18 48
I II I I
10
OD
action #
109
l -
r 
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cpm
Table 3.1: [14 C]-ATP Produced (cpm) in ATP/[ 14C]-ADP Exchange Experimentsa
425 pM ADPb
110
146
138
171
425 piM ADPC
245
233
176
232
1.5 mM ADPb
568
552
501
542
a All reactions contained 1 mM ATP
b Reactions contained 2.8x10-3 units AIR synthetase
c Reactions contained 2.8x10 -2 units AIR synthetase
Does AIR synthetase Catalyze PIX? Positional Isotope Exchange is an ingenious
method first used by Midelfort & Rose (1976) to probe for the existence of a
phosphorylated intermediate in the glutamine synthetase reaction. The
advantage of this type of exchange is that PIX does not require the diffusion of
the intermediate from the active site. However, PIX does require that the active
site allow for rotation about the P(x-O-P3 bond of ADP so that 180 label placed in
the 3-y bridge is transferred to the 5-non-bridge position in the regenerated ATP
(see chapter 2 for a more complete discussion). Assuming that this rotation does
occur and is not sterically limited, one should observe a PIX rate that is equal to
or greater than the rate of product formation. As with ATP/ADP exchange, PIX
should be demonstrably enzyme dependent.
Design of these experiments was based on the studies of von der Saal &
Villafranca (1985) and von der Saal et al. (1985) with CTP synthetase, and reviews
by Rose (1979) and Raushel and Villafranca (1988). PIX has a number of technical
pitfalls, which can be avoided with careful technique and the use of proper
controls. The ATPy 180 4 used in these experiments must contain as little
ATPy18 0 3160 as possible. Introduction of H 216 0 in the synthesis will cause
formation of this undesired ATP species, and thus rigorously dry conditions
must be used during synthesis. Additionally, if PIX is observed it must be shown
that the activity is not due to a contaminating ATPase present in the AIR
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min
0
1
3
5
10
control
152
148
148
138
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synthetase preparation. In the case of AIR synthetase an additional purification
step using anion exchange chromatography was added to the normal procedure
to remove contaminating ATPase activity. The PIX experiments described below
were designed to investigate the intermediacy of an E-P, in the absence of the
second substrate FGAM or of a substrate analog.
To look for E-P formation using PIX, ATPy1804 (Fig 3.3A) was incubated
with 1.38 units of AIR synthetase and the reaction analyzed by 31p NMR
spectroscopy as a function of time. The amount of ATP 180 3160 present after a
sixty min incubation with AIR synthetase was indistinguishable from the amount
initially in the ATPy180 4 sample (Fig 3.3B). Although the initial amount of
ATPy 180 3160 in this sample was higher than the usual 15-20% (see chapter 2),
the lower limit of detection in these experiments was for a Vpix/Vcat of 0.02.
This would be the rate of exchange if 35% of the total ATP in the reaction had
been converted to ATPy 180 3 160 after a one h incubation. AIR synthetase,
therefore, does not catalyze positional isotope exchange. However, as in the case
of ATP/ADP exchange, failure to catalyze PIX does not rule out the existence of
an enzyme phosphorylated species. It is possible that an E~P exists, but the
enzyme active site does not allow PcaO-P3 bond rotation necessary for PIX to be
observed.
Analysisfor Intermediates in the AIR synthetase Reaction Using Rapid Quench
Methods. These experiments can provide direct evidence for any acid labile
phosphorylated intermediate along the reaction pathway, provided that the
kinetics of the reaction allow for buildup of the intermediate and this
intermediate does not decompose to generate product under the quench
conditions. Rapid quench reactions are one turnover experiments in which an
intermediate species may be trapped as a function of time. In the case of AIR
synthetase, the expected acid reactivity of the proposed intermediate(s)
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Figure 3.3. PIX Catalyzed by AIR synthetase. 31p NMR of ATPy1804 incubated
with 1.38 U AIR synthetase for zero (A) and for sixty (B) minutes. The spectra
display the Pp signal of ATP, and show only one half the doublet. 180 effects a
0.2 ppm down field shift on the 31p chemical shifts. The label on the graph
identified the peaks due ATpy 1803160 and those due to ATPy 180 3. The table
included in this figure lists the amount of ATPy180 3 present at each time point,
represented as % total ATP.
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complicates the analysis. If AIR synthetase catalyzes either of the two pathways
shown in Scheme 3.2, and intermediates 3 or 4 accumulate during the reaction,
then the cyclic phosphate intermediate(s) depicted would be expected to
decompose to give the product, AIR (Hand & Jencks, 1962; Kandel & Cordes,
1967). Such a scenario is discussed further, below. However, if the reaction
proceeds by the upper pathway A (Scheme 3.2) and intermediate 1 accumulates,
then an acid quench would be expected to hydrolyze the phosphorylated species
to starting material (FGAM) and phosphate. The net result would be an apparent
non-productive ATP hydrolysis, forming ADP and phosphate but no AIR.
The ability to detect an excess of phosphate production depends on the
amount of intermediate present at the time of the acid quench. In the most
desirable case, breakdown of a phosphorylated intermediate will be partially rate
limiting, allowing one to see an excess of phosphate production relative to AIR
formation in the first turnover. This excess, also referred to as a burst, should be
dependent on enzyme concentration, as intermediate is formed only on the
enzyme. However, if the enzyme reaction involves a rate determining step
before the intermediate is formed, no or little intermediate will build up and the
small amounts of excess phosphate generated will be undetectable. In a case
where the release of products is rate limiting, both Pi and AIR will appear to
form in a burst. Again, each apparent burst should be enzyme dependent.
In performing these experiments, it is important to use radiolabeled reagents
which are as pure as possible. Both substrates are unstable; ATP will form
phosphate over time, while FGAM will hydrolyze to FGAR, which co-migrates
with AIR under the conditions of the separation. Thus, breakdown of substrate
will give unnecessarily high backgrounds, and reduce the sensitivity of product
quantitation. For this reason, ATPy32P and [14C]-FGAM were purified just before
use. In addition, a number of controls were performed to insure that AIR
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synthetase did not catalyze ATP hydrolysis, the quench/reneutralization
procedure used inactivated AIR synthetase on the millisecond time scale, and
reactivation of the enzyme did not occur upon reneutralization.
When attempting to quantitate the inorganic phosphate produced by AIR
synthetase under one turnover conditions, reactions were run with ATPy32P. The
production of phosphate was determined using the phosphate extraction
procedures described in Methods. The conditions providing the most efficient
extraction of phosphate were determined using stock H 332po 4 and ATPy32P, and
occurred when using only 500 nmol of carrier Pi. These conditions gave
extraction efficiencies of 98%. Once optimized, this technique was especially
attractive as a set of reactions could be run and analyzed the same day.
Backgrounds for these experiments were very low, amounting to only 150 cpm
(70 pmol, 0.3% hydrolysis), and remained constant throughout the short duration
of the experiment. An example of data from this type of analysis is shown in Fig
3.4. Burst amplitudes (AO) were determined by extrapolating the steady state
data to zero time (Fig 3.4), and are compared to the amount of enzyme used in
the reaction. The expected rates were calculated from the amount of enzyme in
the experiment. The amount of excess Pi produced in these experiments is
enzyme dependent (Fig 3.5), but the calculated steady state rate for each reaction
does not agree with the experimentally determined steady state rate in all cases
(Table 3.2, below):
Table 3.2: Burst in Pi Production for E. Coli AIR synthetase
reaction
(gM enzyme)
15
25
35
50
rate observed
(gmol/min)
0.30
0.41
0.47
0.66
rate calculated
(gtmol/min)
0.29
0.50
0.71
1.00
extrapolated
burst (nmol)
0.54
0.95
1.7
2.2
AIR synthetase
present (nmol)
1.0
1.7
2.4
3.4
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Figure 3.4. Rapid Quench Data with ATP732P. The rate of 32Pi formation was
determined for a series of reactions varying AIR synthetase concentrations. Time
points were taken at 100 msec intervals from 100 - 500 msec. AIR synthetase
concentrations used were: o - 15gM, + - 25 gM, A - 35 gM and x - 50 jiM. Lines
shown were fit using a least squares linear regression, assuming a linear fit from
100-500 msec. R2 constants were 0.97 (15 giM), 0.93 (25 gM), 0.92 (35 IM) and 0.81
(50M).
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Figure 3.5. Dependence of Apparent Burst of 32Pi Formation on Concentration
of AIR synthetase . The apparent burst (y intercept) of each reaction in Fig 3.4 is
plotted versus enzyme concentration. The line, fit to the data by a least squares
fit, has a slope of 0.65 and an R 2 of 0.99
118
10 20 30 40 50
uM enzyme
30
.
=I 20
10
0
0
119
Calculated steady state rates are identical to the observed rates at lower concen-
trations of enzyme, but are off by about a-factor of two for the higher
concentrations of enzyme. In contrast to expectations, the scatter in the data with
higher enzyme concentrations is greater than for the dilute enzyme case. This
anomaly is more fully discussed below.
Similar reactions were performed in which [14C]-o-FGAM replaced ATPy 32P
so that AIR production could be measured. Control experiments revealed that
FGAM is somewhat unstable to the acid quench, decomposing to FGAR, which
co-migrates with AIR under the separation conditions. Five reactions without
enzyme were run under the quench conditions described above. The
background for these controls was found to be 1538 + 83 cpm, corresponding to
0.9 nmol or 4.5% hydrolysis of starting material. Thus, when these experiments
were run using enzyme, the background was a significant contribution to the
observed 14C signal . The data in Table 3.3 should be approached with some
skepticism, as the 14C bursts observed were only 1-2 times background.
However, these bursts appear to be enzyme dependent, and are approximately
equal to the Pi burst found in the above experiments. This data is displayed
graphically in Fig 3.6, fit assuming a linear reaction from 100-500 ms. As with
some of the ATP 32P data, the enzymatic rate is approximately half that
expected, and the burst sizes are approximately half the enzyme concentration
(Table 3.3).
Table 3.3: Burst in AIR Production for E. Coli AIR synthetase
reaction
(gLM enzyme)
24
48
rate observed
(gmol/min)
0.26
0.48
rate expected
(gmol/min)
0.42
0.86
calculated
burst (Ao,
nmol)
1.0
1.9
maximum
burst (nmol)
1.7
3.5
120
Figure 3.6. Rapid Quench Data with 14C-FGAM. The rate of 14C-AIR formation
was determined for two reactions with AIR synthetase concentrations at 24 (+)
and 48 pM (A). Background determinations are also shown (o).
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Rapid quench reactions were fit to the model in Scheme 3.3 using KINSIM
(Barshop et al., 1983) assuming that k-2 and k-1 are negligible. Only the data
acquired with 15 gM enzyme give a reasonable fit to a model with kl = 15 s-1 and
k2 = 7.5 s -1 (Figure 3.7, 3.8). Thus, this model and the assumptions made are not
adequate to describe the AIR synthetase reaction.
The inability of our original model to accurately predict the steady state rate
of the enzyme reaction lead us to re-examine our assumptions. Analysis of the
data (Tables 3.2, 3.3) reveals that the observed/expected steady state rate
decreases with increasing enzyme concentration. Yet the burst of either Pi or
AIR, calculated by extrapolating the kinetic data to zero time, is consistently
proportional to enzyme, ruling out inactivation of AIR synthetase at the higher
enzyme concentrations. It is known that ADP is a potent inhibitor of AIR
synthetase (Schrimsher et al., 1986b). ADP shows a noncompetitive inhibition
pattern with FGAM with a Kii of 7 pM and Kis of 16.5 gM, while the pattern is
competitive with ADP with a Kis of 11 IM. It was thought therefore that the
lower than expected rates observed with the higher enzyme concentration might
be accounted for by ADP inhibition of the reaction. A reanalysis of the data
allowing the value of k-2 to vary (Scheme 3.3) could not give reasonable fits for
the reaction, as the values required to fit the data were not physically reasonable.
Thus, the most likely reason for our inability to fit the experimental data to the
model in Scheme 3.3 is that our assumption that k-1 is insignificant for this
reaction is erroneous. The validity of this assumption is easily experimentally
testable using pulse chase experiments (Rose, 1980), and these experiments will
be carried out in the future.
Although our data cannot be fit to a model, the detection of a burst of both
phosphate and AIR production suggests two possible mechanistic schemes.
Rapid production of both products is consistent with a mechanism where
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Figure 3.7. 32pi Production from Rapid Quench Data Fit to Model. A general
model for phosphorylated intermediate formation and breakdown (Scheme 3.2)
was used to fit the experimentally determined rapid quench data. The predicted
time courses (lines) shown are for a rate of FGAR-P formation (kl) of 15 s -l and a
rate of combined FGAR-P breakdown and product release (k 2) of 7.5 s-l.
Predictions are poor for reactions containing higher concentrations of enzyme.
AIR synthetase concentrations modeled were o - 15 gtM, + - 25 gM, A - 35 jiM
and x - 50jpM.
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Figure 3.8. 14C-AIR Production from Rapid Quench Data Fit to Model.
Experimental determinations of 14C-AIR production were fit to a model (Scheme
3.2) using rate constants determined with 32Pi release data (Fig 7). The expected
rates of AIR production (lines) at these enzyme concentrations do not match the
experimentally observed values. AIR synthetase concentrations used were o - 25
tL and +- 50 L.
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product release is the rate determining step in the AIR synthetase reaction. If this
is the case, one cannot trap the intermediates that may exist along the reaction
pathway as buildup of intermediates will not occur. An alternate explanation of
this data is that AIR synthetase catalyzes the formation of intermediates 3 or 4
(Scheme 3.2), and the decomposition of these intermediates is partially rate
determining. The fate of these compounds upon acid quench can be modeled by
the tetrahedral intermediate formed when imido esters are reacted with amines,
studied by Hand & Jencks (1962). A comparison of the two structures is shown
in Scheme 3.4. From this work, it is most probable that intermediates 3 and s
H NX H H NHR R'= CH3CH 2-XNIII( X CH 3CH2 -0 3 PO N H2RO HR phenoxy
R
Scheme 3.4: Proposed AIR sythetase Intermediates and Intermediate in the
Reaction of Amines with Imido Esters
(Scheme 3.2) would decompose rapidly to AIR under neutral pH conditions used
in the separation of products and reactants. However, one might expect to be
able to trap these intermediates under basic conditions. In addition, if 1 exists it
may be trapped by reaction with NH20H under acid conditions. The rapid
quench experiments described above cannot be used to distinguish between
product release and involvement of an imino phosphate intermediate along the
reaction coordinate. Future work using a separation scheme with basic
conditions may resolve the ambiguity if the proposed intermediates can indeed
be isolated.
DISCUSSION
AIR synthetase has been proposed to catalyze the cyclization of FGAM
though a substrate phosphorylated intermediate (Scheme 3.2). In addition, the
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enzyme may proceed via an enzyme phosphorylated intermediate, as has been
proposed for FGAR-AT (see chapter 2). PIX, ATP/ADP exchange and rapid
quench kinetics were used to probe the mechanism of AIR synthetase with the
goal of identifying and characterizing the kinetic properties of various possible
enzyme and substrate reaction intermediates. Our efforts to further elucidate the
mechanism of E. coli AIR synthetase have yielded a few new kernels of
mechanistic information, although no previously proposed mechanism can be
ruled out from this work.
Initial experiments employed the classic technique of ATP/ADP exchange in
an attempt to provide evidence for an phosphorylated enzyme intermediate .
The fact that no exchange was observed does not rule out the existence of an E-P
intermediate, but does suggest that if such an intermediate exists, the enzyme
active site is not sufficiently open to allow exchange.
Positional isotope exchange (PIX) experiments also probe, indirectly, for the
existence of an phosphorylated enzyme intermediate. However, with PIX no
dissociation from the enzyme intermediate is necessary to observe exchange. As
no PIX was observed when AIR synthetase was incubated with ATPy180 4 (Fig
3.3), one must conclude that if a phosporylated intermediate exists, rotation of
the ADP Pa-O-P[3 bond is not possible (Rose, 1979).
The above exchange experiments were run in an attempt to provide evidence
for an enzyme phosporylated intermediate in AIR synthetase. Exchange
experiments are usually not the preferred method to address this question, as
negative results do not provide conclusive evidence against an intermediate. A
more direct approach would be to use chiral ATPyS160170 180, first used by
Knowles and co-workers to determine the number of transfers phosphate
undergoes in the reaction of E. coli alkaline phosphatase (Jones et al., 1978).
Unfortunately, AIR synthetase uses ATPyS very inefficiently; the Vmax with
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ATPyS is 0.0003 times the rate of normal turnover with ATP (Schrimsher et al.,
1986b). This extremely slow rate could signify that the mechanism of the enzyme
is different with the alternate substrate, and any mechanistic data gained using
this substrate would be suspect. Thus, it appears that proof for an E-P
intermediate for AIR synthetase will come only if suitable trapping conditions
are found to stabilize the intermediate and allow observation through direct
means.
These exchange experiments do not address the effect of FGAM on the
enzyme reaction. It is possible that an observable E-P intermediate exists, but
forms only after FGAM binds to the enzyme. Likewise, these exchange
experiments do not address the possibility of a substrate phosphorylated
intermediate (FGAM~P), depicted in Scheme 3.2. The 180 experiments
accomplished by Schrimsher et al. (1986a, b) suggest that an FGAM-P
intermediate may exist. However, it is not possible to carry out PIX with AIR
synthetase in the presence of FGAM, as the ATPy1804 will be hydrolyzed. A
similar problem is discussed by van der Saal et al. (1985) for CTP synthetase. An
analog of FGAM able to undergo slow chemistry, or at least bind to AIR
synthetase well enough to allow the phospho intermediate to form, is needed to
address these facets of mechanism. One candidate would be FGAR, which could
work if this nucleotide competes for the FGAM binding site on the enzyme.
However, FGAR has never been tested as an AIR synthetase inhibitor.
Rapid quench experiments can provide direct evidence for a phosphorylated
intermediate along the reaction pathway, provided that the intermediate
decompose to something other than product and the kinetics of the reaction
allow for buildup of the intermediate. The fact that burst of both products are
seen in the rapid kinetics data presented above is consistent with a mechanism in
which product release is the rate determining step for E. coli AIR synthetase. An
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alternative possibility, which can not be distinguished from slow product release,
is that AIR synthetase proceeds with the buildup of intermediates 3 and/or 4,
depicted in Scheme 3.2.
It may be possible to distinguish between these possibilities if the appropriate
quench conditions can be found to stabilize and isolate the intermediate. For
instance, Anderson et al. (1988) were able to stabilize the substrate
phosphorylated intermediate in the reaction pathway of 5-enolpyruvoyl-
shikimate 3-phosphate synthase. The work of various researchers (Hand &
Jencks, 1962; Kandel & Cordes, 1967 and Pletcher et al., 1968) suggest that basic
conditions may provide an environment stable enough to isolate these
intermediates. However, if conditions cannot be found to stabilize the
intermediate there may be no way to prove the existence of either possible
intermediate. Getting at product release through more usual kinetic techniques
is not possible as AIR synthetase is an irreversible catalyst (Schrimsher et al.,
1986b).
SUMMARY
Both ATP/ADP and positional isotope exchange experiments have failed to
provide any convincing evidence for the existence of an E~P intermediate in the
AIR synthetase reaction pathway. Pre-steady state experiments show that an
enzyme dependent burst of both Pi and AIR are formed in one turnover. These
results cannot distinguish between two possible mechanisms. One possibility,
consistent with the data, is that product release as a rate limiting step in the
reaction. The other possible mechanism involves buildup of a phosphorylated
intermediate that is unstable and degrades to product (i. e. through intermediates
2 or 4 in Scheme 3.2).
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Chapter 4
Investigation of the ATP Binding Site of Escherichia coli
AIR synthetase Using Affinity Labeling and
Site-Directed Mutagenesis.
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INTRODUCTION
Aminoimidazole ribonucleotide (AIR) synthetase catalyzes the fifth reaction
of de novo purine biosynthesis. This reaction utilizes ATP to assist in the
4
2
synthetase 0 3 PNH
['D A . D; -
HO OH |r ur + ri HO OH
FGAM AIR
Scheme 4.1: Reaction Catalyzed by AIR synthetase
cyclization of FGAM to generate AIR (Scheme 4.1). The mechanism is thought to
involve an O-phosphorylated amide, which subsequent to attack by the N1 of the
amidine of FGAM forms a five membered ring which can lose both phosphate
and a proton to generate AIR (Schrimsher et al., 1986b). The involvement of ATP
in the dehydration of amides is common to a number of enzymes involved in
purine and pyrimidine biosynthesis (Hardie & Coggins, 1986). Nothing is
known about the structure(s) of the enzyme domains responsible for catalyzing
this type of reaction, or the groups in the active site participating in this catalysis.
AIR synthetase and formylglycinamide amidotransferase (FGAR-AT), successive
steps in the purine biosynthetic pathway, have been proposed by Schendel et al.
(1989) to proceed through similar mechanisms. Comparison of the sequences of
E. coli FGAR-AT and AIR synthetase, however, and additional enzymes thought
to involve analogous mechanisms such as CTP synthetase, reveal no significant
region(s) of homology using the program Compare (Maizel & Lenk, 1981). This
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chapter describes our efforts, using affinity labeling and site directed
mutagenesis to define the ATP binding domain.
Affinity labeling and is an established biochemical technique that has been
used to identify nucleophilic residues within the active sites of enzymes
(reviewed in the issue Methods Enzymol. 46). A number of ATP affinity labels
have been synthesized and used effectively to identify residues within ATP
binding domains (Colman, 1983; Colman, 1989). Fluorosulfonylbenzoyl
adenosine (FSBA), an ATP analog (Scheme 4.3), has been successful in labeling
the active sites of a number of different enzymes at various residues, as discussed
below. The reagent has been found to covalently modify several nucleophilic
amino acids, yielding adducts of differing stabilities. Lysine (Pinkofsky et al.,
1984) and tyrosine (Bitar, 1982 ) adducts of FSBA are the most stable, and only in
these two cases have modified peptides been directly isolated and identified.
Kinetic evidence has suggested that arginine can also be modified by FSBA
(Pandey and Modak, 1988). However, FSBA-histidine adducts are unstable in
acid (Harlow and Switzer, 1990), while enzymes labeled at cysteine regain
activity upon incubation with DTT or P-ME (Krieger and Miziorko, 1986). Serine
has been shown to react with FSBA (Poulos and Price, 1974), but this has not
been demonstrated in a protein. This wide reactivity makes FSBA useful as a
general ATP affinity label.
Labeling of specific amino acids with an affinity label is not always an
indication that these residues are required for binding or catalysis. Numerous
examples in the literature show the importance of confirming the role of labeled
amino acids in binding and/or catalysis through the use of a complementary
methodology such as site directed mutagenesis (Freitag & McEntee, 1991; Parakh
& Villafranca, 1990) or structural determination (Vollmer & Colman, 1990;
Kohlstaedt et al., 1992).
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E. coli AIR synthetase is amenable to investigation by both of these
techniques. It has been cloned and overexpressed (Smith, and Daum, 1986;
Schrimsher et al., 1986b), and the purification can be accomplished to provide
gram quantities of pure enzyme. Furthermore, the kinetic mechanism of this
enzyme has been determined to be sequential ordered with the ternary complex
formed by addition of ATP followed by FGAM (Schrimsher et al., 1986b).
This paper describes the use of FSBA (Pal et al., 1975) as an ATP affinity label
for E. coli AIR synthetase. Enzyme inactivation is shown to occur
stoichiometrically with specific labeling of a single amino acid residue. The
peptide containing this residue has been isolated and sequenced and the
modified residue identified as lysine. Site-directed mutagenesis of this residue
has shown this position to be near, or in, the ATP binding site.
MATERIALS AND METHODS
Materials. Sephadex G-25 and G-50 were obtained from Pharmacia. E. coli
lactate dehydrogenase (LDH, 860 U/mg), pyruvate kinase (PK, 470 U/mg),
phosphoenolpyruvate (PEP), reduced 3-nicotinamide adenine dinucleotide
phosphate (NADH), gelatin, bovine serum albumin (fraction V, BSA), 5'-(p-
fluorosulfonylbenzoyl) adenosine (FSBA) and adenosine-5'-triphosphate (ATP)
were purchased from Sigma Chemical Co. ATPy32P (6000 Ci/mmol) and 14C-
[C-8] FSBA (55 mCi/mmol) were obtained from New England Nuclear. HPLC
reverse phase C-18, 5 g, 4.6 x 250 mm columns used in purification of peptides
were purchased from Vydac. Dithiothreitol (DTT) was purchased from Amresco
(Solon, OH). Guanidine hydrochloride (Gu-HCl) was recrystalized from
methanol. SintATM scintillation fluid was purchased from Packard. The
synthesis of FGAM, as 40:60 c/ mixture, was accomplished using the methods
described in this thesis (chapters 2 and 3). All FGAM referred to in this paper is a
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mixture of anomers, and concentrations are given for the relevant f3 anomer only.
TaqTM polymerase was from Perkin Elmer. T4 DNA ligase was purchased from
BRL. All restriction enzymes as well as HindIII and BstEII digested X DNA
molecular weight standards were purchased from New England Biolabs.
Oligomers for sequencing and site directed mutagenesis were obtained from the
MIT Biopolymers Lab. MermaidTM, glass beads for purification of oligomers of
<200 bp, was purchased from American Bioanalytical. USBiocleanTM, glass beads
for purification of DNA >200 bp, was purchased from the United States
Biochemical Corp. TX635 (F' lacZ+ cI857), which contains an episome-borne
temperature-sensitive X repressor (Mieschendahl & Muller-Hill, 1985), pJSl119, a
plasmid containing purM under the control of a XPL (heat inducible) promoter
(Inglese et al., 1990), and TX393 [ara A (lac) purM srlC300::TnlO recA56] (Smith &
Daum, 1986) were gifts from Dr. John Smith and Louise Thomas of Seattle
Biomedical Research Institute, Seattle, WA.
General Methods. Sodium dodecylsulfate polyacrylamide gel electrophoresis
(SDS-PAGE) samples were prepared and run as described by Laemmli (1970)
and developed using the alternate fix and staining technique described by
Cooper (1977). Protein assays were accomplished using the method of Lowry et
al. (1951) with BSA (279 = 0.667 mL mg-1 cm-1; Schachman & Edelstein, 1966) as
a standard. Protein sequencing was effected using an Applied Biosystems Model
477 Protein Sequencer with on-line Model 120 PTH Amino Acid Analyzer by the
MIT Biopolymers Lab. Small scale (-10 ktg) plasmid preps were accomplished
using the Magic MiniprepTM system from Promega, and larger scale plasmid
isolation was effected using the Maxiprep kit from Qiagen. The DNA of all site-
directed mutants prepared in this work was sequenced using a kit from BRL Life
Sciences which employs Sequenase and the dideoxy chain termination method
(Sanger et al., 1977). Mass spectral analysis was performed on an Applied
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Biosystems Biopolymer Mass Analyzer, BIO-IONTM 20. Radioactivity was
quantitated using a Packard 1500 Tri-Carb Scintillation Counter. Purification of
PCR (polymerase chain reaction) derived short (<200 bp) oligomers was effected
on acrylamide gels in Tris-borate EDTA buffer (TBE), whereas larger DNA
samples were purified using 1% agarose and Tris-acetate EDTA (TAE) buffer
(Sambrook et al., 1989). Competent cells were made using the method of
Hanahan (Sambrook et al., 1989). Electroelution of primers was accomplished
using a Centrilutor Microelectro-eluter from Amicon using directions from the
manual. Activity assays for AIR synthetase, both Bratton-Marshall and
spectrophotometric, were as previously described (Schrimsher et al., 1986a). One
unit of activity is defined as the amount of enzyme needed to form 1 4mol of
product in 1 min at 37 oC.
Kinetics of AIR synthetase Inactivation by FSBA. Inactivation reactions were
carried out at 15 oC and contained 50 mM HEPES (pH 7.7), 3 mM MgC12, 400
mM KC1, 0.14 mM -FGAM (a3 mix), 2.7%(v/v) DMSO, 2.7%(v/v) EtOH, and
0.3 units AIR synthetase in a final volume of 100 gL. FSBA concentrations ranged
from 0 - 440 pM. Enzyme concentrations were too high to assay from this
mixture directly, and so after initiating the reaction with enzyme, 10 gL aliquots
were removed at various times and diluted 1:10 into 90 4L of buffer containing
50 mM HEPES (pH 7.7), 3 mM MgC12 and 400 mM KC1. From this diluted
sample, exactly 30 s after removing the enzyme from the inactivation mixture, a
10 pIL aliquot was used to initiate a Bratton-Marshall assay solution. Inactivation
studies were also carried out (separately) with either the omission or addition of
FGAM or ADP, respectively, to the inactivation mixture.
Analysis of the inactivation data used Eq 4.1, (Foster et al., 1981) where E is
enzyme activity at time t, and E0 represents the activity at
log (E/Eo) = -(kobs/2.303) x t Equation 4.1
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time zero. Multiple inactivation experiments were fit to Eq 4.2, in order to
1/kobs = (Ki/k 2) (1/I) + 1/k2 Equation 4.2
determine Ki, the dissociation constant for FSBA binding to AIR synthetase, and
k2, the rate of inactivation (Scheme 4.4)
Stability of FSBA. Samples of FSBA (2.4 mM) were prepared in D 2 0 and
contained 10% v/v d6-DMSO, 9 mM EDTA and 90 mM potassium phosphate
(pH 6, 7 or 8) in a final volume of 600 gL. NMR spectra were taken periodically
over a three week period. Control experiments were carried out in which
adenosine (2.5 mM) replaced FSBA. The pD of the solutions were redetermined
at the end of each experiment.
Stoichiometry of Inactivation by FSBA. Inactivation mixtures contained in a
final volume of 180 IL: 50 mM HEPES (pH 7.7), 3 mM MgC12, 400 mM KCl, 0.29
mM [-FGAM, 1.5 mg (specific activity 3.3 U/mg) AIR synthetase and either 0 or
0.23 mM FSBA. After a 3 h incubation at 15 oC, samples were loaded onto a
Sephadex G-50 column (0.75 x 20 cm) equilibrated in 50 mM potassium
phosphate (pH 6.5). Fractions of 0.5 mL were collected and the fraction
containing the protein was assayed for activity (Bratton-Marshall) and protein
concentration. Difference spectra were recorded using the control sample (0 mM
FSBA) as a reference, with care being taken to insure that the protein
concentrations were equal in sample and reference cuvettes. The £259 for FSBA
used is 15,800 M- 1 cm- 1 (Pal et al., 1975).
Alternately, [14C]-FSBA was employed to measure the stoichiometry of
inactivation. A typical reaction mixture contained 440 gM -FGAM, 440 pM [8-
14C] FSBA (specific activity 1.1x10 6 cpm/nmol), 2.1 mg AIR synthetase in a final
volume of 200 gL. Aliquots of 20 gL were removed at 0, 5, 10, 25, 45, 90, 120 and
180 min and placed on separate Sephadex G-50 columns (0.75 x 17 cm)
equilibrated with 100 mM sodium phosphate (pH 7.0). Fractions of 0.5 mL were
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collected, and the fractions containing the protein were pooled and assayed for
activity. The amount of radiolabel was quantitated by scintillation counting.
Stability of the E. coli AIR synthetase-FSBA adduct. An incubation mix in a final
volume of 400 gL contained 50 mM HEPES (pH 7.7), 3 mM MgC12, 400 mM KC1,
570 mM [14C]FSBA (specific activity 3.1x106 cpm/jmol), 550 pM 3-FGAM, 4.3
mg AIR synthetase (SA 3.3 U/mg) and 15% (v/v) DMSO. The mixture was pre-
incubated at 25 oC and the reaction initiated by addition of enzyme. Aliquots of
10 L were removed at 2, 21, 60 and 180 min and loaded onto separate columns
of Sephadex G-50 (0.75 x 10 cm) at 4 oC equilibrated in 100 mM sodium
phosphate (pH 6.5). Fractions of -300 L were collected. The fractions
containing protein were pooled and assayed for activity. At 4.5 h, the time
calculated to give 99% inactivation, four 85 gL aliquots of this inactivation
mixture were loaded onto separate Sephadex G-50 columns (0.75 x 20 cm ) at 4
oC, equilibrated in 0.1%(v/v) trifluoroacetic acid (TFA), 50 mM
triethylammonium acetate (TEA.OAc) (pH 6.0), 100 mM sodium phosphate (pH
7.0) and 50 mM HEPES (pH 7.5). respectively. Fractions of 0.5 mL were collected
and the fractions containing protein were pooled. The samples containing
protein-FSBA adducts in TEA.OAc, sodium phosphate and HEPES buffers were
incubated at 25 oC, while the sample in TFA was incubated at 4 oC. At various
times (every -12 h over 96 h) a 100 gL aliquot was removed from each sample,
placed onto a 10,000 molecular weight cutoff filter (Ultrafree MCTM) and spun at
2000 x g for 60 min. The radioactivity in the filtrate and that retained on the filter
were quantitated by scintillation counting. Control experiments were performed
to insure the filters used above did not cause 14C quenching.
Isolation of E. coli AIR synthetase-FSBA labeled peptide. All yields in this section
refer to the overall yield, and are normalized to the amount of protein (110 nmol)
in the original inactivation. A reaction mixture identical to that previously
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described but containing 675 gM 14C-FSBA (specific activity 2.7x10 6 cpm/gmol),
550 gM -FGAM, 5%(v/v) DMSO, 10%(v/v) EtOH and 4.2 mg (110 nmol) AIR
synthetase was incubated at 30 oC in a final volume of 220 gL. The reaction,
initiated by addition of enzyme, was allowed to proceed for 3.5 h. The entire
mixture was then loaded onto a Sephadex G-50 column (0.75 x 20 cm ) in 50 mM
HEPES (pH 7.5) at 4 oC and eluted with the same buffer. Fractions (300 gL) were
collected, and those containing protein were pooled. Solid guanidine HC1, and
stock solutions of HEPES, EDTA and DTT were added to the this mixture, and
the solution was adjusted to pH 7.5 using 1 M NaOH. The contained, in a final
volume of 1.2 mL, 5.4 M GuHCl, 100 mM HEPES (pH 7.5), 10 mM EDTA, -90
gM protein and 1 mM DTT. Reduction of the disulfide bonds was accomplished
by incubating this reaction mixture at 25 oC for 30 min. Iodoacetic acid was then
added to give a final concentration of 5 mM. The reaction vessel was wrapped in
foil and incubated at 25 OC for 3 h, then was loaded onto a Sephadex G-50
column (1.5 x 18 cm) at 4 oC in 100 mM sodium phosphate (pH 7.0) and eluted
with the same buffer. Fractions (0.5 mL) were collected and analyzed for A280
and radioactivity by scintillation counting. Fractions containing protein were
pooled (5 mL) and the protein concentration was determined (Lowry et al., 1951).
The recovery of protein through the inactivation and carboxymethylation steps
was 52% (58 nmol). Trypsin (10 mg/mL in 1 mM HCl) was added (2.2 gL, 580
pmol) to this 5 mL inactivated AIR synthetase sample. After 6 h at 37 oC,
conditions determined by control experiments to give complete digestion, the
reaction mixture was frozen in liquid N 2 and stored at -80 °C.
The proteolyzed [14C]-AIR synthetase was purified using a Vydac C18
analytical column equilibrated in 0.1% (v/v) TFA in water (solvent A), and
eluted with an increasing 0.1% (v/v) TFA acetonitrile gradient. [14C]-Adduct
(9 nmol) in 1 mL was injected onto the column which was eluted at 1 mL/min.
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One min fractions were collected. A single radioactive peak eluted at 37% (v/v)
acetonitrile using a linear gradient of 0 - 60% acetonitrile/0.1% TFA over 75 min
(Fig 4.1). Fractions from all 5 injections, containing radioactivity were pooled
and concentrated in vacuo, but not to dryness, to a final volume of 980 pL.
Radioactivity recovered through this step was 25% (30 nmol) of the initial
adduct. The [14C]-adduct was then rechromatographed in a second solvent
system using 20 mM sodium phosphate (pH 7.0) as solvent A and 70% CH3CN in
20 mM sodium phosphate (pH 7.0) as solvent B. Each injection contained 15
nmol of adduct in 500 gL, and a single radioactive peak was isolated at 39 min
using 30% B in an isocratic elution (Fig 4.2). Fractions containing radioactivity
were pooled and concentrated in vacuo to 350 gL (nt to dryness). Quantitation
revealed that the overall yield of radioactivity through this second isolation was
17% (19 nmol). This material was then desalted using the TFA system described
above. Again, a single peak eluted at 38% acetonitrile/0.1% TFA, and fractions
containing radioactivity were pooled and concentrated to 520 LL in vacuo (again,
not to dryness). The adduct was isolated in a final yield of 14% (15 nmol). This
sample was submitted for Edman degradation and mass spectral analysis.
Analysis of the Interaction of chicken liver AIR synthetase (purDMN) with FSBA.
Incubation mixtures contained 50 mM HEPES (pH 7.7), 20 mM MgC12, 200 mM
KCl, 9% (v/v) DMSO, 0.1 mM -FGAM, 1.3x10 -2 units AIR synthetase (specific
activity 0.45 units/mg) and either 10 gM, 0.1 mM or 1 mM FSBA in a final
volume of 55 iL. A control reaction was identical to that described above except
that FSBA was omitted. Incubations were carried out at 25 oC and the reaction
was initiated by addition of FSBA. Aliquots were removed at 30 sec, 5 min, 15
min, 30 min and 45 min and AIR synthetase activity determined using the to
Bratton-Marshall assay. Results were analyzed using Eq 4.1 as above.
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Figure 4.1: Isolation of FSBA-AIR synthetase Adduct Using Vydac C18
Reverse Phase HPLC and an Aqueous TFA in an Acetonitrile Gradient. The
A220 profile of the initial purification with the elution gradient as indicated on
the axes at right. The radioactive profile of fractions eluted from the column is
below the absorbence trace.
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Figure 4.2: Isolation of FSBA-AIR synthetase Adduct Using Vydac C18
Reverse Phase HPLC and Sodium Phosphate in an Acetonitrile Gradient. In
this second purification step, adduct (13 nmol) was injected onto an HPLC C-18
column and eluted using an isocratic gradient of 30% B (see text for buffer
compositions) at 1 mL/min. Fractions were collected every 30 sec, an aliquot of
which was quantitated by scintillation counting. Shown are the A220 and
radioactive profiles off the HPLC column.
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Strategyfor Mutagenesis. Mutagenesis was first attempted using a variation of
the PCR overlap extension method described by Horton et. al. (1989). The
strategy used in these experiments is described in Scheme 4.2, and employs a
double stranded template, in this case the plasmid pJS119. The primers
employed in these experiments are shown in Table 4.1, and were desalted before
use by EtOH precipitation (Sambrook et al, 1989).
Table 4.1: Primers Used in PCR Mutagenesis
primer N 5' GTG TGT CAT ACG AAA CGA AGC A 3'
L 5' GCC TAG GAT TCT TCC AAC CAG 3'
Q 5' GCC TTG GAT TCT TCC AAC CAG 3'
R 5' GCC TCT GAT TCT TCC AAC CAG 3'
C1 5' TTA CGC CAA GCT TGC ATG CC 3'
C2 5' TGA TTA CGC CAA GCT TGC AT 3'
Underlined regions identify mutated codons.
(A) Isolation of pJS119. A 5 mL culture of E. coli TX635/pJS119 was grown at
28 OC to saturation and used to inoculate a flask containing 200 mL LB media.
Cells were harvested in late log by centrifugation (12,400 x g for 15 min).
Plasmid DNA was isolated using the Qiagen "Maxi" scale preparation (an
alkaline lysis followed by anion exchange purification). Total yield was 160 gg of
ds DNA using 8260 20 mL mg- 1 cm- 1.
(B) Initial PCR Reactions (Scheme 4.2). PCR reactions contained, in a final
volume of 50 gL, 10 mM Tris-HC1 (pH 8.3, 25 oC), 50 mM KC1, 1.5 mM MgC12,
0.01% (w/v) gelatin, 0.2 mM each dATP, dTTP, dGTP and dCTP, 0.1 pgM mutant
primer, 0.1 pM primer N, 30 ng pJS119 previously cut with ScaI and 5 units Taq
polymerase. A mineral oil overlay was placed on top of the reaction mixture.
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Amplification of the DNA was accomplished using 31 iterative thermal cycles of:
denaturation for 1 min at 94 OC, reannealing for 2 min at 50 oC and elongation for
varied times at 72 oC. The elongation time for the first 10 cycles was for 2 min,
which was followed by ten cycles with 2.5 min elongation incubations. The next
10 cycles were allowed to react for 3 min, and the final, single cycle incorporated
a 15 min elongation time.
Final products were purified on 10% acrylamide gels run in TBE, and
removed from the gel using either the crush and soak method (Sambrook et al.,
1989c) or electroelution at 200 volts into a Centricon-3. In one case an acrylamide
gel slice containing product DNA was inserted into a slit in a 1% agarose gel, and
current was applied to allow the small (182 bp) ds DNA product to migrate into
the agarose. This DNA was isolated from the agarose using the MermaidTM glass
bead system. Yields, as ascertained by the saran wrap (or dot blot) method
(Sambrook et al., 1989), averaged -125 ng ds DNA for a 50 gpL reaction.
Final PCR Reactions (Scheme 4.2). The N-terminal primer in these reactions
was the PCR piece isolated as described above, and was used at 8 to 35 nM final
concentrations (50 - 200 ng) in 50 tL reaction mixtures identical to those
described above. The C-terminal primer, (either C1 or C2, see Table 4.1), was
used at 0.1 M, and magnesium concentrations were varied from 1.5 - 45 mM.
The thermocycling protocol was as described above, but in a few reactions
annealing temperatures were changed to 60 °C. Reactions products were
isolated on 1% agarose gels in TAE buffer. Product bands were excised and
removed from the gel using USBiocleanTM.
Analysis of PCR generated mutants. Plasmid pJSll19 DNA was isolated as
described in Methods. Vector DNA was generated by digesting 1 gg of this DNA
with 10 units EcoRl and 5 units BamH1 at 37 oC in an Eppendorf tube for 45 min.
The 3 kb fragment was purified from a 1% agarose gel and ligated to DNA from
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the second PCR reaction (insert) which had been likewise digested with BamH1
and EcoRl, and subjected to ethanol precipitation. Ligase reactions were run in a
final volume of 8.5 gL at 16 OC for 11 h with an insert to vector ratio of 0.03-0.3
(-5-50 ng PCR insert, 200 ng vector) and 1 U BRL T4 DNA ligase. Control
ligations with no added insert were also performed. Transformations were
effected by mixing 100 gL of competent TX 625 cells with 3 gL of the reaction
mixture subsequent to ligase treatment (Sambrook et al., 1989). After adding 200
gIL of sterile LB media and allowing the transformed cells to recover at 37 °C for
90 min, the entire transformation mixture was spread onto a LB agarose plate
containing 50 [tg/mL ampicillin. Cells were incubated at 37 oC for -12 h, and a
portion of the surviving colonies (typically 1-6 per transformation) were removed
from the plate, grown to saturation in LB/ampicillin media and used for
isolation of plasmid DNA. The DNA was subjected to restriction digestion
analysis with EcoRl and BamHl/EcoRl. Colonies manufacturing plasmid DNA
of the expected size were grown up for storage in glycerol cultures. Plasmid
DNA from these bacteria was isolated an subjected to DNA sequencing in the
region of the site of the mutation.
Preparation of Site-Directed Mutants. Mutants were prepared by the method of
Taylor et al. (1985), using a kit from Amersham (version 2). The strategy for this
mutagenesis is shown in Scheme 4.3. M13 ds DNA was isolated using Magic
Minipreps. DNA containing the purMN gene was isolated as a 2-kb fragment
from an EcoRI/BamHI digest of pJSll19, and purified on a 1% agarose gel before
use in subsequent ligations. M13mp18 DNA was likewise digested with
EcoRI/BamHI and purified on a 1% agarose gel. Ligations were run for 14 h at 25
oC and contained 60 ng purMN fragment and 25 gg M13 derived DNA with 1 U
BRL T4 DNA ligase in 10 gL. Transformation of TG1 bacteria (Sambrook et al,
1989) with 5 gIL of ligation mixture and growth on media containing isopropyl-p-
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D-thio-galactopyranoside and 5-bromo-4-chloro-3-indolyl--galactoside yielded
10 colorless plaques.
Preparation of purMN containing M13mp18 ss DNA was accomplished using
PEG precipitation followed by phenol, diethyl ether and chloroform extraction
(Appendix C). Mutagenesis was accomplished with this ss DNA and the primers
N, Q and R above were used to direct the mutation. Transformations generated
50-150 plaques per attempt.
The 2-kb DNA fragment of the replicative form, mutant purMN M13mp18
was isolated for each mutant, digested with EcoRI and BamHI and purified on 1%
agarose. This DNA was ligated with the 3-kb, gel purified EcoRI/BamHI
digested pJSll19 DNA fragment using a insert:vector ratio of 3-5:1 (600 ng vector
DNA) Ligation mixtures were used to transform either E. coli. strain TX635 or
TX393. Transformants were selected on LB media with 50 gg/mL ampicillin, and
a small number of resulting >100 colonies were analyzed using restriction
analysis and DNA sequencing across the site of the expected mutation. All
transformants sequenced contained the expected base changes.
Defining Growth Conditionsfor TX635/pJSl 19 K27X mutants. To define optimal
growth conditions pJS119 wild type mutant plasmids in TX635 were grown in LB
media at 30 oC. Aliquots were removed just before induction and then at 1, 2, 3
and 4 h after induction, for wild type (pJSl119), K27L, K27Q and K27R cultures.
Each sample was spun for one min in an Epifuge at 4 oC, the supernatant was
removed and the pellet quick frozen in liquid nitrogen. Samples were stored at
-20 OC. Each sample removed during growth was resuspended in 10 mM Tris-
HC1 (pH 7.5) such that an aliquot would produce an A600 of 0.075 OD. A 40 gL
aliquot of this resuspended sample was added to 10 gL 5X Laemmli buffer
(Laemmli, 1970) and placed in a boiling water bath for 5 min. Theses samples
were then loaded onto a 10% acrylamide gel and subjected to SDS-PAGE.
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The doubling time of each overproducing strains was 0.9 h, identical to the
pJS119 wild type overproducing. Bacteria were induced in late log phase (-0.6-
0.8 OD600) by adding equal volume of media at 54 oC with rapid stirring, then
the cultures transferred to 42 oC and allowed to grow for 4 h.
Growth of K27X mutants of AIR synthetasefrom TX393/pJS119. Studies in the
previous section revealed that mutant AIR synthetases are expressed
constituatively. TX393 strains were grown at 30 oC in LB media and were
harvested three h after their transition to the stationary phase. Cells were
collected by centrifugation (10 min, 2700 x g at 4 oC), and stored at -80 °C. Yields
from a 1 L culture ranged from 1.5 - 2.8 g of cell paste.
Isolation and Characterization of K27X mutants. Isolation of wild type and
mutant E. coli AIR synthetases was as described by Schrimsher et al. (1986b),
except that the final size exclusion column was omitted. The apparent KmATP
for each K27 mutant enzyme was determined. A typical reaction mixture
contained, in a final volume of 300 pL, 50 mM HEPES (pH 7.7), 3 mM MgC12, 970
mM KC1, 230 M 3-FGAM, 2 mM PEP, 0.2 mM NADH, 10 U PK, 10 U LDH, AIR
synthetase and varied amounts of ADP (0.2 - 5 Km). Data was fit using the
programs of Cleland (1979).
RESULTS
Kinetics of Inactivation of AIR synthetase by FSBA. FSBA is an ATP analog that
has been successfully used to covalently modify the ATP binding site of a
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Figure 4.3: Structures of FSBA and ATP
number of proteins (Colman, 1983; Colman et al., 1989). In an effort to label the
active site of AIR synthetase, various concentrations of FSBA were incubated
with AIR synthetase and saturating amounts of FGAM, and at various times
aliquots were removed and assayed for remaining enzyme activity (Fig 4.4).
Saturating levels of FGAM were present in the reaction mixture as kinetic studies
showed that FGAM increases the rate of the inactivation. The results of a series
of experiments are summarized in Fig 4.4. The model for inactivation is shown
in Scheme 4.4, where E is enzyme, I is the inhibitor, Ki is the thermodynamic
dissociation constant and k2 is the rate constant for inactivation.
E+I . Ki E.I dke E-I*
Scheme 4.4: Model for Irreversable Enzyme Inactivation
A replot of the data obtained from Fig 4.4 using Eq 4.2 gives a straight line (Fig
4.5) from which the kinetic constants of Ki = 25 [M and k 2 = 5.6 x 10-2 min- 1 were
determined (Main, 1973). The Ki measured in these experiments is of the same
order as the apparent Km for ATP of 65 glM (Schrimsher et al., 1986b). The rate
of inactivation forty-one times less than the rate constant for turnover with the
natural substrate.
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Figure 4.4: Time Dependent Inactivation of AIR synthetase by FSBA. AIR
synthetase was incubated with (o) 0, (+) 11 gM, () 22gM, (A) 66 gM and ( ) 440
gM FSBA. Aliquots were removed periodically and assayed for activity.
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Figure 4.5: Determination of Inactivation Constants Using Eq 4.2. A plot of
1/kobs vs 1/[FSBA]. The line was determined by a least squares best fit (R 2 =
0.989).
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Control experiments revealed that dilute AIR synthetase samples incubated at
37 OC slowly lost activity. Raising the enzyme concentrations to 0.8 mg/mL
increased the stability of AIR synthetase so that no activity was lost in a 90 min
incubation. In addition, using more concentrated enzyme reaction mixtures
allowed inactivations to be run at higher temperatures (up to 30 oC) without loss
of activity in the control samples. This resulted in shorter incubation times to
give complete inactivation. Inactivation studies were therefore carried out at
high concentrations of protein to avoid these problems, however this necessitated
that samples from the inactivation mixture be diluted prior to assaying for
remaining activity.
A repetition of the experiments in the absence of FGAM gave a two-fold
reduction in the rate of inactivation, while ADP gave complete protection against
inactivation (Fig 4.6). ADP, a competitive inhibitor with respect to ATP
(Schrimsher et al., 1986b), was used in protection experiments instead of ATP, as
inactivation experiments were normally carried out in the presence of FGAM and
would have undergone turnover if all substrates were present. The effects of
FGAM and ADP both suggest that inactivation occurs through a specific
interaction between the inhibitor and AIR synthetase.
Stoichiometry of Inactivation by FSBA. Initial experiments to examine the
stoichiometry of inactivation of AIR synthetase by FSBA used UV/vis difference
spectroscopy, as 14C-FSBA was unavailable. A difference spectrum comparing
FSBA inactivated AIR synthetase versus AIR synthetase is shown in Fig 4.7. The
extinction coefficient for FSBA (259=15,800 M-lcm- 1) and the protein
concentration (Lowry) were used to determine of the ratio of FSBA/AIR
synthetase subsequent to complete in activation. This ratio was found to be 0.95.
Closer examination of the difference spectrum, however, suggests that the
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Figure 4.6: Effect of FGAM and ADP on Inactivation of AIR synthetase by
FSBA. The rate of inactivation of AIR synthetase is enhanced by addition of
saturating FGAM, while 0.1 mM ADP affords complete protection against
inactivation. A. Effect of FGAM on FSBA Inactivations: (o) 140 JIM FGAM, no
FSBA; (+) no FGAM, 66 jiM FSBA; (A) 140 jiM FGAM, 66jM FSBA. B. Effect of
ADP in FSBA Inactivations: (o) no ADP, no FSBA; (+) 66 M FSBA, 100 iM ADP;
(A) 66 gM FSBA, no ADP.
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Figure 4.7. Difference Spectrum of AIR synthetase Labeled with FSBA and
Unlabeled AIR synthetase. The resulting spectrum was used to calculate the
stoichiometry of adduct formation. Using E260 = 15,800 M -1 cm-1 and knowing
the protein concentration of the sample (Lowry), the ratio of synthetase was
determined to be 0.95.
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amount of adduct formed may be slightly underestimated as FSBA has a )Smax of
260 nm, while the difference spectrum shows a Xmax of 254 nm. This shift in
)max is most probably the result of inability to accurately balance the amount of
protein in the reference relative to the sample cuvette.
Once radioactive FSBA became available, it was used to follow the
stoichiometry of adduct/enzyme formation during the course of an inactivation
(Fig 4.8). Several experiments of this type have been completed, and none
deviate from linearity down to 5% remaining activity. These results indicate that
despite the slow rate of inactivation, the labeling is stoichiometric with 1.1 + 0.2
FSBA per active site, and suggests that there is a specific interaction between the
inhibitor and the enzyme. However, these experiments do not distinguish
between a covalently bound and a tightly bound inhibitor.
Stability of FSBA. The stability of FSBA under a variety of pH conditions was
studied in order to insure that the ester linkage (Fig 4.3) would be stable to the
conditions required for peptide purification. The hydrolysis of FSBA to
adenosine can be followed by the appearance of resonances at 6 8.17 ppm (H8 of
the adenosine moiety) and 8 8.07 ppm (H2 proton of the adenosine ring) (Fig 4.9).
Integration of the observed resonance at C2 allows a kinetic analysis of the
hydrolysis process (Fig 4.10). From this analysis a half life for FSBA at pH 7.0 can
be extrapolated to be ~2 months and at pH 8, 13 days. No measurable
decomposition of inhibitor at pH 5.5 was found after 450 h. These results agree
with those of Esch and Allison (1978), who determined using adenosine
deaminase to monitor adenosine formation that the half life of FSBA at 23 OC (pH
8) to be 3.6 days.
Stability of E. coli AIR synthetase-FSBA adduct. The stability of the linkage of
the AIR synthetase-FSBA adduct was also determined, to define the conditions
required to purify the modified FSBA containing peptide(s). These experiments
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Figure 4.8: Stoichiometry of FSBA-AIR synthetase Adduct Measured Using
[14C]-FSBA. The stoichiometry of FSBA labeling of AIR synthetase was followed
during the course of an inactivation reaction. Samples were removed at various
times and protein was separated from unbound [14C] using Sephadex G-50
columns. The protein concentration (Lowry) and the radioactivity (scintillation
counting) was determined for each sample. Extrapolation to total inactivation
suggests that 1.1 adducts per AIR synthetase are needed to completely inactivate
the enzyme.
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Figure 4.9: Stability of FSBA Determined by 1H NMR. The gradual hydrolysis
of the ester bond in FSBA (Fig 4.3) can be monitored by observing the generation
of adenosine over time. The H2 and H8 signals (respectively) for the adenosine
ring protons in FSBA can be observed at 8 7.88 and 7.96 ppm. The same protons
for free adenosine are observed at 8 8.07 (C2) and 8.17 (C8) ppm. This series of
NMR spectra shows the formation of adenosine from FSBA in 100 mM potassium
phosphate (pD 8.0). The C8 proton in both compounds slowly exchanges with
D 20, and thus appears to disappear over time.
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Figure 4.10. Degradation of FSBA vs pH. FSBA was incubated with 100 mM
potassium phosphate at pD 5.5 (o), 7.0 (+) and 8.0 (A). The amount of FSBA
remaining after incubation at 37 oC was determined at various times using 1H
NMR (Figure 4.8). Degradation of FSBA was pseudo first-order under these
conditions. FSBA was found to have a half-life of 13 days at pH 8.0 and -2
months at pH 7.0. No decomposition of the inhibitor at pH 5.5 was detected after
450 h.
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use size exclusion filters to separate enzyme bound [14C]-FSBA adduct from
[14C]-labeled small molecules. Control experiments revealed that the filters used
in this study cause no quenching of 14C labeled material.
Results from the stability experiments are depicted in Table 4.2. From this
data it is clear that the AIR synthetase.FSBA adduct is stable in all buffers tested
for at least 84 hours. The high stability of the adduct suggests that either lysine
or tyrosine are the residues modified by FSBA.
Table 4.2: Stability of the FSBA-AIR synthetase Adduct Monitored by [14C] Label
Retained on a Size Exclusion the Filter
time TFA TEA.OAC NaP HEPES
(hours) (pH 2) (pH 6) (pH 7) (pH 7.5)
0 0.99 .99 .99 1.0
4 .98 nd nd nd
12 .98 nd .98 .99
24 .98 .98 nd .88
36 .98 .98 .99 .98
48 .98 .98 .83 .97
60 .98 .98 .99 .97
72 .97 .97 .97 .97
84 .96 .97 .92 .92
Data presented as % label bound
nd = not determined
Isolation of E coli AIR synthetase-FSBA labeled peptide. FSBA inactivated AIR
synthetase (111 nmol) was subjected to carboxymethylation and trypsin digestion
and the peptides isolated using a Vydac C18 reverse phase column with
TFA/CH3CN elution as shown in Fig 4.1. The fractions containing the radiolabel
were pooled, lyophilized and reanalyzed using sodium phosphate (pH 7)
acetonitrile elution shown in Fig 4.2. Yields through each step were typical for
peptide isolations, ranging from 50-60%. However, it was determined
experimentally that if the peptide was lyophilized to dryness, recoveries were
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extremely poor. The peptide isolated appears to be the major adduct of FSBA
inactivation. Throughout the procedure only one radioactive component was
detected, indicating no degradation of the labeled peptide occurred. In the final
desalting procedure, which used a TFA/CH 3CN elution system identical to that
used in the initial purification step, the radioactive adduct eluted with the same
retention time.
The peptide was sequenced using the automated Edman degradation
method, and was found to consist of the sequence I X G V V K. This sequence
is consistent with the expected AIR synthetase tryptic fragment:
... G R ^ I K ^ G V V K K T...
24 25 26 27 28 29 30 31 32 33
where A indicates a position predicted to be cleaved by trypsin and the sequence
of interest is underlined. It is interesting to note that if the lysine at position 27
were alkylated, trypsin would no longer be expected to cleave after that residue.
Thus, the sequence is consistent with the adduct stability data and the fact that
trypsin was used to digest the protein.
Characterization of the FSBA-AIR synthetase Adduct. In an attempt to define the
structure of the FSBA adduct on the peptide, plasma desorption mass
spectrometry was performed. The resulting parent peak of 1077.3 amu (Fig 4.11)
is consistent with the expected structure (Fig 4.12), which has a calculated MH+
of 1077.25 amu.
H
G2 8
V2 9
v30
K3 1
Figure 4.12: Proposed Structure for FSBA-AIR synthetase Adduct
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Figure 4.11: Plasma Desorption Mass Spectral Analysis of Purified [14C]-
labeled AIR synthetase Peptide. The determined m/z of the labeled peptide
MH+ was found to be 1077.3 amu, which compares well to the calculated m/z for
the expected adduct of 1077.25 amu (Figure 4.12).
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Incubation of chicken liver AIR synthetase with FSBA. After successfully
determining the site of interaction of FSBA with E. coli AIR synthetase, we were
curious to find if FSBA also modified the enzyme from chicken liver in the same
manner. AIR synthetase from this source is a trifunctional protein containing
GAR synthetase and GAR-transformylase in addition to AIR synthetase.
Sequence comparisons show that the chicken liver enzyme has 68% sequence
similarity and 51% identity with the E. coli enzyme (Fig 4.13). Although chicken
liver enzyme in the presence of FGAM was treated with FSBA in concentrations
up to 1 mM, no inactivation was evident over 45 min (data not shown).
Mutagenesis of E. coli AIR synthetase (pJS119). With the site of interaction
between FSBA and E. coli AIR synthetase determined, site directed mutagenesis
of lysine-27 to glutamine, lysine or arginine was employed to substantiate the
essentiality of this residue suggested by the affinity labeling studies. Two
different strategies for mutagenesis were employed; one using a modification of
the PCR mutagenesis method developed by Horton et. al. (1989) (Scheme 4.2),
and the second using the method developed by Taylor et al. (1985) (Scheme 4.3).
The PCR mutagenesis strategy employs two PCR reactions. The first reaction
generates a 180-bp mutant 5' product, which is used in the second PCR reaction
as a primer to generate the entire gene. All attempts at mutagenesis using PCR
were unsuccessful. While the initial PCR reactions always gave the expected
product, the final PCR reactions worked only occasionally and then in low yield.
Increasing the amount of primer in the final PCR reactions from 8 to 35 nM had
no effect. Attempts to purify the primer by either ethanol precipitations and
glass bead procedures (U. S. BioCleanTM) afforded no product. Likewise isolation
of initial PCR products using the crush and soak method or the electrophoresis
techniques failed to increase yields. Changing the C-terminal primer (primer C1,
C2 in Table 4.1) in the attempt to minimize possible primer dimerization also had
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Figure 4.13. Sequence Alignment of Nine AIR synthetases from Various
Sources. Sequences were aligned using PileUp (Feng & Doolittle, 1987).
Positions in which residues are identical in eight of the nine sequences are
capitalized, and denoted in the consensus sequence. AIR synthetase from
chicken (G. gallus, accession number P21872, residues 434-805 of trifunctional
peptide, Aimi et al., 1990), human (H. sapiens, accession number P22102, residues
434-809 of trifunctional peptide, Aimi et al., 1990), S. cerevisiae (accession number
P07244, residues 451-802 of bifunctional peptide, Henikoff, 1986), S. pombe
(accession number P20772, residues 440-750 of bifunctional peptide, McKenzie et
al., 1987), B. subtilis (accession number P12043, Ebbole & Zalkin, 1987), E. coli
(accession number M13747, Smith & Daum, 1986), Arabidopsis (accession number
L12457, Senecoff & Meagher, 1993) and the two D. melanogaster enzymes (A,
residues 435-789 and B, residues 790-1154, Henikoff & Eghtedarzadeh, 1987) are
aligned.
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no effect. Lowering the annealing temperature also afforded no product.
Titrating magnesium was successful, but not reproducible. The products from
each successful second PCR reaction (3 for 87 attempts) were used in
ligation/transformation reactions with the 3 kb piece generated by digestion of
pJS119 with EcoRl and BamH1. None of the transformants isolated, however,
were found to be mutants. Most were found by restriction analysis to contain no
insert. The two colonies that passed this screen were found to have a wild type
sequence.
The mutagenesis method of Taylor et al. (1985) was therefore attempted and
resulted in preparing the desired mutants in 100% efficiency. Sequencing of the
-84 through 173 bp region of the newly generated purM gene indicated that each
of the desired mutants had been successfully prepared. However, three
cytosines were found to be absent from the -50 through -52 region in all mutant
constructs. While a deletion of three base pairs is unusual and at present
inexplicable, it leaves the reading frame for translation intact. However, as
indicated below, while the protein is expressed at high levels, it is no longer heat
inducible as is the wild type construct.
Growth and induction of pJSll9 K27X mutants. The doubling times for E. coli
TX635/pJS119 mutants were indistinguishable from identical constructs
expressing the wild type enzyme when grown in LB media; both mutant and
wild type AIR synthetase expressing bacteria doubled every 0.9 h. SDS-PAGE
showed that while wild type expression induces subsequent to heat treatment,
the mutants are all constituatively expressed. This difference may be attributable
to the deletion of three cytosines in the -50 region of the gene. The optimum time
to harvest the mutants was found to be 1-2 hours after reaching late log phase of
growth; AIR synthetase levels slowly decrease after that time (Fig 4.14). When
enzyme was expressed in host strain TX393 (purM), the growth of the strains
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Figure 4.14. Production of Mutant and Wild Type AIR synthetases as
Determined by SDS PAGE. E. coli TX635/pJS119 K27X strains were grown on
LB media at 30 oC. Upon reaching late log (0.6-0.8 OD600 ), cultures were shifted
to 42 OC. Samples of the growing cultures were taken periodically before and
after induction, pelleted by centrifugation and stored frozen. Samples from each
time point were resuspended to a constant OD600, boiled in Laemmli buffer
(containing SDS), and loaded onto a gel.
A. Lanes 1 and 13: molecular weight markers. Lanes 2-6: pJS119 (wild type)
samples taken before and then 1, 2, 3, and 4 h after induction. Lane 7: AIR
synthetase Standard (32 gg). Lanes 8-12: pJS119 (K27L) samples taken before
and then 1, 2, 3, 4 h after induction.
B. Lanes 1 and 13: molecular weight markers. Lanes 2-6: pJS119 (K27Q)
samples taken before and then 1, 2, 3, and 4 h after induction. Lane 7: AIR
synthetase Standard (32 pig). Lanes 8-12: pJS119 (K27R) samples taken before
and then 1, 2, 3, 4 h after induction. Production of wild type enzyme shows the
expected increase after heat induction while mutant strains appear to be
constituatively produced.
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producing mutant enzymes were also indistinguishable from the wild type
expressing system, with doubling times of 1.3 h.
Isolation and Determination of KmATP for AIR synthetase K27X mutants. AIR
synthetase mutants were purified by a procedure identical to that described for
wild type AIR synthetase. In the crucial purification step using a C8 linked ATP
affinity column, the mutant enzymes were retained in the same way as the wild
type protein. This behavior suggests that the ATP binding site of the mutants is
essentially the same as the wild type enzyme. Mutant preparations were -80%
pure, as judged by SDS-PAGE, while the wild type protein was purified to
homogeneity using the same procedure (Fig 4.15)
The kinetic parameters for the mutants were measured using substrate
concentrations that are saturating for the wild type enzyme, but may not be
saturating for the mutants (Table 4.3). The final specific activity of the mutant
enzymes were surprisingly all slightly higher than that observed for the wild
type AIR synthetase. Even more unexpected was the observation that in all cases
the KmATP for each mutant was lower than that previously determined for the
wild type protein of 65 p.M (Schrimsher et al., 1986b). The K27R mutant,
however, appears to have dramatically different kinetic characteristics from the
other AIR synthetases, with an apparent KmATP five-fold lower than the wild
type enzyme. The catalytic activity of the mutants (V/K) increases as position 27
is mutated from lysine to glutamine, leucine and finally arginine. The fact that
the mutations apparently affect the catalysis of the enzyme is consistent with the
proposal that lysine-27 does in fact lie within the ATP binding site of AIR
synthetase.
187
Figure 4.15: Isolation of Mutant AIR synthetases. SDS-PAGE showing the
purity of mutant K27X AIR synthetases at various stages in the isolation.
Samples were taken in each preparation: from the crude mixture, after DE-52
cellulose isolation, from the Mg2+ wash off the C8 linked ATP affinity column
and from the EDTA wash off the ATP affinity column.
Lane A 60 gg crude K27L AIR synthetase
B 40 gg crude K27L AIR synthetase
C 40 gg DE-52 purified K27L AIR synthetase
D 40 gg ATP affinity Mg 2+ wash
E 40 gg ATP affinity EDTA wash K27L AIR synthetase
F molecular weight markers, as marked to the right
G 60 glg crude K27Q AIR synthetase
H 40 ig DE-52 purified K27L AIR synthetase
I 40 glg ATP affinity Mg2+ wash
J 10 gg purified AIR synthetase
K molecular weight markers, as marked to the right
L 60 gg crude K27R AIR synthetase
M 40 glg DE-52 purified K27R AIR synthetase
N 40 gg ATP affinity Mg2+ wash
O 40 gg ATP affinity EDTA wash K27R AIR synthetase
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Table 4.3: Kinetic Parameters for K27X Mutant AIR synthetases
Mutant Km ATP kcat V/K
(gM) (s-l ) (s-1 gM- 1 x 102)
wild type* 73 + 14 2.3 + 0.1 3.5 ± 0.8
K27Q 58 4.5 3.0 ± 0.2 5.2 ± 0.75
K27L 46 + 3.1 2.6 + 0.1 5.7 ± 0.60
K27R 12 + 1.1 2.5 0.1 21.0 + 2.9
*re-determined in these studies
DISCUSSION
FSBA interacts with E. coli AIR synthetase as an active site affinity label,
covalently modifying the enzyme specifically at lysine 27. ADP protects AIR
synthetase against inhibition, while addition of FGAM to the inactivation
mixture enhances the rate of inactivation. This evidence taken alone suggests
that FSBA acts on E. coli AIR synthetase at or near the ATP binding site.
Additional mutagenesis experiments confirm this conclusion; when position 27
of AIR synthetase is specifically altered from lysine to either glutamine, leucine
or arginine, the Km for ATP is decreased in comparison with wild type enzyme.
The evidence presented in this paper thus suggests that lysine-27 lies within or
near the ATP binding site of AIR synthetase.
The increase in catalytic efficiency from a conservative lysine to arginine
mutation is surprising, but not unprecedented. Recently, single mutants of
superoxide dismutase have been shown to display a three-fold increase in
catalysis (kcat) as compared to wild type enzyme, giving a rate that is greater
than simple diffusion (Getzoff et al., 1992; Banci et al., 1993). This change was
effected by mutating one of two glutamate residues located at the opening to the
active site to neutral (glutamate) or positively charged lysine residues. The
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authors attribute this increase to "electrostatic guidance" of the substrate into the
active site. (Getzoff et al., 1992).
The sequences of a nine AIR synthetase genes from different organisms have
been published, and are aligned in Fig 4.13 using the program Pileup (Feng &
Doolittle, 1987). Although these enzymes have a high number of identical
residues, it is interesting to note that the lysine labeled by FSBA is not absolutely
conserved. Human AIR synthetase has a glutamine residue in the position
analogous to E. coli lysine-27, while Arabidopsis contains an alanine in this
position. Furthermore, the chicken derived trifunctional enzyme is not affected
by FSBA. This leads us to speculate that in E. coli lysine-27 may not lie near the
y phosphate of enzyme bound ATP.
The nucleotide affinity label FSBA has been successfully used to covalently
modify specific residues in a number of ATP and NADH utilizing enzymes
(Colman, 1989). However, those enzymes that have been studied further
demonstrate that while FSBA can accurately identify residues near the
triphosphate moiety of ATP, many instances of FSBA labeling occur at residues
that appear to have no interaction with bound ATP. cAMP-dependent protein
kinase, for instance, is modified by FSBA at lysine 72; this residue has been
shown in the crystal structure to be near the ax and 3 phosphates of ATP (Taylor
et al., 1993). On the other hand, glutamine synthetase was found to be covalently
labeled by FSBA at lysine-47 (Pinkofsky et al., 1984), but subsequent mutagenesis
studies of that residue showed that the normal lysine was not required for
catalysis or binding (Parakh & Villafranca, 1990). The structure of the glutamine
synthetase suggests that lysine-47 is ~13 A from the bound inhibitor methionine
sulfoxide (Almassy et al., 1986). Perhaps it is not surprising that the benzoyl
moiety of this affinity label does not bind in the same way as the triphosphate
portion of ATP.
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The fact that FSBA may not reflect the binding of ATP on an enzyme is
especially well demonstrated in the case of the protein recA. This protein is
modified by FSBA only at tyrosine-264 (Knight & McEntee, 1985a), and
mutagenesis of this residue to phenylalanine or serine decreases the Vmax and
increases the Km of ATP for this enzyme (Frietag & McEntee, 1991). Yet the
recently determined structure of the ADPorecA complex shows no interaction of
ADP to this residue (Story & Steitz, 1992). While this discrepancy could be due
to a conformational change that occurs when ATP (or FSBA) bind to recA
(Eriksson et al., 1993), it is also likely that FSBA binds near tyrosine-264 because
it binds differently than the natural substrate. In light of this information, it is
interesting to note that the photo-affinity label 8-azidoadenosine 5'-triphosphate
also exclusively modifies tyrosine-264 (Knight & McEntee, 1985b). This finding
suggested to those authors that ATP binds to recA in the anti conformation.
However, an alternate explanation is that FSBA binds to recA such that the
benzoyl moiety interacts with the adenosine ring in a base stacking interaction.
In this configuration, FSBA would label near or above the plane of the adenosine
binding pocket of the enzyme. This may explain the increase in catalytic
efficiency found when lysine-27 is changed to leucine, glutamine or arginine, as
these residues may contribute to building a hydrophobic adenosine binding site
in AIR synthetase.
The determination that lysine-27 lies in the ATP binding pocket of AIR
synthetase opens the possibility for the determining the enzyme active site that
can catalyze phosphorylation of carbonyl groups. Further mutational studies
using both deletion and site-directed mutants near position 27 will be necessary
to define the other residues of AIR synthetase important for ATP binding.
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Chapter 5
N 5 -Carboxyaminoimidazole Ribonucleotide: Evidence for a New
Intermediate and Two New Enzymatic Activities in the de novo
Purine Biosynthetic Pathway of Escherichia Coli
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INTRODUCTION
Aminoimidazole ribonucleotide (AIR) carboxylase catalyzes the conversion of
AIR in the presence of HC03- to carboxyaminoimidazole ribonucleotide (CAIR,
Scheme 5.1). Genetic studies of Gots et al. (1976) suggested that this enzyme was
LI
03
ATP
H2 ( C02 (HCOj)
ADP Pi
HO OH HO OH
AIR CAIR
Scheme 5.1: Reaction Catalyzed by "AIR carboxylase"
composed of two subunits: one resulting from the purE gene and the other from
the purK gene. Mutants in either purE or purK, as might be expected, were found
to be auxotrophic for purines. Intriguingly, the purine requirement in the purK-
strain was removed when the bacteria were grown in an atmosphere enriched
with CO2 (Gots et al., 1976). These observations fostered the long held belief that
PurK functions in the AIR carboxylase reaction as a C0 2 carrier.
Early work on these enzymes was accomplished by Smith's (Tiedeman et al,
1989) and Mizobuchi's (Watanabe et al., 1989) laboratories, who found purE and
purK have overlapping coding sequences and are components of the same
operon. DNA sequencing revealed that PurE is a protein of deduced subunit
molecular weight 17,782 Da, and PurK is a protein of subunit molecular weight
39,385 Da. We became interested in the mechanism by which a 39 KDa protein
functions as a "CO2 carrier."
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In previous work from our laboratory, the purE and purK gene products were
purified to homogeneity and their physical and catalytic properties examined,
revealing some surprises (Meyer et al., 1992). Homogeneous PurE was found to
be capable of catalyzing the carboxylation of AIR to CAIR at high HC03-
concentrations (0.18 M) in the absence of PurK. Furthermore, addition of PurK
appeared to have no effect on the activity of PurE. Serendipitously, we made the
observation that PurK did possess an activity, hydrolysis of ATP to ADP and Pi.
This ATPase activity, however, only occurred in the presence of AIR.
Experiments designed to look for CAIR production, or AIR degradation during
this activity both suggested that AIR was not consumed during the reaction. We
were subsequently able to show that PurE and PurK are required to catalyze the
conversion of AIR to CAIR in the presence of "low" concentrations of HC03- (100
RM) only in the presence of ATP. Furthermore, every molecule of AIR consumed
was found to be accompanied by production of an equivalent amount of ADP
and Pi. These studies culminated in the hypothesis described in Scheme 5.2.
O
PurK~ IIATP + HCO3 ' o'C2- + ADP
O
II PurE
- .0' IN 2- AR -'-- CAIR + Pi
Scheme 5.2: Postulated Mechanism for AIR carboxylase (Meyer et al., 1992)
This model proposes that the function of PurK is to generate carboxyphosphate,
as is proposed in the case of biotin dependent enzymes (Knowles, 1989), and that
this intermediate effectively delivers, either directly or indirectly, C0 2 to AIR on
PurE. As carboxyphosphate is quite unstable, with a half-life estimated to be less
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than 70 msec (Sauers et al., 1975), one might suspect a requisite interaction
between PurE and PurK for efficiently coupled catalysis. However, our
preliminary studies failed to detect any significant association (Meyer et al.,
1992).
Our thinking about the problem was reformulated on reading a paper by
Alenin et al. (1987) in which they characterized the nonenzymatic reaction of
Nl-alkyl (R)-5-aminoimidazoles (R = ribose-5-phosphate (AIR) or CH 3) with
molar concentrations of HCO3-. These studies revealed that 5-aminoimidazole
derivatives are rapidly and reversibly converted into a new species which is
distinct from the N 1-alkyl 4-carboxy-5-aminoimidazoles that form on a much
slower time scale.
1 M HCO3 N
nonenzymatic N R=-CH, or
M2N I U2GHN I - -
R R P
HO OH
Scheme 5.3: Formation of Carbamates of Aminoimidazoles
Preliminary proton and 13C NMR analysis of the reaction in which R = CH3
(Scheme 5.3) allowed Alenin and coworkers to postulate the formation of the
N5-carbamate. These studies prompted us to reformulate our hypothesis for the
mechanism of conversion of AIR to CAIR (Scheme 5.4).
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2 a El 
AIR + ATP + HCO3' *_
O'
PurK NCAR + ADP + PiN -CAIR + ADP + Pi
NS-CAIR .PurE CAIR
Scheme 5.4: Proposed Mechanism for the Carboxylation of AIR by PurE and PurK
This model predicts that PurE and PurK are not subunits of the same enzyme,
but that they catalyze two separate steps in the purine biosynthetic pathway.
The carbamate product of the PurK catalyzed reaction between AIR, ATP and
HC03', N 5-carboxyaminoimidazole ribonucleotide, designated N 5-CAIR, is
postulated to be a new intermediate in this pathway. PurE is then postulated to
catalyze the rearrangement of the N 5-carbamate to CAIR. Evidence is presented
subsequently to substantiate this hypothesis.
MATERIALS AND METHODS
Materials. Bovine serum albumin (fraction V, BSA), lactate dehydrogenase
(LDH, 860 U/mg), pyruvate kinase (PK, 470 U/mg), phosphoenolpyruvate
(PEP), phosphoenolpyruvate carboxylase (PEP-C, 3.6 U/mg), malate
dehydrogenase (MDH, 3000 U/mg) and adenosine triphosphate (ATP) were
obtained from Sigma Chemical Co. Filters of 0.45 pgm and Centricon
ultrafiltration units were purchased from Millipore Corp. DEAE A-25 Sephadex
was obtained from Pharmacia. 1-[14C] Aspartate (220 mCi/mmol), KH 13CO3
(WCS 171, Batch 8, 90 atom %) and H 2180 (WOW 420, Batch 3, 95 atom%) were
purchased from Amersham. [y-amido- 15 N]-L-glutamine (Lot CH-211, 99% 15N)
was from Cambridge Isotope Laboratories. Isotope ratio mass spectrometry was
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performed by Geochron Laboratories, Cambridge, MA. -FGAR was
synthesized as described in Chapter 2. Formylglycinamide ribonucleotide
amidotransferase (FGAR-AT) and AIR synthetase were purified using the
techniques described by Schendel et al. (1989) and Schrimsher et al. (1986),
respectively. The syntheses of AIR and CAIR, the purification of enzymes PurE,
PurK and 5-aminoimidazole-4-N-succinylcarboxamide ribonucleotide (SAICAR)
synthetase (PurC), and the assays for these enzymes were accomplished as
previously described (Meyer et. al, 1992). E. coli TX209 (A lac purK) was a gift
from John Smith, R & D Systems Inc., Minneapolis, MN. Restriction enzymes
and DNA molecular weight markers were purchased from New England Biolabs.
General Methods. Protein assays were done according to the method of Lowry
et al. (1951) using BSA (279 = 0.667mL mg-1 cm -1) as a standard. Phosphate
assays were accomplished using the method of Ames and Dubin (1960) with ATP
as a standard (260 =15.4 mM -1 cm-1). Orcinol assays for quantitation of
reducing pentose sugars were conducted using the method of Dische (1962) with
ATP as a standard. Bratton-Marshall assays were carried out as described
(Schrimsher et al., 1986). All standard molecular biological methods were
carried out according to Sambrook et al. (1989). Fixed wavelength UV/visible
assays were carried out using a Cary 210 spectrophotometer. Assays in which
multiple wavelengths were monitored were done on a Hewelet Packard 8452A
diode array spectrophotometer. NMR spectra were recorded on either a Varian
VXR-500 NMR or a Varian Unity 300 NMR spectrometer. 13C NMR spectra were
collected using broad-band proton decoupling. All chemical shifts are reported
in parts per million relative to the methyl peak of 1,1,1 trimethylsilylpropane
sulfonic acid set at 0.0 ppm as an internal standard, unless otherwise noted.
Plasmid DNA was isolated using the Magic Miniprep kit from Promega. DNA
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was purified from agarose gels using U. S. Bioclean, from U. S. Biochemical
Corp.
Determination of the Bicarbonate Concentration. Assays contained 50 mM
HEPES pH 7.7, 2 mM PEP, 2 mM MgC12, 0.2 mM NADH, 0.25 U PEP-C and 5 U
of MDH in a final volume of 400 p.L. Reaction mixtures without enzymes were
degassed by bubbling argon through the reaction mixture for 30 min, and then
pre-incubated at 37 OC for 2 min just before use. Addition of PEP-C and MDH
resulted in rapid consumption of 15% of the NADH due to contaminating
bicarbonate in solution. Once a background rate was established, a small
volume (typically 1-5 p.L) of the sample to be analyzed for bicarbonate was added
and the AA340 recorded. Bicarbonate concentration was calculated using E340 =
6220 M-1cm- 1
Nonenzymatic Conversion of AIR to N 5-CAIR Monitored by NMR Spectroscopy.
A solution, 600 j1L, containing AIR (29 mM) in 200 mM potassium phosphate in
D 20 (pD 6.0) was placed in an NMR tube. After an initial spectrum was
recorded, solid KHCO3 (56.1 mg, 0.63 mmol) was added to give a final volume of
700 gL and the NMR tube was sealed using a flame. The reaction was initiated
by inverting the tube and mixing the solid and liquid phases. 1H NMR spectra
were recorded at various intervals from 1 min to 600 h. Each spectrum was
integrated to determine the amount of each species formed at a given time. At
the end of the experiment the tube was opened and the pD was determined to be
8.0.
Enzymatic Synthesis of [amidino - 15N]-,f-FGAM. The reaction mixture
contained 40 mM Tris-HCl (pH 7.5), 20 mM ATP, 8.8 mM [y-amido- 15N]-
glutamine, 80 mM KCl, 30 mM MgC12, 11 mM PEP, 1.87 mM f-FGAR, 20 U PK
and 5 U FGAR-AT in a final volume of 4 mL. The mixture containing everything
except the enzymes was pre-incubated at 37 oC for 10 min, and the reaction was
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initiated by addition of FGAR-AT. After 25 min, the mixture was diluted to 100
mL with water at 40C and applied to a DEAE A-25 column (2.5 x 10 cm, HC03-
form). The column was washed with 100 mL water and the product eluted with
a 500 x 500 mL linear gradient from 0 to 400 mM triethylammonium bicarbonate
(TEAB) pH 7.6. -FGAM eluted at 75 mM TEAB, determined using the orcinol
assay. Fractions containing product were concentrated in vacuo and assayed by
Bratton-Marshall endpoint assay indicated the recovery of 5.2 mol -FGAM
(70% yield).
Enzymatic Synthesis of [amino-5-15N ]-3-AIR. The reaction mixture contained
50 mM Tris-HCl (pH 7.5), 20 mM ATP, 400 mM KC1, 3 mM MgC12, 14 mM PEP,
1.7 mM [amidino-15N]-3-FGAM, 10 U PK and 3 U AIR synthetase in a final
volume of 2 mL. The mixture without enzymes was pre-incubated for 10 min at
37 OC, and the reaction was then initiated by addition of PK and AIR synthetase.
The reaction was allowed to proceed for 30 min, after which time the mixture
was diluted to 100 mL with cold water and loaded onto a DEAE A-25 column
(2.5 x 10 cm, HC03- form). The column was developed with a 500 x 500 mL
gradient of 0 to 500 mM TEAB, pH 7.6. Fractions were monitored using A 250 and
the Bratton-Marshall and orcinol assays. AIR eluted at 200 mM TEAB and the
appropriate fractions were pooled and concentrated in vacuo to give 1.7 munol AIR
(51% yield). 13C NMR (125 MHz, D 20, 13CH 3 OH standard 8 = 48 ppm): 8 167.5
(s, HC03-), 135.1 (d, J=12 Hz, C5), 131.5 (s, C2), 111.6 (s, C4), 86.4 (s, C1'), 83.8 (d,
J=8.4 Hz, C4'), 72.5 (s, C3'), 69.9 (s, C2'), 62.8 (d, J=3.8 Hz, C5'). Assignments are
based on the work of Schendel and Stubbe (1986) and Alenin et al. (1987). The
13C-15N coupling observed at the C5 resonance is in the range expected (Levy &
Lichter, 1979).
13C NMR Study of [15N 5- carbamoyl-13C]-CAIR. [amino-5-15N ]-AIR (3.8
pgmol) and NaH 13CO3 (375 gmol) were combined in 600 iiL D20 (final pD 7.4)
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and incubated on ice for 30 min. The sample was then adjusted to pD 12.5 using
1M KOD and 13CH30H was added as a standard ( = 48 ppm). The final volume
was 1.2 mL. The spectrum is shown in 5.2A.
Synthesis and Isolation of N 5-CAIR. To AIR (40 gmol) in 1.0 mL of 0.1 M
Tris-HC1 (pH 7.0) was added 0.1 g (1.14 mmol) of KHCO3. The reaction vessel,
chosen to have minimal head space, was sealed with a rubber septum which was
held in place using copper wire. The solution was incubated at 4 0C for 30 min
and the pH was then adjusted to between 12 and 14 using 100 gL of 5 N KOH.
The solution was loaded onto a 7 mL Dowex 1-X8 (OH- form) column which had
previously been equilibrated with 0.5 M potassium phosphate (pH 12.5) followed
by 5 mM potassium phosphate (pH 11.6). N 5-CAIR was eluted using a 100 x 100
mL linear gradient from 0 to 300 mM KC1 in 5 mM potassium phosphate (pH
11.6). Fractions were monitored by absorbance at 240 nm and the Bratton-
Marshall assay; N 5-CAIR eluted at 200 mM KC1. The appropriate fractions, 12
mL, were pooled and concentrated in vacuo to 1 mL. During the concentration
KC1 precipitated out of solution. The supernatant, pH -14, was stored at -20oC.
The concentration of N 5-CAIR was determined using a modification of the
Bratton-Marshall assay in which the sample was incubated in acid for 2 min prior
to addition of NaNO2. This step allowed N 5-CAIR to decompose to AIR, and
thus provides an upper limit for the amount of N 5-CAIR present. Yields ranged
from 42 to 57%. 1H NMR (250 MHz, D20, pD 14): 7.98 (s, 1H, C2), 6.83 (s, 1H,
C4), 5.63 (d, J = 4.9 1H, C1'), 4.48 (m, 1H, C2'), 4.30 (m, 1H, C3'), 4.21 (m, 1H, C4'),
3.91 (m, 2H, C5'). 13C NMR (75 MHz, D20, pD 14): 6 167.3 (KHCO3), 161.6 (s,
C6), 133.5 (s, C5), 127.7 (s, C2), 122.7 (s, C4), 86.5 (s, C1'), 82.5 (d, C4', J POCH2CH =
8.0 Hz), 73.7 (s, C3'), 69.3 (s, C2'), 63.1 (d, C5', J POCH 2 = 5.3 Hz)
Stability of N 5-CAIR. A stock solution of N 5-CAIR was prepared by adding
AIR (8.1 [lmol) to 500gL of 100 mM Tris-HCl (pH 7.0), 600 mM KHCO3. This
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solution was stored at -200C in a tightly stoppered flask on ice and was stable for
at least a week. The decomposition of N 5-CAIR to AIR was followed
spectrophotometrically. The extinction coefficient of N 5-CAIR at 250 nm is small
compared to that of AIR (Alenin et al., 1987), which has a UV spectrum
previously characterized in detail (Meyer et al., 1992). A typical assay in a final
volume of 1 mL contained 300 mM Tris-HC1, 20 mM KCl and 125 ^gM N 5-CAIR at
250C. The pH was varied from 7.5 to 8.9. The increase in A 250 nm was
monitored spectrophotometrically.
Kinetic Analysis by NMR Spectroscopy of PurE Catalyzed Conversion of CAIR to
N 5-CAIR. CAIR (30 jinol) was carefully titrated to pH 7.0 using 1M HC1 and
brought to dryness in vacuo. The sample was exchanged into 500 gL D 20,
titrated to pD 8.0 with 1M NaOD in D 20 and assayed for CAIR (6250=10,980 M-l1
cm- 1) and bicarbonate using the PEP-C assay described above.
PurE was exchanged into 300 mM Tris-HCl, pD 8.0, in D 20 using a
Centricon-30 (dilution of original buffer salts was 1/100). Enzyme activity was
assayed before and after exchange into deuterated buffer.
NMR samples contained in a final volume of 700 gL: 300 mM Tris-HC1, pD
8.0, 7.5 mM CAIR, and PurE (1.5-15 U). After an initial spectrum of CAIR was
taken, reactions were initiated with PurE and successive 16 scan spectra were
collected over time. Spectra were acquired every 30 sec for the first 10 min,
every min for the subsequent 15 min, and finally every 5 min until the reaction
had proceeded for 1 h.
The concentrations of substrates and products were determined by
integration of the NMR spectra taken at each time point. The kinetic data were
analyzed using an IBM compatible version of GIT [PC version 1.31, 12/87, © E. I.
DuPont de Nemours by McKinney, R. and Weigert, F. J. (Stabler & Cheswick
1978, Weigert, 1987)] and plotted using a MacIntosh version of KINSIM (Barshop
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et. al, 1983), HopKinsim 1.3, provided by Professor Robert Kuchta, U of
Colorado, Boulder, CO.
PurK Catalyzed Transfer of 180from NaH13C 180 3 to Pi. NaH13 CO3 - (1.61 mg,
18.9 gmol) was placed in an oven dried Wheaton vial. H 2180 (100 IL) was added
through the septum using an oven dried syringe. The concentration of HCO3-
was confirmed to be 189 mM using the PEP-C assay. The bicarbonate was
allowed to incubate at room temperature for 5 h to insure complete exchange.
Isotope ratio mass spectroscopy of the resulting bicarbonate revealed that the
180/160 ratio was 89:11.
AIR (10 gmol) was acidified to pH 5.5 with 1M HC1, diluted to lmL and
degassed using two freeze-pump-thaw cycles followed by bubbling argon
through the solution at room temperature for 1 h. The pH of the sample was
adjusted to 8.0, and then assayed for AIR (Bratton-Marshall assay), bicarbonate
(PEP-C assay) and for total phosphate (Ames and Dubin, 1960).
Reaction samples contained in a final volume of 500 gL: 100 mM HEPES (pH
8.0), 15 mM KC1, 20 mM MgCl2, 11.4 mM ATP, 1 mM AIR, 11.3 mM NaH 13C 180 3
and 1.8 U PurK. A control containing no AIR was also run. Samples were pre-
incubated for 2 min at 4 oC in the absence of HC0 3 - and PurK, and then the
reactions were initiated with bicarbonate followed 5 sec later by PurK. Reactions
were allowed to proceed for 2 min, then were quenched by addition of 300 gL of
600 mM CHES, 500 mM EDTA (pH 9.0). These samples were rapidly frozen
using liquid nitrogen and stored at -800C until NMR analysis was possible.
NMR samples were thawed in an Eppifuge at 4 OC (spun for 10 min),
d6-acetone was added as a deuterium lock standard to each reaction, and the
samples were forced through a 0.45 gm filter by centrifugation (2800 x g). 31p
NMR spectra were collected for each sample on a VXR-500 NMR spectrometer
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(31p 202 MHz) without 1H decoupling using a sweep width of 7272.7 Hz and an
acquisition time of 2.002 seconds.
PurK Catalyzed Conversion of AIR to N 5-CAIR and Nonenzymatic Decomposition
to AIR Monitored by NADH Consumption. Assays contained in a final volume of
710 pL: 100 mM Tris-HCl (pH 7.8), 20 mM KC1, 4.5 mM MgC12, 1.0 mM ATP, 0.2
mM NADH, 2 mM PEP, 10 U PK, 10 U LDH, and 0.19 U purK. Reactions were
initiated with AIR (3-24 nmol) and run at 200C. The stoichiometry of NADH
consumption and the steady state rate of NADH consumption were calculated
using £340=6220 M -1 cm-1.
NMR Analysis of PurK Catalyzed Conversion of AIR to N 5-CAIR . Reactions
contained in a final volume of 560ptL: 50 mM Tris-HCl (pH 8.0), 15 mM KC1, 10
mM MgC12, 3 mM ATP, 3 mM KHCO3, 3 mM AIR, 3 mM PEP, 8 U PK and 0.4 U
PurK. Samples without enzymes were preincubated at 5 OC for 2 min. To each
sample was added PK, after which the reactions were initiated with PurK.
Reactions were quenched after 2 or 5 min by adding 140 pL 1M NaOD in D 20
(final pH 12.5), and then were rapidly frozen in liquid nitrogen until workup was
possible, within 3 h. A control using no enzyme was also run.
Samples were thawed, brought to dryness in vacuo, and then exchanged with
2 x 1 mL aliquots of D 20. After dissolving each sample in 700pL D 20, 1H NMR
spectra were collected.
Construction of Plasmid pEJM (PurE), Transformation to Generate
TX209/pEJM1, and Analysis for Growth. A 3 mL culture of E coli strain
TX635/pJS355 (Meyer et al., 1992) was grown overnight in LB media at 37 oC and
harvested by centrifugation (3,000 x g for 10 min). The cells were subjected to
alkaline lysis and their plasmid DNA was isolated using a Magic Miniprep kit.
The DNA was incubated for 16 h at 370C in 50 mM potassium acetate/20 mM
Tris-HOAc (pH 7.9), 10 mM Mg(OAc)2, 1 mM DTT, 10 U HpaI and 9 U MscI in a
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final volume of 48 gL. The desired fragment of DNA (3.57 kb) was purified on a
1% agarose gel and isolated using U.S. Bioclean. This DNA fragment (-1 plg) was
incubated with 50 mM Tris-HC1 (pH 7.6), 10 mM MgC12, 1 mM ATP, 1 mM DTT
5% (w/v) polyethylene glycol-8000 and 1 U T4 DNA ligase (BRL) in a final
volume of 20 4iL for 24 h at 14 OC. One-half of this mixture was used to transform
TX209 made competent with CaC12 (Sambrook et al., 1989) Transformants were
selected on LB plates containing ampicillin. Single colonies from these plates
were transferred, using a sterile toothpick, to plates made of minimal media
(M9), minimal media supplemented with 2g/L casamino acids (M9CA) and
M9CA supplemented with 20 mg/L hypoxanthine (M9CAHX) and analyzed for
their ability to grow at 37 oC. Colonies that grew were transferred into Klett
flasks containing 20 mL of liquid media supplemented with 50 gg/mL
ampicillin. The flasks were shaken at 37 oC, and cell growth was monitored
periodically using a Klett meter.
Reaction of CAIR with Chicken Liver PurE. An NMR experiment, similar to that
described with E. coli PurE, was run to determine if chicken liver PurE also
catalyzes the formation of N 5-CAIR from CAIR. Enzyme was exchanged into 300
mM Tris-HCl pH 7.8 in D 20 using a Centricon-30, and was assayed using a
spectrophotometric assay which follows CAIR degradation by monitoring the
decrease at A260 (Meyer et al., 1992). Assays were run at 20 C, and contained, in
1 mL, 300 mM Tris-HC1 (pH 7.8), 0.16 mM CAIR and chicken liver AIR
carboxylase. Rates were calculated using £260 = 10,500 M-lcm-1. The specific
activity of the enzyme sample was found to be 9.7 U/mg.
NMR reactions contained, in 700 gL, 300 mM Tris-HCl (pD 7.8) and 8.8 mM
CAIR. Bicarbonate, contained in the stock CAIR sample, was present in the
reaction at a final concentration of 24 mM. After an initial spectra was collected,
the reaction was initiated with 5.6 U chicken liver PurE. Spectra were recorded
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beginning 70 sec after enzyme addition every 30 s for the first 5 min, and at
various times thereafter up to 60 min after enzyme addition. Separate reaction
were also run using 0.6 and 0.06 U PurE. Enzyme was assayed after the NMR
experiments to insure it had remained fully active over the time of the
experiment.
The effect of chicken liver enzyme on the stability of N 5-CAIR was measured
using the spectrophotometric assay. Assays were run in a final volume of 1 mL
and contained 300 mM Tris-HCl (pH 7.8) and either 0 or 5.6 U (0.58 mg) chicken
liver PurE. After initiation with 100 nmol N 5-CAIR the A250 was monitored over
10 min.
RESULTS
Non-enzymatic Conversion of AIR to N 5-CAIR in the Presence of High
Concentrations of NaHC03-: Isolation and Characterization of N 5-CAIR. Alenin et
al. (1987) observed that incubation of Nl-methyl-4-carboxy-5-aminoimidazole
with 0.5 M potassium bicarbonate resulted in rapid formation of a new product
in equilibrium with the starting material (Scheme 5.3). This new compound
proved to be unstable; upon dilution it was rapidly converted back to starting
material. Both 13C and 1H-NMR spectroscopy were used to characterize this
product. The presence of both C2 and C4 protons suggested that a carboxylation
had most likely occurred on the exocyclic amine group. A similar reaction was
reported to occur with AIR, although no experimental data were provided. A
second set of experiments reported by these workers involved incubation of N 1-
methyl-4-carboxy-5-aminoimidazole or CAIR with 0.6 M KHCO3 at 70 oC for 20
min. New products were observed by 1H NMR and again assigned as the
carbamates of their corresponding exocyclic amines.
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These intriguing results provided the impetus for us to examine this process
in detail using AIR and 1M HC03-. Upon incubation of these compounds, a new
product was generated so rapidly that the reaction was complete before the first
NMR spectrum could be acquired. After an extended period of time (> 70 h),
CAIR was also observed. (See Fig 5.3 for representative spectra of these three
species.) Under the conditions of the experiment (1 M bicarbonate, 4 OC), the
production of CAIR is pseudo first order in HC0 3-, with a rate constant of 1.0 +
0.03 x 10 -2 h -i (tl/2 = 69 h, Fig 5.1). This rate constant is similar to the previously
reported value for the conversion of AIR to CAIR (4.2 x 10-2 h- 1) when the
differences in reaction conditions are considered (Meyer et al., 1992). At that
time we did not realize that AIR was rapidly converted to a new product now
designated N 5-CAIR, which is converted directly or indirectly to CAIR.
The amount of N 5-CAIR produced is roughly proportional to the concentra-
tion of HC03 ' in solution (Table 5.1). The observation that 75% of the AIR can
Table 5.1 N 5-CAIR Produced with Increasing Bicarbonate.
HC03- (M) %N 5-CAIR produced
0.18 17%
0.60 37%
1.1 75%
be converted to N 5-CAIR at -1 M bicarbonate, suggested to us that N 5-CAIR
might be isolable. Studies on a variety of carbamate analogs, as models for
carboxybiotin, revealed that most carbamates are moderately stable under basic
conditions (Caplow, 1968). Our strategy was therefore to incubate AIR with 1 M
HC03-, then rapidly adjust the solution to pH 12-14 and separate the carbamate
from the starling material and excess bicarbonate using anion exchange
chromatography on Dowex-1-X8 (OH form). N 5 -CAIR was isolated in nearly
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Figure 5.1: Rate Constant for CAIR Formation from AIR and HCO3'. The
formation of CAIR was monitored by NMR from an initial reaction mixture of 29
mM AIR and 900 mM HCO3-in a sealed tube. Both the appearance of Cl' (o) and
C2 (A) protons of CAIR were monitored from their first appearance (at 70 h after
initiation of the reaction) over the next 100 h (kobs = 1.0 + 0.03 x 10-2 h-l). Lines
were fit using a least squares analysis with R 2 = 0.976 (C') and R 2=0.987 (C2).
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homogeneous form using this methodology. The 1H and 13C spectra (Fig 5.2A) of
the purified samples were as expected (Materials and Methods).
While the studies of Alenin et al. (1987) strongly suggested that N 5-CAIR was
a carbamate, and our NMR spectra are consistent with this proposal, further
evidence was sought to define its structure. We therefore prepared [15N 5]-AIR,
biosynthetically by a procedure outlined in Scheme 5.5. This compound was
incubated with H 13CO3-, and a 13C spectrum taken. A new signal was generated
in the region of the putative carbamate, and is recorded in Fig 5.2C. Comparison
to the 13C resonance generated using unlabeled AIR (Fig 5.2B) reveals a 13C-15N
coupling constant of 19.7 Hz , consistent with a one-bond couple and
unambiguously defining the structure as the predicted carbamate (Levy &
Lichter, 1979).
It must be pointed out that the H4 proton of AIR can exchange with solvent
(Schendel, 1986). Therefore, spectra recorded from D20 solutions show no H4
resonance, while samples containing H 20 show H4 signals that are reflect the
H 20/D 20 composition of the solvent. The rate of exchange at this position is a
function of pH, and slows dramatically at either pH extreme.
Stability of N 5-CAIR. Once N 5-CAIR had been characterized structurally,
several assay methods were developed to examine its chemical stability. This
knowledge is a prerequisite for examining the interaction of N 5-CAIR with PurE
and PurK. N 5-CAIR, in the absence of HCO3-, is rapidly converted to AIR as
determined by NMR spectroscopy (Alenin et al, 1987). Furthermore, the molar
absorptivity of N 5-CAIR at 250 nm is substantially lower than for AIR (N5-CAIR
= 800 M-1 cm,£AIR _ 3400 M-1 cm- l at pH 7.8) (Meyer et al., 1992; Alenin et al,
1987) and has provided the basis for a spectrophotometric assay to study
stability. The rate of N 5-CAIR decomposition was determined as a function of
pH and temperature (Table 5.2). The tl/2 for N 5-CAIR at 30 °C and pH 7.8, is
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Figure 5.2: 13C NMR of [15N-NH 2]-AIR with 13C HCO3. Spectrum 2A.
Natural abundance 13C NMR spectrum of N 5-CAIR prepared by incubating
HCO3- with AIR. Assignments: 167.3 (KHCO3), 161.6 (s, C6), 133.5 (s, C5),
127.7 (s, C2), 122.7 (s, C4), 86.5 (s, C1'), 82.5 (d, C4', J POCH2CH = 8.0 Hz), 73.7 (s,
C3'), 69.3 (s, C2'), 63.1 (d, C5', J POCH2 = 5.3 Hz). Spectrum 2B. The 161.6 ppm
resonance of the carbamate N 5-CAIR. Spectrum 2C. The carbamate carbon
produced from [15N-NH 2]-AIR incubated with [13C]-HC03- (J=19.7 Hz).
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-0.7 min, with its stability decreasing with decreasing pH. The chemical
instability explains the lack of its previous characterization as an intermediate in
the purine biosynthetic pathway.
Table 5.2: Stability of N 5-CAIR versus (A) pH and (B) Temperature
(A) pH k (min- l) (B) temp (C) k(min 1l )
7.5 0.83 1 0.117
7.8 0.51 5 0.168
8.1 0.32 10 0.285
8.2 0.24 20 0.53
8.5 0.14 30 0.975
8.9 0.05
(A) Reactions run in 300mM Tris-HCl, 25 °C
(B) Reactions run in 200mM Tris-HCl (pH 7.8), 20 mM KC1
PurE Catalyzed Conversion of CAIR to N 5-CAIR. With the availability of large
amounts of PurE, and our knowledge of the stability of N 5-CAIR, we set out to
examine by NMR spectroscopy the PurE catalyzed conversion of CAIR to
N 5-CAIR (Scheme 5.4), the reverse of the physiological reaction. We predicted
that N 5-CAIR, once its generated by PurE, would rapidly decompose to form
AIR in a non-enzyme dependent fashion. As indicated in Fig 5.3, the C1' proton
resonances of CAIR, N 5-CAIR and AIR ( 5.6 to 5.8 ppm) are separately
observable using 500 MHz 1H-NMR spectroscopy. In addition, the C2 protons
(7.5-8.1 ppm) of all these species are separable, as are the C4 protons (data not
shown) of N 5-CAIR and AIR. The number of units of PurE and the temperature
of the reaction were chosen to facilitate kinetic analysis by NMR spectroscopy.
Typical NMR spectra are shown in Fig 5.3 In Fig 5.3A is displayed the spectrum
of CAIR in the absence of PurE. Upon addition of enzyme, new resonances are
observed at 5.67 and 8.06 ppm, attributed to the Cl' and C2 protons of N 5-CAIR,
respectively (Fig 5.3 B) The kinetics of CAIR decomposition and AIR production
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Figure 5.3: PurE Dependent Generation of N 5-CAIR from CAIR. Assignments:
8 8.06 ppm (C2 N 5-CAIR), 7.91 (C2 AIR), 7.52 (C2 CAIR), 5.72 (C1' AIR), 5.67 (C'1
N 5-CAIR) and 5.64 (C1' CAIR). Differences in chemical shifts are attributable to
the different pH conditions of the samples. Spectrum 3A. A zero timepoint in
which only CAIR (and a small amount of contaminating AIR) is present.
Spectrum 3.B. A 1.5 min timepoint after addition of PurE reveals that N 5-CAIR
has formed along with a small amount of breakdown product, AIR. Spectrum
3.C. A 20 min timepoint after addition of PurE reveals a nearly completed
reaction, with AIR as the major species.
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are shown in Figure 5.4. The data have been fit by computer to Scheme 5.5
giving values of kl = 0.18 minl, k-1 = 0.12 min-1, k2 = 0.26 min- l, k-2 = 2.8 x 10-4
min-l in 300mM Tris-HC1 (pD 8.0). The rate of conversion of CAIR to N 5-CAIR
was shown to be dependent on the concentration of PurE, while the rate of
conversion of N 5-CAIR to AIR was found to be independent of PurE. The rate
kl k 2
CAIR N5-CAIR = AIR+ HCO3'
k.1 k-2
Scheme 5.6: Model of Enzymatic Formation of NS-CAIR and subsequent
non-enzymatic degradation to AIR.
constant for the decomposition of N 5-CAIR (k 2), under these conditions, is
virtually identical to that determined as described above, when pH differences,
temperature, and ionic strength are taken into account. Thus PurE catalyzes the
conversion of CAIR to N 5-CAIR as predicted by our model (Scheme 5.4).
PurK Catalyzed Transfer of [180]from HC1 803- to Pi. The model in Scheme 5.2
predicts that, as in biotin dependent reactions (Knowles, 1989), the function of
ATP and HC03- is to generate the elusive carboxyphosphate. HC1803- was
prepared by incubating bicarbonate in H 2180 using the rate constants for
exchange of Knoche (1980) and Faurholt (1925), and its 180 content established
(Material and Methods). Incubation of HC180 3 with ATP and PurK in the
presence of 1 mM AIR gave the 31p NMR spectrum shown in Fig 5.5. Spectrum
5.5B displays the -phosphates of ATP and ADP and that 8% of the ATP has been
hydrolyzed during the reaction. Spectrum 5.5C shows the resolution of signals
for carrier [p160 4]2- at 3.44 ppm and [180p 160 3]2- at 3.42 ppm. Quantitation of
the amount of [180P160 3 ]2 - generated revealed that -one atom of 180 was
transferred from bicarbonate to phosphate for every ADP generated. The
amount of phosphate produced was limited by the amount of AIR (1 mM) in the
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Figure 5.4: Kinetics of PurE dependent conversion of CAIR to N 5-CAIR
followed by nonenzymatic conversion of N 5-CAIR to AIR. NMR spectroscopy
(Figure 5.3) allows monitoring of the reaction species: CAIR (X), N 5-CAIR (o)
and AIR ( ). The lines are a non-linear least squares fit to Scheme 5.6 where
kl=0.18min- 1, k-1=0.12min -1, k2=0.26min -1, k 2=2.8x10 4 min -1. Error bars reflect
integration errors.
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Figure 5.5: 31 p NMR Spectrum Showing the Products of PurE Reaction with
HC180 3-. Spectrum 5.A. Spectrum after completion of the reaction of 1mM AIR,
HC180 3- and 11.4 mM ATP with 1.8 units of PurK. The sample contained 2.3
mM carrier Pi. Assignments: 6 4.54 (broad, AIR), 3.44 (Pi), -4.30 (d, J = 31 Hz, yP
ATP), -4.81 (d, J = 36 Hz, DP ADP), -9.32 (d, broad, J = 36 Hz, aP ADP), -9.92 (d,
broad, 31 Hz, cP ATP), -19.64 (t, J = 31 Hz, [P ATP) Spectrum 5.B. Expanded
region at -3 to -5 ppm reveals that only - 8% of the ATP has been hydrolyzed to
ADP. Spectrum 5.C. Expanded region at 3.4 ppm reveals 71% p16043 - (3.44
ppm) and 29% p 180 16033- (3.42 ppm).
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reaction mixture. Control reactions containing 0.1 mM AIR or no PurK revealed
no perturbation of the chemical shift of the phosphate in the 31p NMR spectrum.
These results are consistent with the intermediacy of carboxyphosphate (Scheme
5.4).
PurK Catalyzed Conversion of AIR to N 5-CAIR in the Presence of ATP. The
following experiment was designed to show the formation of N 5-CAIR catalyzed
by PurK (Scheme. 5.7). Our hypothesis predicts that incubation of small amount
PK/LDH
ATP + HCO3'+ AIR N5-CAIR + Pi + ADP ATP
nonenzvmatic ATP
NADH NAD+
PEP pyruvate
Scheme 5.7: Evidence for the Formation of N5-CAIR
of AIR with an excess of ATP, HCO3' and PurK should produce a burst of
N 5-CAIR, Pi and ADP. The latter can be monitored using a PK/LDH coupled
assay which follows NADH consumption. If sufficient PurK is present, then the
rate determining step in the reaction will be the non-enzymatic decomposition of
N 5-CAIR to AIR. This rate constant can be measured by the slow rate of
consumption of NADH subsequent to the burst and can be compared to the rate
of decomposition determined as described above. The results of an actual
experiment in which the consumption of AIR is monitored by the AA340 of
NADH oxidation is shown in Fig 5.6. The initial burst is followed by a slower
rate of NADH consumption. The observed bursts are equivalent to the amount
of AIR present, while the slow rates of NADH consumption are independent of
the concentration of PurK and reflect the pseudo first-order decomposition of N 5-
CAIR (Table 5.3). These results, obtained by Erik Meyer, support our hypothesis
that PurK catalyzes the formation of N 5-CAIR.
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Figure 5.6: PurK catalyzed conversion of AIR to N 5-CAIR as monitored by a
coupled assay using PK/LDH and consumption of NADH. The kinetics
initially exhibit a rapid, AIR dependent burst of NADH consumption followed
by a slower rate which reflects non-enzymatic conversion of N 5-CAIR to AIR.
Traces A, B and C represent assay solutions in which AIR was added in
increasing amounts (3, 7 and 16 nmoles, respectively). Both the initial burst, and
the final steady state rate of NADH consumption are proportional to the amount
of AIR added.
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Table 5.3: Evidence for N 5-CAIR Formation by PurK Using a Coupled Assay
AIR added NADH Rapidly Steady State NADH
(nmol) Consumed (nmol) Consumption (min-1)
3.2 3.5 0.44
5.9 5.2 0.40
11.9 12.9 0.39
23.9 23.6 0.40
Detection of PurK Catalyzed Formation of N 5-CAIR by NMR Spectroscopy. The
experiments described in the previous sections all corroborate the model
proposed in Scheme 5.4. It remained to be shown, however, that the compound
whose formation is responsible for the burst of NADH consumption is in fact
N 5-CAIR. Thus, an experiment was set up under conditions identical to the
"burst" experiments described above, so that N 5-CAIR could be detected by
NMR spectroscopy. The reaction was quenched with base to a final pH of 12.5 to
decrease the rate of N 5-CAIR decomposition. The results of this experiment are
shown in Figure 5.7, and shows the formation of a new compound with signals at
8.00, 6.82, and 5.59 ppm (Spectrum 7B). N 5 -CAIR at pH 14 (spectrum 7C) gives
an almost identical spectrum with signals at 7.98, 6.83, and 5.63 ppm. The small
differences in chemical shift between the two spectrum are most likely due to the
differences in the sample conditions. In addition, it should be noted that the AIR
used in this reaction was from a D20 solution, and thus the signal for the C4
proton of AIR reflects the extent of exchange at this position (Fig 5.7A).
Likewise, the substoichiometric amounts of C4 proton in the C5-CAIR spectrum
(Fig 5.7B) is a consequence of the exchanged starting material and not due to
exchange during the reaction or workup. We conclude the product formed in the
PurK reaction is N 5-CAIR Thus, direct evidence is provided that PurK catalyzes
formation of N 5-CAIR.
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Figure 5.7: PurK catalyzed conversion of AIR to N 5-CAIR monitored by NMR
spectroscopy subsequent to quenching at pH 13. Spectrum 7A. The reaction
mixture prior to the addition of enzyme. Assignments: 8 8.56 (C8, ATP), 8.28
(C2, ATP), 7.69 (C2, AIR), 6.45 (C4, AIR), 6.06 (d, J = 6 Hz, C', ATP), 5.56 (d, J =
6.9 Hz, C1', AIR), 5.39 (s, C3, PEP), 5.21 (s, C3, PEP). Spectrum 7B. PurK was
added to initiate the reaction which was quenched after 2 min by adjusting the
pH to 13. New peaks (indicated by arrows): 7.96 (s, C2, N 5-CAIR), 6.82 (s, C4,
N 5-CAIR), 6.02 (d, J = 6 Hz, Cl', ADP), 5.58 (d, J = 5.0 Hz, Cl', N 5-CAIR).
Spectrum 7C. Spectrum of N 5-CAIR at pH 14. Assignments: d 7.98 (s, C2,
N 5-CAIR), 6.83 (C4, N 5-CAIR), 5.63 (d, J = 4.8 Hz, C', N5-CAIR). Differences in
the new peak and the N 5-CAIR standard are attributed to the pH differences in
the two samples.
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Characterization of pEJMI and Growth of E. coli TX209/pEJM1. The avian and
methanobacteria genes for PurE were all cloned by complementation to an E. coli
purK- strain, TX209 (Chen et al., 1990; Hamilton & Reeve, 1985a, b). A plasmid
containing E. coli purE was constructed and transformed into TX209 to determine
if it could overcome purine auxotrophy. pJS355, containing both purE and purK
,was digested with two restriction enzymes and the resulting 3.75 kb fragment
religated, subsequent to purification, to form a new plasmid, pEJM1. This
plasmid contains purE and 84 bps of purK, verified by restriction digestion
analysis. When pEJM1 was transformed into a purK- strain, TX209 growth
occurred on M9CAHX, producing visible colonies after only 12 h at 37 oC.
TX209/pEJM1 was also able to grow very slowly at 37 oC on M9CA media.
Small colonies were visible after 3 days. The host TX209 did not show colony
formation under the same conditions. However, all attempts to grow these
bacteria in liquid M9CA media failed, with no growth seen in numerous
attempts even though the cultures were incubated for up to five days. This result
strongly suggests that overproduction of PurE can not compensate for the
purK-phenotype in E. coli.
Reaction of Chicken Liver PurE with CAIR. The avian enzyme was found to
catalyze the conversion of CAIR to AIR, but unlike the E. coli enzyme, no N 5-
CAIR was observed during this conversion. Fig 5.8 shows the result of adding of
5.6 U avian PurE to CAIR. The enzyme catalyzed the complete conversion of
CAIR to AIR within 70 s, the first timepoint, without any evidence of N 5 -CAIR
formation. The half-life of N 5-CAIR under the conditions of this reaction was
determined to be -2 min, and thus if the carbamate were formed it would be
stable enough to observe. This finding suggests that the mechanism of the E. coli
and avian enzymes are different.
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Figure 5.8: Catalysis of CAIR to AIR by Chicken Liver PurE. Spectrum 8A.
Initial spectrum of 8.8 mM CAIR in 300 mM Tris-HC1 (pD 7.8) before enzyme
addition. Assignments: d7.45 (s, C2, CAIR), 5.55 (d, J = 6.6 Hz, Cl', CAIR).
Spectrum 8B. Spectrum 70 s after addition of 5.6 U avian PurE. Assignments:
d7.84 (s, C2, AIR), 5.63 (d, J = 6.6 Hz, Cl', AIR). No N 5-CAIR resonances are
evident, which would appear at 6 -8.0 (C2, N 5-CAIR) and ~5.58 (Cl', N 5-CAIR).
Differences in chemical shifts from reported values are attributed to changes in
pH and ionic strength.
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DISCUSSION
In 1992, Meyer et al. reported that PurK catalyzes ATP hydrolysis at a high
rate, 80 pumol min-lmg-1 at 37°C. The intriguing, but at the time, inexplicable
observation was that this reaction was absolutely dependent on the presence of
AIR, which did not appear to be consumed during this reaction. This
observation remained confusing until we became aware of the important
experiments reported by Alenin et al. in 1987. Their studies suggested that
N-substituted carbamates of 5-aminoimidazole derivatives could be rapidly
generated, in a chemical process from aminoimidazole derivatives in 1 M HCO3-
solutions. Furthermore, their studies revealed that on dilution of these HCO3'
solutions, the putative carbamates decomposed back to starting aminoimidazole
derivatives. Their observations provided an explanation for our observation of
AIR dependent ATPase activity and allowed us to formulate a new biosynthetic
pathway for CAIR production in E. coli (Scheme 5.4) which has been established
by the experiments reported herein.
Our initial efforts focused on the isolation and structural characterization of
the compound produced when 1M HCO3- was incubated with millimolar
concentrations of AIR. Studies of Caplow (1968) on model carbamates for biotin-
dependent decarboxylations provided the insights needed about carbamate
stability to successfully complete these tasks. 1H, 15N, and 13C-NMR
experiments (Fig 5.2) indicate that this species is the N 5 -carbamate of AIR.
Kinetic analyses, both spectrophotometric and enzymatic assays performed by
Erik Meyer, have shown that its half life in solution at 30 °C, pH 7.8, is 0.7 min.
We were thus in a position to characterize the role of N 5-CAIR in purine
biosynthesis. The availability of large amounts of PurK and PurE (Meyer et al.,
1992) and of homogeneous N 5-CAIR, albeit at pH 12, allowed us to test two
hypotheses using NMR spectroscopic methods. The first is that PurK catalyzes
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conversion of AIR, ATP, and HC03- to N 5-CAIR, ADP, and Pi and the second is
that PurE catalyzes the reversible interconversion of N 5-CAIR and AIR.
The instability of N 5-CAIR made the experiments to test these hypotheses
challenging. As shown in Fig 5.7, however, PurK does catalyze the formation of
a new, "unstable", species with a 1H-NMR spectrum identical to that of N 5-CAIR.
An explanation for our previously reported AIR-dependent ATPase catalyzed by
PurK is now readily apparent. PurK catalyzes the stoichiometric conversion of
ATP and AIR to ADP, Pi, and N 5-CAIR. The N 5-CAIR, however, rapidly
undergoes non-enzymatic breakdown to regenerate AIR, which can then be used
to promote the hydrolysis of additional molecules of ATP. Thus, millimolar
quantities of ATP can be consumed in the presence of catalytic quantities of
CAIR.
The instability of N 5-CAIR also rendered detection of the PurE catalyzed
conversion of N 5-CAIR to CAIR challenging. Both 1H-NMR and kinetic
experiments were undertaken to examine this reaction. Using NMR
spectroscopy, we examined the PurE catalyzed conversion of CAIR to N 5-CAIR.
CAIR is stable, and conditions of temperature and pH were carefully chosen so
that N 5-CAIR formation would be detectable using this methodology. These
studies (Fig 5.3 - 5.4) unambiguously established that PurE catalyzes the
conversion of CAIR to N 5-CAIR, which non-enzymatically and irreversibly
decomposes to AIR.
An additional proof that N 5-CAIR is indeed a substrate for PurE has been
found in enzyme kinetic studies performed by Erik Meyer. He has determined
the Km and Vmax for N 5-CAIR with PurE, a difficult set of experiments as assay
conditions required appropriate pH control, as well as selection of a temperature
that minimized interference by the decomposition of N 5-CAIR. The assays were
carried out in 100 mM Tris buffer (pH 7.8) and 20°C. The half-life for
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decomposition of N 5-CAIR in the assay mixture was determined to be 3 min.
Under these conditions the KmN5-CAIR is -140 gM and the Vmax is -100
gmol/min/mg. The Km for AIR under these conditions with 180 mM HC 3 -
was recently redetermined by Erik Meyer to be 100 M.
The observation that N 5-CAIR is a substrate for PurE seems contradictory to
the report by Meyer et al. (1992) that AIR in the presence of high concentrations
of HC03- (180 mM) is a substrate for PurE. The recent revelation, however, that
N 5-CAIR is the product of the rapidly non-enzymatic reaction between AIR and
HC03- provides an explanation for these results. Under these conditions, 1H
NMR spectroscopy reveals that the ratio of N 5-CAIR to AIR is 0.16: 0.84,
suggesting that the actual substrate for PurE is N 5-CAIR and not AIR. Using this
information, one can calculate a predicted Km of N 5-CAIR for PurE, which is 16
percent of the 100 pM Km for AIR, or 16 piM. The reason for this discrepancy
between the determined and calculated Kms is unknown, and is the major
contradictory evidence against the model for "AIR carboxylase" activity shown
in Scheme 5.4. Work continues to understand the reason for these differences.
Our previous studies defining the requirement for ATP in the "AIR
carboxylase" reaction in conjunction with the results presented herein require the
addition of a previously unrecognized intermediate designated N 5-CAIR and
two new enzymatic activities to the purine biosynthetic pathway in E. coli. We
propose to designate PurK as N 5-CAIR synthetase and PurE as N 5-CAIR mutase
or isomerase depending on the chemical mechanism which remains to be
established.
This new understanding of the roles of PurE and PurK in the E. coli pathway
leads to the question of their significance in the purine biosynthetic pathways of
all organisms. The answer to this question remains to be determined
unambiguously, but information described subsequently allows us at present to
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favor the hypothesis that at least in avian systems and methanogens, alternate
methods of CO2 fixation may have evolved.
The purE and/or purK genes have been cloned from a variety of organisms,
usually by complementation into an appropriate E. coli or S. cerevisiae strains.
The homology of these enzymes to those in E. coli, and their genetic organization
are set forth in Table 5.4. The alignment of these PurK and PurE sequences are
shown in Fig 5.9 and 5.10, respectively. The enzymes fall into two categories. B.
subtilis and yeast express enzymes that have homology with E. coli purE and purK
, and these genes can be made to compliment either purE or purK deletions. H.
sapiens purE also has been cloned and found to compliment ada2B (purE)
deficient yeast, but not yeast with ada2A (purK) deletions (Minet & Lacroute,
1990). The origins of the mutants used in these complementation experiments is
not well described, and this ambiguity cast doubt on these findings. In contrast
to the above organisms, AIR carboxylase cloned from chicken (Chen et al., 1990)
and two different methanogens, M. smithii and M. thermoautotrophicum (Hamilton
& Reeve, 1985a, b) compliment both purE- and purK' strains, yet the responsible
gene from these organisms is homologous only to purE; there is no apparent
homology to purK. The fact that chicken lacks a purK gene equivalent but can
compliment E. coli purK deleted strains been noted by Chen et al. (1990). The
authors suggested that either the function had been incorporated into the purE
domain, or the activity was not needed in chicken.
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Figure 5.9: Alignment of PurK from Different Sources. Alignment made using
the program Compare (Maizel & Lenk, 1981) between E. coli, B. subtilis, S.
cerevisiae, S. pombe, and Synechococcus sp.. Positions with identical residues for
four of the five sequences are indicated with a capital letter, and are recorded on
the consensus line. The literature source for each of these sequences is listed in
Table 5.4.
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Figure 5.10: Alignment of PurE from Different Sources. Alignment made
using the program Compare (Maizel & Lenk, 1981) between chicken, human, E.
coli, B. subtilis, S. cerevisiae, S. pombe, M. smithii and M. thermoautotrophicum.
Positions with identical residues for seven of the eight sequences are indicated
with a capital letter, and are recorded on the consensus line. The literature
source for each of these sequences is listed in Table 5.4.
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Table 5.4: Homology to E. Coli PurE and PurK in other organisms
organism genetic % homology PurE % homology PurK
construction identity similarity identity similarity
Synechococcus sp. a pur- - 28% 61%
B. subtilis b purE purKpurBi 58% 83% 24 52
S. pombe c purK purE 48 84 23 57
S. cerevisiae d IPur puree 43 80 26 57
human e [urC purE 22 59 - --
chickenf pu--rV' 23 64 - --
M. thermoautotrophicum g purE 38 71
M. smithii h purE 38 74 - -
a. Schwarz et al. (1992), accession number M91187.
b Ebbole & Zalkin (1987), accession numbers P12044 (purE), P12045 (purK).
c Szankasi et al. (1988), accession number P15567.
d Sasnauskas & Janulaitis (1992), accession number M58324.
e Minet & Lacroute (1990), accession number P22234.
f Chen et al. (1990), accession number A35641.
g Hamilton & Reeve (1985b), accession number X03250.
h Hamilton & Reeve (1985a), accession number P22348.
Both the methanogen and chicken complementation studies were performed
with TX209. One possible explanation for these anomalous complementation
experiments with chicken and the methanogen constructs is that expression of
heterologous PurE by transformed E. coli TX209 allowed non-enzymatically
produced N 5-CAIR to be converted to CAIR in amounts sufficient to overcome
purine auxotrophy. To test this hypothesis, E. coli PurE was re-engineered into a
multicopy plasmid, transformed into E. coli TX209, and examined for its ability
to suppress this strain's requirement for purines. The results indicate that purine
auxotrophy can not be overcome by overproduction of E. coli PurE. Therefore,
this argument can not be used to explain the complementation of E. coli purK-
strains by chicken liver PurE (Chen et al., 1990).
The cloning and expression of the avian AIR carboxylase (Chen et al., 1990)
allowed its overexpression and purification to homogeneity (Davisson,
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unpublished results). An NMR experiment was therefore designed to monitor
the reaction of CAIR with this enzyme. Preliminary results (Fig 5.8) indicate that
CAIR is rapidly converted to AIR in the presence of avian PurE without forming
N 5-CAIR. Control experiments revealed that under these conditions N 5-CAIR
should have been detected had it been produced. These results provide the
strongest evidence that carboxylation, in at least the avian system is different
from E. coli. Biochemical studies of carboxylases from avian liver, methanogens
and other organisms are essential to address their mechanistic similarities and
differences with the carboxylation system from E. coli.
Regardless of the mechanism of CAIR biosynthesis in avians and
methanogens, this new twist in the E. coli pathway returns us to a long standing
unresolved problem in carboxylation chemistry: the mechanism by which
carboxybiotin and now N 5-CAIR delivers C02 to its substrate(s). There are
striking similarities and a few differences in these two CO2 delivery systems
(Knowles, 1989). Both are chemically unstable: carboxybiotin has a half-life of
105 min at pH 8, while N 5-CAIR has a half-life of 0.7 minutes under
physiological conditions. Carboxybiotin and N 5-CAIR are both generated in
ATP dependent processes which presumably generate carboxyphosphate. In
both cases the existence of carboxyphosphate has been inferred by incorporation
of 180 from HC180 3- into Pi. In biotin dependent reactions, the biotin
dependent carboxylase activity is on a separate subunit from that required to
catalyze the carboxy-biotin dependent carboxylation of substrate. The two
subunits, as well as the biotin carboxyl carrier protein are part of a multienzyme
complex. While a second protein (PurE) is required to catalyze the formation of
CAIR from N 5-CAIR as the substrate, in contrast to the biotin requiring systems,
there is no evidence that PurE and PurK are subunits of the same enzyme.
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Finally, the mechanisms by which carboxybiotin and N 5-CAIR deliver their
CO2 to their respective substrates are unprecedented chemically. In the case of
the N 5-CAIR system the problems associated with removing HC03- from
solutions, due to the acid instability of both CAIR and N 5-CAIR will make
mechanistic studies very challenging. Whether the CO2 is transferred from
N 5-CAIR to produce CAIR through a C02 intermediate or an enzyme bound
carbamate and whether the carboxylate of the carbamate of N 5-CAIR becomes
the C4-carboxylate of CAIR are still unresolved questions that will require
further experimentation.
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Appendix A
Following are four 1H NMR spectra, taken of compounds 5-8 in Scheme 2.3
Spectrum A.1: 1H NMR of 1'-N-(Benzyloxycarbonylglycyl)-2', 3'-0 -
isopropylidene-D-ribofuranosylamine 5' dibenzylphosphate (5). Taken in CDC13
with TMS as a standard.
Spectrum A.2: 1H NMR of 2', 3'-O-isopropylidene-1'-N-(glycyl) -D-
ribofuranosyl-amine 5' phosphate (6). Taken in D 20 with TPS as a standard.
Spectrum A.3: 1H NMR of ac3 glycinamide ribonucleotide (/ GAR) (Z).
Exchanged into the potassium form. Taken in D20 with TPS as a standard.
Spectrum A.4: 1H NMR of aJ3 formylglycinamide ribonucleotide (/[ FGAR)
(8). Taken in D 20 with TPS as a standard. Note triethylamine excess.
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Appendix B
Below are the experimentally measured loop sizes used in these experiments,
determined using 32p as described in the manual (8 Dec 88).
loop # volume (L)
used in this work
1 14.4 ± 0.85
2 29.4 + 1.32
3 57.8±2.14
4 89.9 ±2.72
5 132.8 ± 4.58
6 172.4± 5.81
7 221.6 ± 6.27
8 268.8 ± 7.31
sample A 46.3 + 1.55
sample B 41.6 + 1.71
exit line 64.8 + 1.86
load A 35.5 ± 2.34
load B 34.2 ± 2.36*
*loading of loops A and B vary from individual to individual, and should be
determined by each different operator.
In addition, it was determined that the push syringes A and B delivered
2.0964±0.0041 gL per step.
Calibration of the rapid quench machine was accomplished by measuring the
rate constant for base catalyzed hydrolysis of 2,4-dinitrophenyl acetate. The
determined rate constant of 31 M-1 s-1 compared reasonably well to the
published value of 50 M-1 s-1 (Froehlich et al., 1976; Berger, 1964). The error in
the determined rate constant is due to a small (6%) uncertainty in the measuring
the too value.
Froehlich, J. P., Sullivan, J. V., and Berger, R. L. (1976) Anal. Biochem. 73, 331-41.
Berger, R. L. (1964) in Rapid Mixing and Sampling Techniques in Biochemistry.
(Chance, B. Eisenhardt, R. H., Gibson, Q. H., Lonberg-Holm, K. KI eds.) p363,
Academic Press, NY.
256
Appendix C
Isolation of M13 ssDNA
Innoculate 2.5mL of a log growth culture of TG1 with 500pL of M13 infectious
stock. Let sit for 5 min, then add to a sterile 200mL LB culture and shake at 37oC
for 5h. Harvest infected cells by spinning at 4000 x g or 15 min at 4oC. Use
supernatant for prep.
1. To supernatant of M13/TG1 growth at 0.2 volumes of 20% (w/v) PEG 8,000,
2.5 M NaCl. Stir well for > lh (may stir overnight which affords slightly better
yields). Spin at 5000xg for 20 min at 4oC.
2. Discard supernatant and respin the pellet to remove excess media at 5000xg
for 5min at 4oC.
3. Blot out all liquid and redissolve the DNA in 500p.L TE buffer. Place in a 1.5
mL sterile eppendorf and spin in an epifuge at 4oC for 5 min.
4. Decant the supernatant and add 200p1L of the PEG/NaCl solution. Mix by
inverting the tube several times. Let stand at room temperature for 5 min, then
spin in an epifuge at room temp for 5 min.
5. Remove the supernatant with an aspirator, and wipe out all remaining
PEG/NaCl with a Kimwipe. Dissolve in 500gL of TE.
6. Add 200p.L of phenol saturated with TE. Vortex 15-20 sec, then allow to sit at
room temp for -15 min. Vortex again, as above and spin for 3 min in an epifuge.
Remove and discard the lower, pheol layer using a pipette. Repeat this one more
time (two times total).
7. Transfer to a clean eppendorf. Add 500gL of ethyl ether. Mix well and spin
briefly (- 1min). Remove and discard top layer. Repeat three more times (four
times total).
8. Transfer to a dean eppendor tube. Add 500gL of 24:1 chloroform:isoamyl
alcohol. Mix by inverting several times and spin briefly (- 1min). Remove and
discard lower layer. Repeat once more (two times total).
9. Transfer to a 2mL eppendorf tube and add 50gL 3M NaOAc (pH 5.2) After
adding 1.25mL EtOH (room temperature), a white precipitate should form. Place
tube at -80oC for 20 min and spin 15min in epifuge at 4oC. Discard the
supernatant and carefully wash the pellet with 500gL room temperature EtOH.
Remove all traces of alcohol, invert and let dry at room temperature for -10 min.
10. Dissolve in 100gL TE buffer. A260 = 1 for 40gg/mL DNA
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Solutions to be prepared beforehand:
TE Buffer: 10 mM Tris-HCl (pH 8.0), 1mM EDTA
PEG/NaCl: 20% (w/v) PEG 8000, 2.5 M NaCI
Phenol saturated with TE
Chloroform:isoamyl alcohol 24:1
3M NaOAc (pH 5.2)
-20oC Ethanol
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Appendix D
Construction of plasmid pJS119
756 Sfr 
726 PpuM I
726 EcoO109 
671 EcoR I
665 Cia 
601 EcoN 1
478 BlaB 
416 89gl I
412 Xho I
412 PZR7 I
412 Ava I
405 Nru I
235 Nar I
235 Ras r
235 Wbe I
183 Nde I 1102 
1 II ii l l !
:1 I 1861
I
pJS119
Sc
Spl I
2721
2715
2715
2709
2703
I
5021 base pairs
Pst I
Sal I
Ace I
xba I
BarH 
4052 bs& 1 4973 Aac II
3794 B8a I 4533 Sca I
!, 
Unique Sites
683
939
BamH I 2703
Plasmid name: pJS119
Plasmid size: 5021 bp
Constructed by: A. Shiau & J. M. Smith
Construction date:
Comments/References: Inglese, J., Johnson, D. L., Shiau, A., Smith, J. M.
& Benkovic, S. J. (1990) Biochemistry, 29, 1436-43.
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